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Abstract
Toxicity Evaluations of Nanoclays and an Associated Nanocomposite
throughout their Life Cycle
Alixandra Wagner
Nanoclays are layered mineral silicates that originate from the clay fraction of soil and
carry a platelet thickness of about 1 nm and lengths and widths of up to several microns. Due to
their nanoscale dimensions, they have been used for numerous applications ranging from media
for oil well drilling to sorbents in treatment of waste-water. Additionally, upon functionalization
with organic modifiers, nanoclays have been incorporated into polymers to form nanocomposites
with increased mechanical strength, barrier properties, UV dispersion, and fire resistance to be
implemented in food packaging or medical devices related applications. Such increased
implementation into industrial and commercial products has brought scrutiny onto nanoclays and
associated nanocomposites toxicity. Previous studies have shown for instance that nanoclays
induce cytotoxic and genotoxic effects upon cellular or model animal exposure, however little
investigations were performed to identify how nanoclay functionalization may influence such
toxicological profiles. Moreover, most of the studies related to nanoclays and nanocomposites
toxicity only refer to their consumption/usage exposure and fail to assess manufacturing or
disposal exposures.
Herein, we aimed to understand how the physical and chemical properties of nanoclay
systems (i.e. pristine and organically modified, along with a nanoclay-enforced nanocomposite) in
both their as-received (mimicking manufacturing) and thermally degraded (mimicking end of life
cycle incineration) forms influence lung cells, used to model inhalation toxicity. Physical and
chemical properties of the materials were investigated via microscopical and spectroscopical
approaches, while toxicity profiles were assessed both in real-time or at disparate time points via
in vitro cellular and molecular assays, cell imaging, and electric cell-substrate impedance sensing.
Our analyses showed that nanoclays and nanocomposites properties (both physical and chemical)
influence the materials’ degradation profile and ultimately their induced toxicity in model cellular
systems. The toxic effects were displayed either by reductions in cell proliferation and viability,
changes in cell morphology, and/or alterations in the cell cytoskeleton. Overall, our results provide
unique insights into how materials properties, both physical and chemical dictate materials’
toxicological profiles throughout their life cycle (from manufacturing to disposal) with such
information to be possibly aiding in safe-by-design strategies as well as safety protocols
implementation in areas of exposure.

Dedication
To my family

iii

Acknowledgements

First and foremost, I would like to express my sincere gratitude to my advisor Dr. Cerasela
Zoica Dinu for all her guidance, advice, and support throughout my graduate studies. Without her
encouragement, I would not have entered the Ph.D. program and been given the opportunities I
have now. Further, her continuous assistance on all aspects of these studies have made such
research a possibility and helped me learn and grow as a researcher.
In addition, I would like to thank Dr. Todd A. Stueckle for all his advice and assistance on
the projects performed throughout my studies. I would also like to thank my committee members
Dr. Rakesh K. Gupta, Dr. Konstantinos A. Sierros, and Dr. Charter Stinespring for all their
assistance on these projects, as well as for serving on my committee. In addition, I would like to
thank Dr. Yon Rojanasakul and Dr. Sushant A. Agarwal for their advice and assistance in
laboratory space and materials that helped support this research.
I would like to thank the staff of the WVU Shared Research Facilities for all their help on
equipment used for the material characterization studies in this research, with special thanks to Dr.
Marcela Redigolo, Dr. Weiqiang Ding, and Dr. Qiang Wang. I would also like to thank Gabriela
Perhinschi for her help with the TGA and the members of Dr. Sierros’s lab for help with the DLS.
I would also like to express my gratitude for the current and former members of Dr. Dinu’s
and Dr. Rojanasakul’s lab with whom I have worked with over the years and have helped greatly
with numerous aspects of my graduate studies. I would also like to give a special thanks to the
former and current faculty, staff, and students of the Chemical and Biomedical Engineering
Department for all their help and support over the years.
Finally, I would like to thank my family and friends for all their continuous support over
the years and for always being there for me.

iv

TABLE OF CONTENTS
Abstract……………………………………………………...………..………………………….ii
Dedication…………………………………………………………………..…………………….iii
Acknowledgements……………………………………………………………………………….iv
Table of Contents………………………………………………………………………………….v
List of Figures…………………………………………………………………………………….vi
List of Tables……………………………………………………………………………………..xi
List of Symbols/Nomenclature………………………………………………………………….xvi
Introduction………………………………………………………………………………………1
Chapter 1: Nanoclays: A Review of their Toxicological Reports and Risk Assessment
Implementation Strategies………………………………………………………………………...4
Chapter 2: Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts through
Spectroscopical and Microscopical Approaches……………………………………………...…33
Supporting Information………………………………………………………………...53
Chapter 3: Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical and
Chemical Properties……………………………………………………………………………...67
Supporting Information…………………………………………………………………93
Chapter 4: Toxicity Assessment of Byproducts Resulted from Nanoclay Composite Disposal by
Incineration……………………………………………………………………………………..114
Supporting Information………………………………………………………………..137
Conclusions…………………………………………………………………………………….160

v

LIST OF FIGURES
Chapter 1: Nanoclays: A Review of their Toxicological Reports and Risk Assessment
Implementation Strategies

Figure 1: Cellular uptake of nanoclays by A549 cells. A549 cells grown onto 8-well
chamber slides were (a) fixed (control) or (b) incubated with rhodamine (red) labeled Cloisite Na+
(25 µg/ mL) for 4 h, (c) or 24 h. Cells were also counterstained with Alexa Fluor 488 phalloidin
(green) for their cytoskeletal organization identification and Hoechst (blue) for their nuclear
localization. Intracellular accumulation of the nanoclays was detected by confocal microscopy; the
representative images show the nanoclays localization mostly concurrent with the nuclear regions.
(Copyright after Verma et al. 2012). HepG2 cells uptake (d) 0-62.5 µg/ml Cloisite Na+ labeled
with Neutral red uptake (NR) or (e) 0-500 µg/ml Cloisite 30B labeled with NR. All values are
expressed as mean ± SD. *Significantly different from control (p≤0.05). (Copyright after
Maisanaba et al. 2013). Comet assay results of: (f) Caco-2 cells after 24 and 48 h of exposure to
8.5, 17, or 34 µg/ml Clay 2; (g) HepG2 cells after 24 and 48 h of exposure to 22, 44, and 88 µg/ml
Clay 2. Results from 3 independent experiments with 2 replicates/experiment. All values are
expressed as mean ± s.d. *Significantly different from control (p < 0.05). **Significantly different
from control (p ≤ 0.01). (Copyright after Houtman et al. 2014)…………………………………..15
Figure 2: (a) Comet assay performed on Wistar rats (n = 6) exposed to Cloisite30B
suspended in water (being administered at 250, 500 and 1000 mg/kg body weight of rat) or cellculture medium (being administered at 1000 mg/kg body weight of rat). Ethylmethane sulfonate
(EMS) suspended in water was the positive control. For the experiments, six rats were exposed to
250 mg/kg body weight. Data from liver, kidney and colon cells of the EMS-exposed group were
statistically significantly different (p < 0.001, p < 0.001: *** and p < 0.05: *), respectively, from
the values in the corresponding control group (two-tailed, unpaired t-test). Internal standards:
positive controls (Caco-2 cells exposed to 0.05% ethylmethane sulfonate):16 slides, % tail DNA,
mean ± S.D., 21.6 ± 6.6; negative controls (untreated Caco-2 cells): 16 slides, % tail DNA, mean
± S.D., 1.8 ± 0.6. (Copyright after Sharma et al. 2014). (b) Catalase (CAT) and (c) superoxide
dismutase (SOD) activities (nKat/mg protein) in kidney of rat exposed to Clay 1. The values are
vi

expressed as mean ± SD (n=10). The levels observed are significant at *p<0.05 in comparison to
control group values. (Copyright after Maisanaba et al. 2014)…………………………………..20
Figure 3: Histopathological evaluations of liver of Wistar rats exposed to a PLA-Clay1
extract as beverage for 90 days. (a) He-stained liver section and (b) He-stained kidney sections.
Bars, 100 μm. (a,b) Control rats. (a) Liver parenchyma with hepatocytes with normal morphology,
central nuclei and light cytoplasm (He), organized in hepatic cords (circle). (b) Normal structure
of kidney parenchyma with glomerulus (circle), proximal convoluted tubules (Pct), and distal
convoluted tubules (Dct). (c,d) Exposed rats (c) Liver parenchyma with hepatocytes with normal
morphology, central nuclei, and light cytoplasm (He), organized in hepatic cords (circle). (d)
Normal structure of kidney parenchyma with glomerulus (circle), proximal convoluted tubules
(Pct), and distal convoluted tubules (Dct). (Copyright after Maisanaba et al. 2014)……………...21

vii

Chapter 2: Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts
through Spectroscopical and Microscopical Approaches

Figure 1: (a) Thermal degradation profile of UC and CC (n=2). (b) FTIR spectrum for UC
and CC along with their thermally degraded byproducts (n=2)…………………………………..41
Figure 2: Surface morphology of (a) UC, (b) CC, and thermally degraded (c) UC900, and
(d) CC900 as determined by SEM. (e) Elemental composition of as-received nanoclay and their
thermally degraded byproducts as determined by EDX at 1 µm (n=5). The symbols * and ~ indicate
significant differences between UC and CC and between as-received nanoclay and its thermally
degraded byproduct, respectively………………………………………………………………...43
Figure 3: Average particle diameter size distribution of UC, CC, UC900, and CC900 in
solutions of (a and b) media or (c and d) PBS…………………………………………………….45
Figure 4: (a) Representative real-time measurements of normalized resistance for BEAS2B cells before (Region A), during (Region B), and after treatment (Region C) with as-received
and thermally degraded nanoclays. (b) Real-time measurements of normalized alpha (α) parameter
for BEAS-2B cells before (Region A), during (Region B), and after treatment (Region C) with asreceived and thermally degraded nanoclays……………………………………………………...47
Figure 5: Toxicity of as-received and thermally degraded nanoclays determined by (a) live
cell count and (b) cellular viability via WST assay, for unsterilized nanoclay (n=6). The symbols
* and ~ indicate significant differences between the control and nanoclay treatments and between
as-received nanoclay and thermally degraded byproducts, respectively…………………………49
Figure 6: Fluorescent images of the cell membrane (red) and nucleus (blue) for (a) control
cells and cells treated with (b) UC, (c) CC, (d) UC900, and (e) CC900 after 24 h. (f) Cell area (µm)
after 24 h of treatment with nanoclays (n=3)……………………………………………………..51

viii

Chapter 3: Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical and
Chemical Properties

Figure 1: (a) Chemical structures of the organic modifiers present in I.31PS, I.34TCN, and
I.44P (b) Thermal degradation profile of PGV and the 3 organically modified nanoclays (n=2).
FTIR spectrum for (c) I.31PS, (d) I.34TCN, and (e) I.44P along with their thermally degraded
byproducts, all relative to PGV and PGV900 (n=2).……………………………………………..78
Figure 2: Surface morphology of (a) PGV, (b) I.31PS, (c) I.34TCN, and (d) I.44P and
thermally degraded (e) PGV900, (f) I.31PS900, (g) I.34TCN900, and (h) I.44P900 as determined
by SEM…………………………………………………………………………………………...80
Figure 3: Elemental composition of (a) as-received nanoclay and (b) their thermally
degraded byproducts as determined by EDX at 1 µm (n=10). The symbol * indicates significant
differences between the unmodified clay (PGV/PGV900) and the organically modified clays.
Average size of <90% of (c) the as-received nanoclays in solutions of PBS, DMEM, SAGM, or
Survanta (d) as well as their byproducts (n=3).…………………………………………………...83
Figure 4: (a) IC50 values (µg/cm2) for BEAS-2B cells and SAECs treated with as-received
nanoclays and byproducts. The symbol * and ~ indicate significant differences between the
unmodified nanoclay (PGV/PGV900) and the organically modified nanoclays and between the asreceived nanoclay and its thermally degraded byproduct, respectively (n≥4 for each treatment). (b)
Representative optical images of BEAS-2B cells and SAECs treated with as-received nanoclays
and byproducts at their respective IC50 dose after 24 h of exposure. (c) Extracellular ROS
production by BEAS-2B cells after treatment with as-received nanoclays and byproducts at their
respective IC50 dose over 72 h (n=4)…………………..………………………………………….89

ix

Chapter 4: Toxicity Assessment of Byproducts Resulted from Nanoclay Composite
Disposal by Incineration

Figure 1: (a) Thermal degradation profile of PLA and PLACC as determined by TGA
(n=2). Chemical characteristics analysis. (b) Elemental composition of PLA, PLACC, and
PLACC900 as determined by EDX (n=5). The symbol * and ~ indicate significant differences
between PLA and PLACC and between PLACC and its incinerated byproduct, PLACC900,
respectively. (c) FTIR spectra for PLA, PLACC, and PLACC900 (n=2)……………………….124
Figure 2: Surface morphology of (a) PLA, (b) PLACC, and (c), (d) the two morphologies
displayed by PLACC900 as determined by SEM……………………………………………….128
Figure 3: (a) Dose response curve (based on live cell counts) for BEAS-2B cells exposed
to PLACC900 from 0-750 µg/ml (n=5). (b) Cellular viability (based on WST assay) for cells
exposed to PLACC900 (n=6). The symbol * indicates a significant difference between the control
cells and exposed cells. The values are normalized relative to the controls. (c) Extracellular ROS
of cells exposed to varying doses of PLACC900 (n=4). The symbol * indicates a significant
difference between the control cells and exposed cells………………………………………….130
Figure 4: Fluorescent images of the cell membrane (red) and nucleus (blue) for (a) control
cells and cells exposed to PLACC900 at (b) 100 µg/ml, (c) 300 µg/ml, and (d) 500 µg/ml after 24
h…………………………………………………………………………………………………132
Figure 5: (a) Representative real-time measurements of normalized resistance for BEAS2B cells before and during exposure to PLACC900 from 100-500 µg/ml. Representative real-time
measurements of normalized resistance for the recovery of BEAS-2B cells over 72 h after exposure
to PLACC900 for (b) 24 h, (c) 48 h, and (d) 72 h. (e) Percentage of cells in the G1, G2, or S phase
of the cell cycle after exposure to 1-100 µg/ml PLACC900 (n=4)………………………………133

x

LIST OF TABLES
Chapter 1: Nanoclays: A Review of their Toxicological Reports and Risk Assessment
Implementation Strategies

Table 1: Examples of nanoclays researched along with their organic modifiers,
applications, and associated references…………………………………………………………..15

xi

Chapter 2: Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts
through Spectroscopical and Microscopical Approaches

Table 1: Amount of moisture, volatile, ash, and fixed carbon present in UC and CC as
determined by TGA. The symbol * indicates a significant difference between UC and CC……40
Table 2: Average particle diameter distribution sizes (µm) in solutions of media relative
to the number of particles………………………………………………………………………...45
Table 3: Average particle diameter distribution sizes (µm) in solutions of PBS relative to
the number of particles………………………………………………………………………...…45

xii

Chapter 3: Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical and
Chemical Properties

Table 1: The percent amount of moisture, high temperature volatiles, ash, and fixed carbon
present in the Nanomer nanoclays as determined by TGA. The symbol * indicates a significant
difference between PGV and the organically modified nanoclays (n=2)…………………………75

xiii

LIST OF SYMBOLS / NOMENCLATURE


ANOVA: analysis of variance



BEAS-2B: immortalized human lung epithelial cells



CC: as-received Cloisite 30B



CC900: thermally degraded Cloisite 30B



DLS: dynamic light scattering



DMEM: Dulbecco’s Modified Eagle’s Medium (cellular media for BEAS-2B cells)



ECIS: electric cell-substrate impedance sensing



EDX: Energy dispersive X-ray spectroscopy



FACS: fluorescence activated cell sorting



FBS: fetal bovine serum



FTIR: Fourier Transform Infrared Spectroscopy



I.31PS: as-received Nanomer I.31PS



I.31PS900: thermally degraded Nanomer I.31PS



I.34TCN: as-received Nanomer I.34TCN



I.34TCN900: thermally degraded Nanomer I.34TCN



I.44P: as-received Nanomer I.44P



I.44P900: thermally degraded Nanomer I.44P



MMT: montmorillonite



PBS: phosphate buffered saline



PGV: as-received Nanomer PGV



PGV900: thermally degraded Nanomer PGV



PLA: polylactic acid



PLACC: polylactic acid-Cloisite 30B nanocomposite



PLACC900: thermally degraded polylactic acid-Cloisite 30B nanocomposite



ROS: reactive oxygen species



SAECs: small airway epithelial cells



SAGM: small Airway Growth Medium (cellular media for SAECs)



SEM: scanning electron microscopy
xiv



TGA: thermogravimetric analysis



UC: as-received Cloisite Na+



UC900: thermally degraded Cloisite Na+



WST: tetrazolium salt (cellular viability assay)



XRD: X-ray diffraction

xv

INTRODUCTION
Montmorillonite (MMT) is the most common type of phyllosilicate nanoclay, which
consist of 2 silicate-oxygen tetrahedral sheets and an aluminum octahedral sheet. However, MMT
has a negative charge due to the substitution of aluminum for silicon in its tetrahedral sheets and
magnesium for aluminum in its octahedral sheets, respectively. Positively charged ions, such as
sodium and calcium, are attracted to the inner galleries of such a negative nanoclay, allowing for
its functionalization with organic modifiers through ion exchange reactions. The organic modifier
increases nanoclay’s basal spacing and leads to a more hydrophobic material with substantially
improved ease of implementation into polymer mixtures for nanocomposites formation.
Nanoclays high aspect ratio along with their abundance in soil and low cost have made
nanoclays applicable to numerous areas from sorbents for the treatment of waste water or
hazardous spills, to rheological modifiers for oil well drilling fluids, paints, and cosmetics.
Additionally, their functionalization with organic modifiers and incorporation into polymers to
form a nanocomposite with increased mechanical strength, barrier properties, UV dispersion, and
fire resistance, extended their usages to areas such as food packaging, medical devices, or
automotive industry. However, with larger consumer implementation, nanoclays and
nanocomposites have the extended potential for human exposure throughout their life cycle, i.e.,
from manufacturing, consumption/usage, to disposal. Impactful assessment strategies are needed
to evaluate their possible toxicity profiles in order to establish consumer and worker exposure
limits or design strategies that minimize their possible deleterious effects.
This thesis looks at identifying the toxicological profiles of nanoclays or nanoclay-enforced
composites (nanocomposites) during their life-cycle, i.e. from manufacturing to disposal.
Specifically:
Chapter one introduces structural and functional characteristics of nanoclays that have led
to their increased ability for processing and applicability in numerous areas from sorbents in
pollution prevention, to environmental remediation, paints, and cosmetics. Additionally, the
chapter highlights the properties and applications of nanocomposites in the food packaging
industry. Further, a comprehensive summary of the current studies differentiating toxicity and
toxicity-related mechanisms resulted from cellular exposures to commercially available nanoclays
(e.g., with different physico-chemical characteristics as provided by the organic modifier or the
size of the nanoclay itself etc.) currently in use is presented. Lastly, this chapter highlights the gaps
1

in knowledge related to the toxicological profiles of the nanoclays and proposes that the logistical
burden associated with their toxicological risk assessment could be circumvented through
implementation of tailored strategies that ensure a greener route for nanoclay functionalization and
implementation. (Book Chapter: Wagner, A., Gupta, R., Dinu, C.Z. Nanoclays: A Review of their
Toxicological Profiles and Risk Assessment Implementation Strategies, in Nanotechnology
Commercialization: Manufacturing Processes and Products. 2017. John Wiley & Sons, Inc.,
Hoboken, NJ, USA.)
Chapter two details the specific investigation as related to the potential inhalation toxicity
of a pristine nanoclay, Cloisite Na+, and an organically modified nanoclay, Cloisite 30B, as well
as their thermally degraded byproducts, thus uniquely accounting for exposure in both
manufacturing and disposal environments. With studies showing that nanoclays have the potential
to come into contact with humans during manufacturing and handling, and considering that their
disposal potentially leads to increased reactivity at interfaces with biological systems, this chapter
highlights why it is important to understand nanoclays’ life cycle and induced interactions with
cellular systems. Through material characterization and toxicity analyses, the chapter demonstrates
that the greatest degree of toxicity occurs for the organically modified nanoclay. Further, different
toxicological profiles were obtained for the thermally degraded nanoclays relative to their asreceived counterparts. The results show that both manufacturing and disposal exposures need to
be considered when evaluating materials’ toxicity profiles; further, the chapter emphasizes that
viable safety protocols need to be implemented when nanoclays are being considered for consumer
products. (Publication: Wagner, A., Eldawud, R., White, A., Agarwal, S., Stueckle, T.A., Sierros,
K.A., Rojanasakul, Y., Gupta, R.K., Dinu, C.Z. Toxicity Evaluations of Nanoclays and Thermally
Degraded Byproducts through Spectroscopical and Microscopical Approaches. Biochimica et
Biophysica Acta. 2017, 1861 (1 Pt A), 3406-3415.)
Chapter three extends the existing literature and provides a comprehensive analysis of the
physical and chemical characteristics of four types of nanoclays used in food packaging
applications as well as differentiates their toxicity-related mechanisms based on their different
physico-chemical characteristics. A variety of microscopical and spectroscopical materials
characterization techniques, as well as two in vitro model lung cell lines, an immortalized and a
primary line (to provide a more realistic view of nanoclay-related toxicity and a verification of
results in pertinent human-related exposure models), were used. Additionally, the toxicity of the
2

nanoclays was investigated at levels of exposure that mimic a manufacturing and a disposal
environment to thus establish valid toxicity pathways during the life cycle of the nanoclays.
(Publication: Wagner, A., White, A.P., Stueckle, T.A., Banerjee. D., Sierros, K.A., Rojanasakul,
Y., Agarwal, S., Gupta, R.K., Dinu, C.Z. Early Assessment and Correlations of Nanoclay’s
Toxicity to their Physical and Chemical Properties. ACS Applied Materials & Interfaces. 2017, 9
(37), 32323-32335.)
Chapter four establishes that toxicity studies do not only need to account for nanoclays
themselves or for their exposure at both manufacturing and disposal areas, but further, have to
account for nanoclays implementation. As such, this chapter establishes correlations between the
consumption/usage and disposal stages of a nanocomposite while also allowing the individual
toxicological impacts of the components themselves, i.e. polymer (model polymer considered is
polylactic acid) and nanoclay, as well as their associated byproducts (i.e. products resulted from
incineration), to be explored. The results of this chapter show that the byproduct of such a
nanocomposite does induce changes to human lung cellular systems with effects being associated
with the multiple stages of the nanocomposite life cycle. (Publication: Wagner, A., White, A.P.,
Tang, M.C., Agarwal, S., Stueckle, T.A., Rojanasakul, Y., Gupta, R.K., Dinu, C.Z. Incineration of
Nanoclay Composites Leads to Byproducts with Reduced Cellular Reactivity. Scientific Reports.
2018, 8, 10709.)
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CHAPTER 1
Nanoclays: A Review of their Toxicological Reports and Risk Assessment
Implementation Strategies
Abstract
Nanoscale properties and increased ability for processing, along with abundance in soil
and low cost, make nanoclays applicable to numerous areas from sorbents in pollution prevention
to environmental remediation, paints, and cosmetics. Further, reinforcement of polymer films with
nanoclays has led to implementation of nanoclays in the next generation of nanocomposites with
increased mechanical strength, barrier properties, UV dispersions, and fire resistance capabilities,
to be applied in the food packaging industry.
The first part of this review describes the characteristics of nanoclays and how they can
be exploited for synthetic applications, especially food packaging applications, while the second
part of the review focuses on the challenges associated with nanoclay integration in consumer
products and their potential to induce deleterious effects that could affect humans at the exposure
levels of manufacturing, consumption, and disposal. Lastly, the review highlights the potential
mechanisms of toxicity resulted upon cellular exposure to nanoclays and proposes that logistical
burden associated with risk assessment resulted from such exposures could be circumvented
through implementation of tailored strategies to ensure a greener route for nanoclay
functionalization and implementation.

4

Nanoclay structure and resulting applications
Nanoclays are layered, mineral silicates that originate from the clay fraction of the soil.1,2
Carrying platelet thickness of around 1 nm and lengths and widths of up to several microns,3,4 the
smectite group of nanoclays are largely made up of 2:1 phyllosilicates, a silicate-oxygen
tetrahedral and an aluminum octahedral sheet.1,5 Such features differentiate them from chlorite and
kaolinite nanoclays which consist of two tetrahedral and two octahedral sheets and one tetrahedral
and one octahedral sheet, respectively.1,6 Montmorillonite, the most common type of phyllosilicate
clay,1 has a negative charge due to the substitution of aluminum for silicon in its tetrahedral sheets
and magnesium for aluminum in its octahedral sheets.7 Bentonite, a source of montmorillonite,
also contains crystalline quartz, cristobalite, and feldspar,8 and due to the presence of inorganic
cations in its galleries is hydrophilic in nature.7,5
Positively charged ions, such as, sodium, potassium, and calcium, are attracted to the inner
galleries of negative nanoclays,7 allowing for cations exchange and organic modification via an
ion exchange reaction9. The addition of the organic modifier increases basal spacing to allow for
a relatively larger distance between nanoclay platelets further allowing for the naturally
hydrophilic clay to become more hydrophobic.7,8,10 Smectite clays for instance have a cation
exchange capacity (CEC) of 70-130 meq/100g,6 where CEC is a measure of the number of
positively charged ions that are able to be held by the negatively charged surface of the clay
platelets.8
Due to their nanoscale thickness and longer relative lengths and widths, nanoclays have a
high aspect- and surface area-to-volume ratios that lead to an increase of their reactivity.1,9 This,
along with their abundance in soil1 and low cost,1 have made nanoclays applicable to numerous
areas from sorbents in pollution prevention,7 to environmental remediation,7 waste water
treatment,11,12 as well as rheological modifiers for oil well drilling fluids,11,13 paints,11 and
cosmetics,11 food packaging,14,15 automotive,16,17 medical devices,18,19 and coatings-related
industry.20,21 A comprehensive list of the numerous organically modified nanoclays currently in
use in consumer applications is shown in Table 1.

5

Table 1: Examples of nanoclays researched along with their organic modifiers, applications, and
associated references.
Nanoclay

Organic Modifier

Applications

References

Montmorillonite
(MMT)

None

Adsorbents in water and
wastewater treatment,
drilling fluid, paints,
cosmetics, coatings, drug
delivery

Pluta et al.33 Mondal
et al.24 Meera et al.20
Introzzi et al.21 Baek
et al.63 Rawat et al.64
Li et al.65 Liu et al.66
Murphy et al.70

Octadecyl amine

Food packaging

Barua et al.19
Manikantan et al.40

Trimethyl stearyl ammonium

Coatings

Meera et al.20

Halloysite

None

Coatings, drug delivery,
implants, food packaging,
composites

Alipoormazandarant
et al.26 SadeghHassani and Nafchi38
Verma et al.58
Vergaro et al.67

Bentonite

None

Drilling mud, absorbent,
groundwater barrier,
cosmetics, pharmaceutical

Barua et al.19 Meibian
et al.44 Murphy et
al.70 Meibian et al.75
Yuwen et al.83

3-5 wt.% Na2CO3

Geh et al.48

HCl

Geh et al.48

Distearyl-dimethylamoniumchloride

Geh et al.48

H2SO4

Meibian et al.44
Meibian et al.75

Quartz

None

Drilling, glass making,
foundry sand, electronics,
abrasives

Gao et al.59

Kaolin

None

Coatings, cosmetics, paints,
adsorbents in water and
wastewater treatment,
medical

Gao et al.59

None

Cosmetics, food
technology, medical

Yoshida et al.46
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Amorphous
nanosilica
particles

Amine groups

Yoshida et al.46

Carboxyl groups

Yoshida et al.46

Montmorillonite
dellite

None

Adsorbents in water and
wastewater treatment,
drilling fluid, paints,
cosmetics, coatings, drug
delivery

Janer et al. 45

Cloisite Na+

None

Adsorbents in water and
wastewater treatment,
drilling fluid, paints,
cosmetics, coatings, drug
delivery

Shojaee-Aliabadi et
al.35 Rhim et al.25
Houtman et al.49
Maisanaba et al.50
Maisanaba et al.52
Lordan et al.53 Verma
et al.58 Maisanaba et
al.62 Sharma et al.47

Cloisite 10A

Dimethyl, benzyl, hydrogenated
tallow, quaternary ammonium

Composites, food
packaging, paints, coatings

Molinero et al.31

Cloisite 11B

Benzyl(hydrogenated tallow
alkyl)dimethyl

Composites, food
packaging, automotive

Dalir et al.17

Cloisite 15A

Dimethyl, dihydrogenated
tallow, quaternary ammonium

Composites, drilling fluid,
food packaging, medical,
automotive

Agarwal et al.13
Krikorian et al.28
Pereira de Abreu et
al.14 Plackett et al.22
Dalir et al.17

Dimethyl dihydrogenated
tallow quaternary ammonium
chloride

Composites, drilling fluid,
food packaging, paints,
coatings

Agarwal et al.13
Molinero et al.31
Rhim et al.25
Lertwimolnun and
Vergnes36
Lertwimolnun and
Vergnes37 Choi et
al.15 Houtman et al.49

Dimethyl, hydrogenated tallow,
2-ethylhexyl quaternary
ammonium methyl sulfate

Composites, drilling fluid,
medical, food packaging

Agarwal et al.13
Krikorian et al.28
Plackett et al.22

Methyl, tallow, bis-2hydroxyethyl, quaternary
ammonium

Composites, drilling fluid,
food packaging, medical,
automotive, paints, coatings

Agarwal et al.13
Krikorian et al.28
Molinero et al.31
Plackett et al.22 Rhim
et al.25 Beltrán et
al.39 Dalir et al.17

(MMT)

(MMT)

Cloisite 20A
(MMT)

Cloisite 25A
(MMT)
Cloisite 30B
(MMT)
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Abreu et al.41
Maisanaba et al.50
Maisanaba et al.52
Sharma et al.47
Sharma et al.80
Methyl dehydrogenated tallow
ammonium

Composites, paints,
coatings, food packaging

Molinero et al.31
Lordan et al.53

Dimethyl dihydrogenated
tallow ammonium

Composites, drilling fluids,
medical, food packaging

Janer et al.45

Dimethyl benzyl hydrogenated
tallow ammonium

Composites, drilling fluids,
medical, food packaging

Janer et al.45

PSAN-MMT

Oligo(styrene-co-acrylonitrile)

Drug delivery

Liu et al.66

Halloysite MP1

None

Coatings, drug delivery,
implants, food packaging,
composites

Verma et al.58

Delilite LVF

None

Composites

Verma et al.58

None

Composites, rheological
modifier

Verma et al.58

Clay 1

Quaternary ammonium salt
hexadecyltrimethyl-ammonium
bromide (HDTA)

Composites, food
packaging

Houtman et al.49
Maisanaba et al.51
Jorda-Beneyto et al.54
Maisanaba et al.81
Maisanaba et al.82

Clay 2

HDTA and acetylcholine
chloride (ACO)

Composites, food
packaging

Houtman et al.49
Maisanaba et al.51
Jorda-Beneyto et al.54

Cloisite 93A
(MMT)
Montmorillonite
dellite
(MMTdell 72T,
MMTdell 72Ts,
MMTdell 67G,
MMTdell 67Gs)
Montmorillonite
dellite
(MMTdell 43B,
MMTdell 43Bs)

(Bentonite)
Nanomer PGV

(Bentonite)
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Anionic
Nanoclay

Bentone MA

Carbonate

Composites, catalyst,
pharmaceuticals, filters

Chung et al.60

Chloride

Composites, catalyst,
pharmaceuticals, filters

Chung et al.60

None

Cosmetics, adhesives,
paints, cleaners, coatings

Verma et al.58

None

Composites

Verma et al.58

(hectorite clay)
ME-100
(Somasif—a
synthetic
fluoromica clay)

Nanoclays in food packaging applications
Polymers such as polylactic acid (PLA),22,23 polycaprolactone (PCL),23 methylcellulose,
starch, lignin, and poly(vinyl alcohol) have been of interest to replace the petroleum-based, nonbiodegradable packaging materials.22,24,23 However, such polymers do not always have the thermal
stability,25 strength,24 or barrier properties25 of conventional, synthetic polymers thus making their
implementation as effective food packaging materials challenging. Further, gases, such as oxygen,
carbon dioxide, water vapor, or ethylene, can penetrate the polymer matrix and diffuse throughout
it14 in the process decreasing matrix quality.14,26
The addition of nanoclays into a polymer matrix at a low silicate content3,27 allows for
better reinforcement within the polymer plane,28,29 as well as an increase in its mechanical
strength,30,28 barrier properties,3,31,14 UV dispersions,31 and fire resistance,

32,33

and makes it

applicable to food packaging industry.14,15 As such, nanoclay-enforced polymers were shown to
maintain their transparency,14,26 with further research showing that nanoclay addition into a
polymer matrix creates a tortuous path in which the nanoclays are acting as physical barriers to
slow down the movement of gases14 and create a greener route for production and disposal of
packaging.14,26,25,34 For instance, Plackett et al. found that nanoclays only caused a slight reduction
in light transparency when incorporated into PLA-PCL films,22 with Shojaee-Aliabadi et al.
showing that the addition of up to 10% weight of nanoclays into polymers can still lead to
translucent films when kappa-carrageenan/Cloisite Na+ (a pristine montmorillonite with Na+
between the platelets) were used for instance.35 However, Rhim et al. found that nanoclays
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significantly reduced the light transmittance when introduced in PLA alone, with a better
exfoliation within PLA being observed for Cloisite 20A (a hydrophobic dimethyl dihydrogenated
tallow quaternary ammonium chloride nanoclay).25
The degree of exfoliation14 was shown to depend on the organic modifiers being used, as
well as the temperature,36 processing time,22 and processing conditions.37 For example, Pereira de
Abreu et al. showed that longer processing mixing times generally have a positive influence on the
dispersion of nanoclays.14 Studies also found that between 180° and 200°C, better exfoliation of
Cloisite 20A in polypropylene (PP) was obtained at 180°C presumably as a result of the polymer
stress in this domain of temperature.36 Further, Lertwimolnun and Vergnes showed that exfoliation
of Cloisite 20A in PP films increased with decreasing feeding rate from 29 to 4.5 kg/h and
increasing the screw speed from 100 to 300 rpm.37
Other studies showed that the addition of a low percent weight of nanoclays can increase
mechanical properties of polymers.14, 24 The displayed increases in mechanical strength was shown
to help nanocomposite packaging materials withstand the stresses encountered during handling
and transportation of food products.38 Pereira de Abreu et al. for instance showed that the addition
of Cloisite 15A (nanoclay organically modified with dimethyl, dihydrogenated tallow, quaternary
ammonium) into PP increased the Young’s modulus of the material by 692 MPa relative to the
control PP14 while the addition of halloysite (a 1:1 aluminosilicate) nanoclay to soluble soybean
polysaccharide (SSPS) films increased their tensile strength by 4.1 MPa relative to SSPS with no
halloysite.26 Shojaee-Aliabadi et al. showed increases in tensile strength of 8.38 MPa when
montmorillonite (MMT) was exfoliated in kappa-carrageenan (KC) films relative to KC films
without MMT.35 Sadegh-Hassani and Nafchi showed that tensile strength increased 2.49 MPa for
potato starch films containing halloysite nanoclay38 while Beltrán et al. showed that the addition
of Cloisite 30B (nanoclay organically modified with methyl, tallow, bis-2-hydroxyethyl,
quaternary ammonium) increased elongation at break for PCL.39
Studies also revealed that addition of nanoclays to polymers such as PLA reduced water
vapor permeability (WVP) by 6-33% when compared to control PLA alone.25 Sadegh-Hassani and
Nafchi also showed a decrease in oxygen permeability upon addition of halloysite nanoclay,38
while Alipoormazandarani et al. showed that halloysite nanoclay reduced water vapor and oxygen
permeability by 56% and 58%, respectively, when incorporated into soluble soybean
polysaccharide (SSPS).26 Complementarily, Manikantan et al. found that nanoclays added into
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polypropylene (PP) also decreased the WVP with banana chips packaged in 2% nanoclay/ PP films
showing 22% lower moisture content and banana chips packaged in 4% nanoclay/PP films having
24% lower moisture content respectively all relative to the control,40 while Shojaee-Aliabadi et al.
showed a decrease in WVP by around 78% upon addition of MMT into kappa-carrageenan (KC)
films.35 Numerous other studies have shown similar results with different nanoclays and polymer
matrices, 26,35,24,38,39,40 with further analysis of PLA reinforced with Cloisite 30B also displaying
antimicrobial activity against L. monocytogenes25 while starch films containing Cloisite 30B
decreased microbial growth for S. aureus and E. Coli.41
Possible toxicity upon implementation of nanoclay in consumer applications
The large consumer implementation of nanoclays, especially in food packaging
applications as indicated above, has the potential to affect humans at the exposure levels of
manufacturing, consumption/usage, and disposal.42,43 As such, studies aimed to differentiate
toxicity and toxicity-induced mechanisms based on the organic modifier or the size of the
nanoclays. For the organic modifier for instance, Meibian et al. found that activated bentonite
particles had a greater cytotoxic response relative to untreated counterparts, indicating that surface
characteristics may be playing a large role in mechanisms of toxicity, such as the adsorption
capacity, cation exchange, charge interactions, and surface area.44 Janer et al. also observed
differences in toxicity based on the organic modifier being used, with the modifier dimethyl benzyl
hydrogenated tallow ammonium displaying greater toxic effects relative to the modifier dimethyl
dehydrogenated tallow ammonium for instance.45 However, Yoshinda et al. found that the
organically modified silica particles coated with amine or carboxyl groups were less toxic than the
unmodified silica particle, as the modified particles reduced the amount of reactive oxygen
generated in a human keratinocyte cell line (HaCat) and a murine hepatocyte cell line (TLR-1) and
the amount of DNA damage in HaCaT cells.46
For the size, Sharma et al. showed that samples of Cloisite 30B that had been filtered
through a 0.2 µm filter, thus eliminating particles in the micro range, were less cytotoxic than their
unfiltered counterparts.47 However, Janer et al. did not observe any differences in cytotoxicity
between the small (100-822 nm) and large (100-3230 nm) sized pristine MMT particles.45 Size
played a role in the uptake of bentonite particles, with a maximum uptake for particles in the size
range of 0.4-1.6 µm for the activated bentonite particles, and a less selective size range for the
unactivated particles.48 Other in vitro studies evaluated the toxicity of nanoclays (both pristine and
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organically modified nanoclays) and differentiated the observed nanoclay-induced effects based
on the exposure levels or the cell type being used, with the majority of studies focusing on
understanding toxicity at the consumption level of exposure (i.e. around 48%, 24%, and 28% for
consumption exposure, inhalation exposure, and other, respectively) and assuming that nanoclays
will eventually migrate out of the polymer matrix into food stocks when used for food packaging
applications.49,50,51,52,53,54 Detailed below are several investigations that mean to identify the
deleterious effects that nanoclays can have and possibly propose means to reduce the logistical
burden associated with developing meaningful risk assessment strategies for evaluating their
potential and feasibility for implementation in food packaging industry.
In vitro studies reveal the potential of nanoclay to induce changes in cellular viability
Studies proposed that the small size and platelet morphology of nanoclays have the
potential to allow for their inhalation and deposition in the bronchial or alveolar regions of the
lung.42,55,56,57 In support of this hypothesis, Verma et al. investigated the inhalation toxicity of both
platelet and tubular shaped nanoclays using in vitro models, i.e., human alveolar epithelial cells
(A549), and a dosage ranging from 1 to 250 µg/ml.58 Analyses showed that tubular nanoclays did
not induce toxicity until doses of 250 µg/ml, which was in contrast with the platelet nanoclays that
induced toxicity at only 25 µg/ml and 24 h exposure.58 Further studies by the same authors showed
that the pristine nanoclay, i.e., Cloisite Na+ was internalized by the exposed cells and accumulated
in their perinuclear region (Figure 1b,c; nanoclays were labeled in red using rhodamine dyes and
their localization is indicated with white arrowheads).58 Figure 1a displays the control cells; all
cells were also counterstained with Alexa Fluor 488 phalloidin (green) for cellular cytoskeleton
and Hoechst (blue) for nucleus identification. Analysis showed that the uptake was time dependent
with increases in the amount of Cloisite Na+ occurring accumulatively over the 24 h exposure time.
Geh et al. also observed uptake of bentonite particles into human lung fibroblasts (IMR90 cells)
over 24 h exposure at a dose of 10 µg/cm2, with uptake increasing when the bentonite particles
were activated with quartz (5-6%).48 Such nanoclays were also more cytotoxic when compared to
non-activated or lower quartz content particles with the observed cytotoxicity being attributed to
the lysis of the cell membrane upon translocation of the activated nanoclays.48
Complementarily, Janer et al. found that organically modified nanoclays induced a greater
toxicity than the pristine nanoclays.45 For instance, when A549 cells were treated with pristine clay
or nanoclays modified with dimethyl dihyrdrogenated tallow ammonium or dimethyl benzyl
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hydrogenated tallow ammonium respectively (doses <500 µg/ml), a greater loss in cellular
viability was experienced even though both the nanoclays were taken up by the cell during the 72
h window of incubation, with the internalization being more prevalent for the pristine clay.45 Other
studies showed that quartz and kaolin dust decreased pulmonary alveolar macrophage viability
within 1 day of exposure at doses of 40 µg/cm2 and 20 µg/cm2 respectively,59 however quartz and
kaolin treated with the surfactant dipalmitoyl phosphatidylcholine (DPPC) did not induce
significant decreases in viability even after 3 or 5 days of treatment.59 Lastly, Chung et al.
examined both the short- and long-term toxicity of anionic nanoclays (carbonate and chloride
forms) on A549 cells and found no toxic effects at high exposure doses of 1000 µg/ml,60 however
the anionic nanoclay seemed to have inhibited colony formation after 10 days of exposure to doses
ranging from 250 to 500 µg/ml.60
However, due to the nanoclay incorporation into nanocomposites for food packaging
applications,14,15,61 it is likely that nanoclays will not only come into contact with humans through
the route of inhalation but also through the route of ingestion. Studies aimed to examine the toxicity
of nanoclays upon exposure to cell lines isolated or belonging to the ingestion track have shown
toxic effects induced by Cloisite 30B on human hepatocellular carcinoma epithelial cell line
(HepG2) for instance, with significant decreases in both cellular growing rate and viability (Figure
1d,e).50 In particular, analyses showed that significant decreases in uptake occurred starting at the
dose of 62.5 µg/ml to 500 µg/ml upon both 24 and 48 h cellular exposure to Cloisite 30B (Figure
1e). However, analyses on pristine nanoclay Cloisite Na+ did not reveal any cytotoxic effects on
the HepG2 cells up to a dose of 62.5 µg/ml upon the same time of exposure (Figure 1d).50 Further,
Cloisite Na+ again did not show any cytotoxicity after 24 h of exposure to cells in doses up to 62.5
µg/ml.62 Similarly, Sharma et al. found that Cloisite 30B showed increased toxicity relative to
Cloisite Na+ (40% toxicity in human colon carcinoma cells-Caco-2) after 24 h exposure to a dose
of 226 µg/ml,47 with Cloisite 30B inducing greater toxicity than Cloisite Na+ and also causing both
time and dose-dependent decreases in protein content (PC), 3-(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) reduction,52 all standards for
the in vitro evaluation of cytotoxicity. A significant toxic effect for Cloisite Na+ was only obtained
using the MTS assay after 48 h of exposure to doses of 31.25 µg/ml, all relative to control cells.52
Janer et al. complemented the above studies showing that the organically modified
nanoclays were more toxic than the pristine ones when a colorectal carcinoma cell line (HCT116)
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and HepG2 cells were assessed, with all organoclays displaying IC50’s at doses below 25 µg/ml
whereas the IC50 of pristine clays were above 100 µg/ml.45 Houtman et al. treated HepG2 and
Caco-2 cells with 3 other types of clays used in packaging namely Cloisite 20A, Clay 1 (modified
with quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA)), and Clay 2
(modified with HDTA and acetylcholine chloride (ACO)) respectively.49 Analyses showed that
Clay 2 caused significant decreases in viability in both HepG2 cells and Caco-2 cells, with more
prevalent effects being observed in Caco-2 cells.49 In another study, Clay 1 was shown to cause
significant reductions for HepG2 cells at the same dosage.54 Both Cloisite Na+ and Cloisite 93A
(modified with methyl dehydrogenated tallow ammonium) caused significant dose-dependent
decreases in HepG2 cell viability after 24 h starting from a dose of 1 µg/ml.53 Similarly, MMT
caused significant decreases in the viability of human normal intestinal cells (INT-407) in a dose
and time-dependent manner at doses of 100 µg/ml or above, all over 24-72 h.63 For instance, Rawat
et al. found that MMT induced 50% cytotoxicity in the human embryonic kidney cell line at a dose
as low as 0.005 µg/ml.64 When examining the effects on HepG2 or Caco-2 cells after 24 and 48 h
of exposure to extracts of PLA-Clay 1 and PLA-Clay 2 nanocomposites for instance, Maisanaba
et al. did not observe any cytotoxic effects up to 2.5-100% extracts.51 Li et al. showed that
nanosilicate platelets (NSP) originated from MMT produced significant decreases in viability of
Chinese Hamster Ovary (CHO) cells after 24 h of treatment with doses from 62.5 to 1000 µg/ml,65
while Meibian et al. treated a human B lymphocyte cell line (HMy2.CIR) with active and native
bentonite particles and showed that both the active (treated with 10-15% H2SO4) and native
bentonite particles resulted in dramatic decreases in cellular viability within only 4 h of exposure,
with 1000 µg/ml exposure dose causing almost complete loss of cellular viability.44 Mouse
embryonic fibroblast (NIH 3T3) and Human Embryonic Kidney 293 (HEK) cells however did not
show a loss in cellular viability when treated with MMT or MMT modified with oligo(styrene-coacrylonitrile) (PSAN-MMT) until exposure doses of 1 g/L, with MMT showing a greater loss in
viability relative to PSAN-MMT.66 Complementarily, human breast cancer cell line (MCF-7) and
human cervical cancer cell line (HeLa) displayed decreases in viability after concentrations of 75
µg/ml of the tubular nanoclay, halloysite,67 and halloysite coated with amino-propyltriethoxysilane (APTES) produced similar trends in toxicity relative to its uncoated counterpart.67
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Figure 1: Cellular uptake of nanoclays by A549 cells. A549 cells grown onto 8-well chamber
slides were (a) fixed (control) or (b) incubated with rhodamine (red) labeled Cloisite Na+ (25
µg/mL) for 4 h, (c) or 24 h. Cells were also counterstained with Alexa Fluor 488 phalloidin (green)
for their cytoskeletal organization identification and Hoechst (blue) for their nuclear localization.
Intracellular accumulation of the nanoclays was detected by confocal microscopy; the
representative images show the nanoclays localization mostly concurrent with the nuclear regions.
(Copyright after Verma et al. 2012). HepG2 cells uptake (d) 0-62.5 µg/ml Cloisite Na+ labeled
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with Neutral red uptake (NR) or (e) 0-500 µg/ml Cloisite 30B labeled with NR. All values are
expressed as mean ± SD. *Significantly different from control (p≤0.05). (Copyright after
Maisanaba et al. 2013). Comet assay results of: (f) Caco-2 cells after 24 and 48 h of exposure to
8.5, 17, or 34 µg/ml Clay 2; (g) HepG2 cells after 24 and 48 h of exposure to 22, 44, and 88 µg/ml
Clay 2. Results from 3 independent experiments with 2 replicates/experiment. All values are
expressed as mean ± s.d. *Significantly different from control (p < 0.05). **Significantly different
from control (p ≤ 0.01). (Copyright after Houtman et al. 2014).

Proposed mechanisms of toxicity for the in vitro cellular studies
Due to the observed changes in cellular viability upon exposure to different types of
nanoclays, studies aimed to determine the nanoclay-induced mechanisms of toxicity. For this, the
strategies have considered the effects of nanoclays exposure to cell morphology, structure, cell
signaling, cell-cell and cell-substrate interactions, as well as cell progression through cell cycle
and appropriate cellular proliferation since all these aspects are known to be influencing cell
viability and ultimately determine cellular fate.68,69 Further, the evaluations of such changes were
meant to provide the means for assessing and differentiating the nanoclay-induced cyto and/or
genotoxic mechanisms in a clay type-dependent manner.
Analyses showed that HepG2 cells had dilated endo-membranes after treatment with
Cloisite 30B,50 while Caco-2 cells treated with 20 and 40 µg/ml of the same nanoclay displayed
changes in cell morphology, intense vacuolization and euchromatic irregular nuclei.52
Nanoclays exposure led to membrane damage and changes in cellular structure, likely due
to their induced charge interactions with the membrane and resulting membrane lysing ability.70
For instance, Murphy et al. determined that primary murine spinal cord neurons were lysed after
60 min of incubation with 0.1 mg/ml bentonite or MMT, whereas differentiated N1E-115 cells did
not appear to be lysed or undergo any morphological damage.70 Studies by Meibian et al. found
that both active and native bentonite particles induced significant lactate dehydrogenase (LDH)
leakage in human B lymphocyte cells after 4 h of exposure to doses of 60 and 120 µg/ml,
respectively.44 Li et al. also observed significant membrane damage in CHO cells after cell
treatment with NSP particles in 62.5-1000 µg/ml doses.65 Both Cloisite Na+ and Cloisite 93A
caused significant increases in LDH release in HepG2 cells, with the organically modified clay
inducing the greater response.53 However, Baek et al. only observed significant LDH release in
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INT-407 cells at the top dose of 1000 µg/ml MMT after 48 and 72 h.63 The organically modified
MMT, i.e., PSAN-MMT, showed lower LDH release relative to MMT.66
Combined with effects on cellular morphology and structure, changes in mitochondrial
function were proposed as another viable mean to explain nanoclay-induced toxicity since it is
known that the mitochondria regulates redox signaling to cellular cytosol and nucleus.71,72 Studies
by Maisanaba et al. have showed that mitochondria of cells treated with nanoclays exhibited both
matrix and inner membrane degradation.52 However, when reactive oxygen species (ROS) were
assessed in the HepG2 cell line treated with Cloisite Na+ or Cloisite 30B up to a dose of 88 µg/ml
for instance, no significant increases were recorded.50 Further both the HepG2 and Caco-2 cells
showed no ROS generation when treated with Clay 2 up to a dose of 88 µg/ml for 48 h.49 However,
Lordan et al. found that both Cloisite Na+ and Cloisite 93A produced ROS in HepG2 cells, with
Cloisite Na+ inducing more ROS than the organically modified counterpart and with the significant
increases being recorded for smaller doses of 50 µg/ml over 24 h of exposure.53 This is in contrast
with studies performed with both active and native bentonite which showed significant ROS levels
upon only 30 min of exposure to human B lymphocyte cells.44 ROS was also generated in Caco-2
cells upon treatment with 40 µg/ml of Cloisite 30B,52 while MMT generated ROS in INT-407 cells
at concentrations above 50 µg/ml after 48-72 h.63 One possible explanation for the observed dose
and nanoclay-dependent ROS generation was that the toxic effects of nanoclays could be
potentially circumvented by changes in the endogenous antioxidant glutathione (GSH), a known
regulator of the intracellular redox balance.73 Maisanaba et al. for instance found that Cloisite 30B
caused significant decreases in GSH cellular concentration for both HepG2 cells and Caco-2
cells,50,52 with the GSH concentration being dependent on both the type of clay used (e.g., Clay 2
did not affect the GSH content of Caco-2 cells) and the dose of nanoclay.49
With changes in cellular structure and energetic activity being known to influence cell
cycle and overall fate,69,74 the role of nanoclays to induce genotoxicity was also investigated.
Studies of NIH 3T3 cells exposed to 1 g/L MMT for 24 h identified nuclei fragmentation and
condensed chromatin, however the changes were minimal for cells exposed to organically
modified PSAN-MMT.66 Maisanaba et al. also showed that Cloisite 30B caused significant time
dependent DNA breaks in HepG2 cell,50 while Houtman et al. showed that Clay 2 induced DNA
changes in both HepG2 and Caco-2 cells respectively, with Clay 2 having a slightly greater effect
on Caco-2 cells (Figure 11.1f,g).49 However, exposures to Cloisite 20A and Clay 1 did not induce
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DNA strand breaks in either Caco-2 or HepG2 cells after 48 h and concentrations up to 62.5 and
8 µg/ml, respectively.49 Additionally, neither of the extracts of the PLA-Clay 1 or PLA-Clay 2
nanocomposites induced any genotoxicity after 24 or 48 h of exposure.51 Studies by Sharma et al.
also complemented previous findings and showed DNA damage in a nanoclay dose-dependent
manner when Caco-2 cells were treated with Cloisite 30B, with the 2 highest doses of 113 and 170
µg/ml respectively being significantly different from the control (not exposed cells) after 24 h of
exposure.47 However, no change was recorded for the Caco-2 cells treated with Cloisite Na+,47 or
Cloisite 30B.52 However, Cloisite Na+ caused an increase in micronuclei frequency in HepG2 cells
after 24 h at exposure levels of 62.5 µg/ml.62 Similarly, when CHO cells were treated with
nanosilicate platelets from MMT, DNA dose-dependent damage was observed within the exposure
dose range of 62.5 to 1000 µg/ml.65 An increase in DNA damage was observed when human B
lymphoblast cells were treated with active or native bentonite particles from doses of 120 µg/ml
for 24 h, 60 µg/ml for 48 h, or 30 µg/ml over 72 h, with active bentonites showing a greater effect,
and with both particles causing significant increases in micronucleus frequency.75 Untreated quartz
particles induced significant DNA damage in rat pulmonary alveolar macrophages within 1 day of
exposure at a dose of 20 µg/cm2, whereas quartz/DPPC induced damage after 3 days at double that
dose.59 Additionally, untreated kaolin induced DNA damage after 1 day at an exposure dose of 40
µg/cm2 and kaolin/DPPC inducing DNA damage after 5 days at a dose of 40 µg/cm 2.59 Lastly,
Janer et al. observed a slight increase in caspase 3/7 for HepG2 cells exposed to 100 µg/ml
nanoclay.45 Caspases 3 and 7 are cysteine asparate proteases with similar structures76,77 that control
apoptotic pathways. Briefly, intrinsic apoptosis is mediated by mitochondrial outer membrane
permeabilization with cytosol release of pro-apoptotic proteins such as cytochrome c activating
caspase-9.78,79 The resulting activated caspase-9 then cleaves and actives caspase-3 and 7
respectively to initiate the degradation of cellular structures and cell detachment, eventually
leading to cell death.78
Maisanaba et al. proposed to further investigate genotoxicity of nanoclays by investigating
the effect of Cloisite Na+ on the regulation of genes in HepG2 cells.62 Cloisite Na+ was found to
deregulate genes associated with cellular metabolism, immediate-early response/signaling, DNA
damage response, oxidative stress, and apoptosis/survival.62 Specifically, 4 out of the 5 genes
studied for metabolism and 2 DNA damage responsive genes were found to be upregulated at the
tested concentrations of 6.25 µg/ml or 62.5 µg/ml of Cloisite Na+ after 24 h of exposure. Catalase,
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an oxidative stress responsive gene, was down regulated however at both concentrations used.
Complementarily, both apoptosis responsive genes and early response/signaling genes were also
affected after 24 h, with early response/signaling also having a gene (JUNB) affected at 4 h at the
dose of 62.5 µg/ml.62
In vivo evaluation of nanoclay toxicity
While the mechanism of toxicity is still not completely understood, the deleterious effects
observed upon exposure to both pristine and organically modified nanoclays from the in vitro
studies have prompted increased interest for their in vivo evaluations at a consumer level of
exposure. Herein the consumer level of exposure is defined as exposures to nanoclays when in use
by the public who buys the product embedding nanoclay. Analyses by Sharma et al. found that
Wistar rats orally exposed for two times to Cloisite 30B ranging from 250-1000 mg/kg of their
body weight, with 24 h apart the exposures, did not induce changes in their organs nor DNA strand
breaks in the cells isolated from the colon, liver, or kidney (Figure 2a).80 Specifically, analyses
showed that the Wistar rats treated with Cloisite 30B suspended in water or cell culture media had
no significant differences in % tail DNA relative to the controls, even up to a dose of 1000 mg/kg
body weight for the liver, kidney, or colon. However, the tracer element aluminum was found in
the rat’s feces thus indicating there was no absorption of the clay from the gastrointestinal tract.
Complementarily, results by Maisanaba et al. administering Clay 1 over 90 days at 40 mg/kg/d
showed that rats underwent an adaptive response in result of an increased oxidative stress.81
Specifically, significant increases in catalase (CAT; responsible in maintaining ROS levels)
activity in the kidney (Figure 2b) as well as changes in proteins expressions level of CAT in the
kidney of the rat were observed, which was in contrary to no significant effects on the antioxidant
enzymes, superoxide dismutase (SOD), glutathione peroxidase (GPx), and gluthatione Stransferase (GST) responsible for maintaining ROS levels respectively (Figure 2c).81
Maisanaba et al. also tested the migrant extract of a PLA-Clay 1 (4%) nanocomposite on
the same animal models over an exposure of 90 days and showed no significant effects on their
biomarkers, which included the oxidative stress biomarkers of enzymes gluthatione S-transferase
(GSH)/ glutathione disulfide (GSSG) ratios, lipid peroxidation via thiobarbituric acid (TBA), and
antioxidant enzyme activities (CAT, SOD, GPx, and GST).82 Further, unlike the previous study
dealing with Clay 1, the migrant extract did not cause any changes in CAT activity or in genetic
and protein expressions of CAT.81,82
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Figure 2: (a) Comet assay performed on Wistar rats (n = 6) exposed to Cloisite 30B suspended in
water (being administered at 250, 500 and 1000 mg/kg body weight of rat) or cell-culture medium
(being administered at 1000 mg/kg body weight of rat). Ethylmethane sulfonate (EMS) suspended
in water was the positive control. For the experiments, six rats were exposed to 250 mg/kg body
weight. Data from liver, kidney and colon cells of the EMS-exposed group were statistically
significantly different (p < 0.001, p < 0.001: *** and p < 0.05: *), respectively, from the values in
the corresponding control group (two-tailed, unpaired t-test). Internal standards: positive controls
(Caco-2 cells exposed to 0.05% ethylmethane sulfonate):16 slides, % tail DNA, mean ± S.D., 21.6
± 6.6; negative controls (untreated Caco-2 cells): 16 slides, % tail DNA, mean ± S.D., 1.8 ± 0.6.
(Copyright after Sharma et al. 2014). (b) Catalase (CAT) and (c) superoxide dismutase (SOD)
activities (nKat/mg protein) in kidney of rat exposed to Clay 1. The values are expressed as mean
± SD (n=10). The levels observed are significant at *p<0.05 in comparison to control group values.
(Copyright after Maisanaba et al. 2014).
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There were also no major differences being observed in the histopathology of the control
versus the exposed groups to the migrant extract of PLA-Clay 1 (Figure 3). Specifically, Figure 3a
and 3b display the unexposed rat liver and kidney tissues, respectively, stained with hematoxylin
and eosin (HE).82 Figure 3c and 3d displays the exposed rat liver and kidney tissues, with analyses
showing that the liver tissue displayed hepatocytes similar to that of the control and with the kidney
tissue displaying a normal parenchyma and normal proximal convoluted tubules (Pct) and distal
convoluted tubules (Dct) relative to the control group.82 Li et al. also evaluated the LD50 of NSP
particles being fed to Sprague-Dawley rats at doses of 1500, 3000, and 5700 mg/kg over 14 days
and showed no acute oral toxicity of these nanoclays,65 while results by Baek et al. obtained in
ICR mice exposed to MMT particles orally in single administered doses in between 5-1000 mg/kg
showed that after 14 days there was no significant accumulation of nanoclay in any specific organs
and the LD50 was estimated to be over 1000 mg/kg.63

Figure 3: Histopathological evaluations of liver of Wistar rats exposed to a PLA-Clay1 extract as
beverage for 90 days. (a) He-stained liver section and (b) He-stained kidney sections. Bars, 100
μm. (a,b) Control rats. (a) Liver parenchyma with hepatocytes with normal morphology, central
nuclei and light cytoplasm (He), organized in hepatic cords (circle). (b) Normal structure of kidney
parenchyma with glomerulus (circle), proximal convoluted tubules (Pct), and distal convoluted
21

tubules (Dct). (c,d) Exposed rats (c) Liver parenchyma with hepatocytes with normal morphology,
central nuclei, and light cytoplasm (He), organized in hepatic cords (circle). (d) Normal structure
of kidney parenchyma with glomerulus (circle), proximal convoluted tubules (Pct), and distal
convoluted tubules (Dct). (Copyright after Maisanaba et al. 2014).

Conclusions and Outlook
In the past decades, research has been trying to answer critical questions related to the
properties and characteristics of nanoclays that could allow for enhancing their consumer-related
utility at minimum toxicological risks. However, even though extensive body of evidence from in
vitro studies supports that nanoclay could be toxic at the exposure level of consumption and
inhalation, it is still unclear as to what extent they could potentially affect humans. The isolated
study performed by Yuwen et al. for instance showed that organic bentonite particles could affect
workers in two different factories producing such nanoclays. Specifically, group I was exposed to
high concentration (around 13 mg/m3), while group II was exposed to moderate concentration
(around 8 mg/m3) of bentonites.83 Preliminary analyses performed in the study identified that
group I had a higher frequency of micronuclei, nucleus buds, micronucleated cells, nucleoplasmic
bridges, apoptotic cell rate, and necrotic cell rate relative to group II and the control (unexposed
individuals) in all the isolated human lymphocytes. Further, group II had higher frequencies of all
the above parameters relative to the control group, indicating that genetic damage can occur.
Further, both groups showed an increase in lipid peroxidation, responsible for cell damage due to
oxidation of lipids in cell membranes, all relative to the control groups, with the age factor further
accentuating such correlations.
We propose that circumventing strategies to limit toxicological risks of nanoclays should
consider that their toxicity is a combination of both cyto and genotoxic effects (Scheme 1), where
effect differentiation is based on the cell and nanoclay type being studied, as well as on the
nanoclay physical and chemical characteristics (size, organic modifier etc.). For risk prevention
for instance, one could envision controlling the synergistically induced toxicological effects by
reducing the nanoclay-induced generation of ROS through direct activation of nanoclay
degradation upon their cellular uptake. As such, if the potential of nanoclays implementation in
user-directed applications is to be fully reached at the minimum human and environmental
logistical burden, both the development of functionalization strategies that allow for such
22

activation strategy to occur, as well as the confirmative body of evidence to demonstrate the
feasibility of the activation need to be established. A technical approach in which the addition of
user-tailored copolymers to the surface of the nanoclay would facilitate both their cellular uptake
as well as their cellular-based autophagy, i.e., the lysosome-based degradation, could be
implemented prior to consumer integration. With degradative pathways being activated at
minimum changes of the lysosome-encapsulated enzymes, the continuous cellular degradation of
any uptaken nanoclays will then take place to maintain cellular homeostasis and reduce any cellular
toxicity. The underlying functionalization techniques that would ensure such a greener route to
nanoclay degradation as well as the lysosome-based degradative pathways will still need to be
elucidated. However, until such means are achieved, the “no harm” policy for the worker
implementing nanoclays in food packaging or derived products can only account for a proper
system of safety measures to be implemented. They could impose limiting the amount of any
airborne particles in workplaces or developing personal protective equipment such as respirators
capable of removing nanoclays in a reliable and timely fashion, and with a high efficiency. Lastly,
high-throughput screening tests to quickly gain an idea of the toxicity of the numerous types of
nanoclays in a time efficient manner could be developed and implemented to allow for realistic
human and environmentally relevant concentrations rather than excessively high concentrations to
be determined and assessed for toxicity of nanoclay risk mitigation.
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Scheme 1: Schematic representation of the proposed mechanisms of toxicity induced by cellular
exposure to nanoclays. In vitro exposure of cells to nanoclays with different physico-chemical
properties undergo changes in their structure and functions, with such changes being directly
correlated with cellular morphology or proliferation rates controlled at the genetic level.
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CHAPTER 2
Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts
through Spectroscopical and Microscopical Approaches
Abstract
Montmorillonite is a type of nanoclay that originates from the clay fraction of the soil and
is incorporated into polymers to form nanocomposites with enhanced mechanical strength, barrier
and flammability properties used for food packaging, automotive, and medical devices. However,
with implementation in such consumer applications, the interaction of montmorillonite-based
composites or derived byproducts with biological systems needs to be investigated. Herein we
examined the potential of Cloisite Na+ (pristine) and Cloisite 30B (organically modified
montmorillonite nanoclay) and their thermally degraded byproducts’ to induce toxicity in model
human lung epithelial cells. The experimental set-up mimicked biological exposure in
manufacturing and disposal areas and employed cellular treatments with occupationally relevant
doses of nanoclays previously characterized using spectroscopical and microscopical approaches.
For nanoclay-cellular interactions and for cellular analyses respectively, biosensorial-based
analytical platforms were used, with induced cellular changes being confirmed via live cell counts,
viability assays, and cell imaging. Our analysis of nanoclays’ or byproducts’ chemical and physical
properties revealed both structural and functional changes. Real-time high throughput analyses of
exposed cellular systems confirmed that nanoclay induced significant toxic effects, with Cloisite
30B showing time-dependent decreases in live cell count and cellular viability relative to control
and pristine nanoclay respectively. Thermally degraded byproducts produced less toxic effects; all
treatments caused alterations in the cell morphology upon exposure. Our morphological,
behavioral, and viability cellular changes show that nanoclays have the potential to produce toxic
effects when used both in manufacturing or disposal environments. The reported toxicological
mechanisms prove the extensibility of a biosensorial-based platform for cellular behavior analysis
upon treatment with a variety of nanomaterials.
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Introduction
Nanotechnology is quickly establishing itself as the next revolution in commercial and
industrial products, with about one third of all produced engineered nanomaterials to occur within
the U.S..1,2 Naturally occurring montmorillonite nanoclays3,4 are readily available, negatively
charged,5 low cost,6 and consist of aluminum or magnesium octahedral sheets sandwiched between
two silica-oxygen tetrahedral sheets. Isolated from the clay fraction of the soil,7 nanoclays are
currently used as sorbents in the treatment of waste water or hazardous spills8 or as media for oil
well drilling,9 paints,10 and cosmetics.11 Functionalization with organic modifiers via an ion
exchange reaction confers montmorillonite increased basal spacing and separation between its
platelets4,12 as well as better mixing ability, and facilitates its interactions with hydrophobic
polymers.3,4,13 Complementary, its high aspect ratio5 ensures better reinforcement within the
polymeric plane itself14 by enhancing polymer’s properties at a fairly low silicate content13 and
leading to the formation of nanoclay-polymer-based composites with increased mechanical
strength,3,14 barrier properties,3,15 UV dispersion,15 and fire resistance capabilities,3,16 to be used
for food packaging,17,18 automotive,19,20 medical devices,21,22 and for coatings-related
applications.23,24
With nanoclay or nanoclay-plastic composites wide implementation,25 analyses of
potential risks of these nanomaterials to exposed workers’ lung health have started to emerge. As
such, recent studies aiming to unravel the nanoclay toxicological profiles showed that its high
aspect ratio resulted from its platelet thickness of about 1 nm and length and width of up to several
microns,5 has led to increased cellular uptake and interactions.26 While such in vitro analyses
allowed for elimination of animal subjects, lower processing time, and cost effectiveness,27,28 they
rely on usage of synthetic compounds such as tetrazolium salts (MTT) to measure mitochondrial
reduction/cellular viability for instance.28 Specific results based on such analyses revealed that
cellular exposure to nanoclays lead to mitochondrial damage,29,30 decreased cellular
proliferation,31 reactive oxygen species (ROS) generation,29,30 as well as membrane29,32 and DNA
damage,33,34,35 with the type and range of toxicity being dependent on the cell model being used,
the dosage, and the organic modifier functionalizing the nanoclay, respectively. 5 However, based
on our knowledge no analyses are currently available to report the toxicological profiles of
nanoclays upon the end of composite life cycle.26,36 High temperatures, oxidation, reduction, and
potential chemical reactions occurring during the incineration process normally used for
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composites disposal37 could induce physical and chemical changes38 and lead to increased
reactivities of the resulting nanoclay-resulting byproducts. Further, previous analyses on other
types of nanomaterials have showed that single-walled carbon nanotubes (SWCNTs), carbon black
nanoparticles, fullerenes, and silica for instance, all interact with indicator dyes such as the MTT
by binding to the formazan crystals and making them insoluble and thus creating false
positives.27,39,40 Additionally, the high adsorptive capacities of nanomaterials due to their large
surface per unit mass have shown interferences with annexin V/PI binding, ELISA and ROS
assays.27,28 Finally, Casey et al. found considerable variation in the toxicity of carbon
nanomaterials on human alveolar carcinoma cells (A549) from MTT, Commassie Blue, Neutral
Red, and WST-1 assays, all of which help indicate cellular viability. 41
Given the complex effects of nanoclays on increased cellular instability, previous research
showing possible interference between nanomaterials in general and the assays being used, and
lastly, given that smaller particles resulting from incineration are more likely to escape filters37
and travel greater distances through the air by Brownian diffusion26 thus leading to deeper
inhalation, larger sedimentation and diffusion rates into the lungs26,42 it is important that we
perform a systemic analyses to assess how parallel exposures to nanoclay or byproducts resulted
during their manipulation, handling, and disposal affects cellular systems’ fate. Such tests should
be cheap, not time intensive43 or invasive,43 and provide results in real-time in contrast with
discrete time points currently achieved through the standard assays named above.44,45 Further, such
assays should be high throughput and should have the ability to provide accurate results that avoid
the artifacts known to result from the interaction of nanomaterials with dyes or chemical
compounds normally found in such standard assays.39,41
Herein we propose to assess toxicological profiles of nanoclays, both during the duration
as well as at the end of their life cycle. Further, to eliminate the concern associated with using
standardized single point assays and chemical compounds interference with nanoclays or their
byproducts, we propose to use an electrical cell-substrate impedance sensing (ECIS) previously
applied to monitor changes in cell adherence, proliferation, motility, and morphology. Our analysis
will allow quantitative measurements, at a nanoscale resolution, and in a noninvasive, real-time
manner44,46 to establish whether nanoclays and their thermally degraded byproducts are leading to
cellular changes when exposed to model target inhalation systems at an occupationally relevant
dose for particles otherwise not regulated.47,48 Exploitation of our findings can further advance
35

implementation of nanoclays or nanoclay-polymer-based composites in “safe-by-design”
consumer-based applications, as well as confirm that ECIS has the potential to be a powerful tool
for quickly, efficiently and non-invasively determining toxicity of a large variety of nanomaterials.

Materials and Methods
Nanoclay Preparation
Raw (as-received) Cloisite Na+ (UC) and Cloisite 30B (CC) were obtained from Southern
Clay Products (Gonzales, TX, USA). Cloisite Na+ is an unmodified montmorillonite while Cloisite
30B is organically modified via an ion-exchange reaction (per the manufacturer specifications)
with methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium at a concentration of 90 meq/100
g clay.4,5
Thermal Degradation
UC and CC samples were thermally degraded using a TGA701 Thermogravimetric
Analyzer from LECO to mimic the end of life cycle of the nanoclay. In order to determine the
moisture content of the samples, around 0.5 g of each of the samples was heated in nitrogen at a
rate of 6 °C/min and in a range of temperatures from 25 °C to 105 °C. To determine the volatile
content, the samples were heated from 105 °C to 950 °C in nitrogen at a rate of 43 °C/min. Finally,
to determine the ash content, the samples were heated from 550 °C to 900 °C in oxygen at a rate
of 15 °C/min. The resulted ash was collected to serve as a model of the byproducts resulted from
incineration i.e., thermally degraded Cloisite Na+ (UC900) and thermally degraded Cloisite 30B
(CC900) respectively.
Materials Characterization
Chemical composition of the samples (i.e., unsterile and sterilized clays, and their
thermally degraded byproducts) was determined using Fourier Transform Infrared Spectroscopy
(FTIR, Digilab FTS 7000) equipped with diamond Attenuated Total Reflection (ATR). Unsterile
and samples sterilized under UV for 30 min were investigated to compare whether the sterilization,
otherwise necessary for further biological-based studies, changes the physical and chemical
properties of the nanoclays. Scans were collected in the range of 4000-400 cm-1 at a resolution of
4 cm-1; a total of 100 scans were co-added to form the final spectrum for each of the samples.
Surface morphology and elemental composition of the samples were investigated using a
Hitachi S-4700 Field Emission Scanning Electron Microscope (SEM, Hitachi High-Technologies
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Corporation) equipped with an energy dispersive X-ray spectroscopy (EDX). Surface morphology
was examined at 5.0 kV while elemental composition was determined at 20.0 kV. For the analyses,
dry powder samples were mounted onto a carbon tape and then sputter coated for 10 s in vacuum
injected with argon using a gold/palladium target. The argon atoms were ionized and collided with
the gold/palladium target, causing the metal ions to deposit on the sample in a thin conductive
layer of about 3 nm as calculated using the equation d=KIVt, where d is thickness, k is a constant
value of 0.17, I is plasma current, V is voltage, and t is the time.
The size distribution of the samples was determined by dynamic light scattering (DLS) via
the Mastersizer 2000 with a Hydro 2000S accessory (Malvern Instruments). For this, solutions of
UC, CC, UC900, or CC900 dispersed and bath sonicated in cell culture media (Dulbecco’s
Modified Eagle Medium: DMEM) containing 5% fetal bovine serum (FBS) or in phosphate
buffered saline (PBS) were dropped into the Hydro 2000S until laser obscuration was within 1020%. The size analysis was performed 3 consecutive times with a stirrer speed of 1750 rpm and
under continuous sonication.
Samples’ sedimentation studies were performed by tracking changes in absorbance upon
different incubation time when using an Evolution 300 UV-VIS spectrophotometer (Thermo
Scientific). Briefly, concentrations of 100 µg/ml of UC, CC, UC900, and CC900 were prepared in
media as described above. The maximum absorbance of each sample was obtained by scanning
the absorbance in the 400-1100 nm range. Sedimentation was determined by measuring the
changes in absorbance of each solution at the obtained maximum absorbance of 560 nm after 0,
0.5, 1, 2, 3, 4, 5, and 6 h incubation in media respectively, with media serving as the blank at each
time point.
Cell Culture
Immortalized human bronchial epithelial cells (BEAS-2B) were cultured in media
containing 1 % L-glutamine, and 1 % penicillin-streptomycin (all reagents were purchased from
Life Technologies, USA). The cells were passaged regularly using 0.25 % trypsin (Invitrogen,
USA) and incubated at 37 ⁰C, 5 % CO2 and 80 % relative humidity. Before each experiment cells
were grown to a confluent monolayer.
Electrical Cell-substrate Impedance Testing
Real-time measurements of cellular resistance and attachment were performed using an
electrical cell-substrate impedance sensing instrument (ECIS-ZΘ, Applied Biophysics, NY). For
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the cellular studies, a 96 well plate (96W10idf) that contained inter-digitated finger connection
electrodes covering an area of 3.985 mm2 of the each well were used. Before addition of the cells,
the electrodes were stabilized for 2 h with 200 µl media to minimize electrode drift during the
experiment. After stabilization the cells were added at a density of 1.50E+05 cells/ml in a volume
of 150 µl/well. The cells were allowed to grow for 24 h until they reached a confluent monolayer,
as indicated by a constant level resistance.49 After 24 h, 100 µg/ml of UC, CC, UC900, or CC900
(unsterilized) dispersed in media was added to their respective wells; cells in media served as the
control. Subsequently, 24 h after treatment, the media was removed and the cells were washed 2
times with PBS. Fresh media was added to all of the wells, and the recovery of the cells was
monitored for 48 h.
Live Cell Count
BEAS-2B cells were seeded in a 12 well plate (Thermo Scientific, USA) at a density of
2.0E+05 cells/ml. After 24 h, the cells were treated with UC, CC, or thermally degraded
byproducts at a dose of 100 µg/ml. Before addition to the respective wells, each of the samples
was sonicated for 8-10 min in media in a bath sonicator (2510 Branson); cells in only media served
as controls. Twenty-four, 48, and 72 h post exposure to UC, CC, or thermally degraded byproducts,
the cells were trypsinized and stained with 0.4% trypan blue solution (Invitrogen, USA).
Subsequently, 10 µl of the sample containing the stained cells was added to a hemocytometer, and
the number of cells in the 4 outer grids was counted through the use of the Leica DM IL optical
microscope (Leica Microsystems) using a 10X objective. Analyses of cellular proliferation after
exposure to UC, CC, UC900, and CC900, along with their sterilized counterparts, respectively
were performed through direct live cell counts to eliminate concerns associated with false positive
as resulted from the similar sizes of the cells and clay suspensions.
Cellular Viability
BEAS-2B cells were seeded in a 96 well plate (Thermo Scientific, USA); 2.0E+05 cells/ml
were used. After 24 h, 100 µg/ml of UC, CC, UC900, or CC900 (unsterilized and sterilized)
dispersed in media was added to their respective wells while cells in media served as control
samples. The 4-[3-(4-Idophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate
known as WST-1 assay (Roche, USA) was used to determine cellular viability as a change in color
produced when cellular dehydrogenases reduced WST-1 to formazan.50 The color change is known
to be directly correlated with the number of metabolically active cells.50 Briefly, after 24, 48, and
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72 h of exposure, 10 µl of WST was added to the wells. Cells (exposed and control) were incubated
for 2.5 h and changes in their absorbances were evaluated using a FLUOstar OPTIMA plate reader
(BMG LABTECH) and 485 nm absorbance. Media, UC+media, CC+media, UC900+media, and
CC900+media (unsterilized and sterilized) served as blanks and resulted absorbance values were
subtracted from the cellular measurements counterparts.
Cell Imaging
BEAS-2B cells were seeded on glass coverslips in a 12 well plate at a density of 1.5E+05
cells/ml overnight. The cells were subsequently exposed to 100 µg/ml of UC, CC, UC900, or
CC900 (unsterilized) dispersed in media. After 24 h, the media was removed and the cells were
washed two times with Hank’s Balanced Salt Solution (HBSS) (Corning, USA), fixed with 4%
formaldehyde (Sigma-Aldrich, USA) for 15 min at 37 ⁰C, and subsequently washed 3x with HBSS
to remove any remaining formaldehyde. The cells plasma membrane and nuclei were then stained
with 3 µg/ml Alexa Fluor 594 wheat germ agglutinin (WGA) and 2 µM Hoechst 33342 (Image-iT
LIVE Plasma Membrane and Nuclear Labeling Kit, Life Technologies) in HBSS for 10 min at 4
⁰C. After incubation, cells were washed 2x with HBSS, mounted on glass coverslips, and imaged
under a Nikon Inverted Microscope Eclipse Ti Series using a 40x objective. The NIS-Elements
BR 3.1 software was used to define and analyze the size and morphology of cells. Around 75 cells
per treatment were considered to allow for 375 cell measurements per replicate; a total of 3
replicates were used.
Statistical Analyses
All cellular experiments were repeated at least 6 times for all samples, with the exception of
cell imaging which was repeated 3 times for unsterilized clay samples and ECIS which was repeated
4 times for unsterilized clay samples. All tables are presented as the average value with (+/-) SD
values. All graphs are presented as the mean value of the number of indicated replicates with (+/-)
SE bars. Significance was determined by one- or two-way analysis of variance ANOVA with
p<0.05* indicating significance; a post-hoc test was also run to identify which groups were different
from each other if statistical differences were recorded.

Results and Discussion
We aimed to investigate the toxicological profiles of as-received pristine and organically
modified nanoclays and their thermally degraded, end of life cycle byproducts using non39

destructive and high throughput real-time electroanalytical approaches.44,51,46 Cloisite Na+ (UC), a
pristine montmorillonite, and Cloisite 30B (CC), an organically modified montmorillonite
frequently used in food packaging17,18 and medical industry,21 were used as testing materials to
mimic potential human inhalation exposure during nanocomposites manufacturing and usage,
while thermally degraded forms of these nanoclays, i.e., Cloisite Na+ (UC900) and Cloisite 30B
(CC900), were used to mimic the municipal solid waste incineration disposal environment
generated at the product-based nanoclay end of life cycle.
Nanoclays and Their Thermally Degraded Byproducts Characterization
First, to mimic the incineration conditions of pristine (UC) or organically modified
nanoclay (CC) and thus generate end of life cycle nanoclay byproducts, thermogravimetric
analysis (TGA) was used. Briefly, samples degraded under temperatures ranging from 25 to 950
⁰C allowed moisture, volatile, fixed carbon content, and ash content identifications (Table 1). If
initially UC had a greater weight loss, with about 20 % weight loss by 105 °C and 5 % more in the
105 to 800 °C temperature range, CC experienced the vast majority of its weight loss (about 30
%) in the 105 to 800 °C temperature range (Figure 1a).33 Further, a significant higher volatile and
ash content were observed for CC relative to the pristine sample, presumably resulted from the
functionalization of CC with methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium (per the
manufacturer specifications).

Table 1: Amount of moisture, volatile, ash, and fixed carbon present in UC and CC as determined
by TGA. The symbol * indicates a significant difference between UC and CC.

UC
CC

Moisture
(%)
17.76 +/- 0.12
2.81 +/- 0.01*

Volatile
(%)
6.31 +/- 0.04
28.87 +/-0.01*

Ash
(%)
75.72 +/- 0.13
67.28 +/-0.01*

Fixed Carbon
(%)
0.22 +/- 0.03
1.05 +/-0.00*
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(a)

(b)

Figure 1: (a) Thermal degradation profile of UC and CC (n=2). (b) FTIR spectrum for UC and
CC along with their thermally degraded byproducts (n=2).
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Differences in chemical composition between UC, CC, and their thermally degraded
byproducts were confirmed using Fourier transform infrared spectroscopy (FTIR) and are shown
in Figure 1b. Both clays revealed the characteristic peaks indicative of the Si-O-Si stretching
vibration of silicate29,52 at 1000 cm-1 and of the Al-OH-Al deformation of aluminates29,53 at 900
cm-1 respectively, while peak shifting was observed after their thermal degradation. The peak
around 840 cm-1 was a result of the deformation of the OH linked to Al3- and Mg2-

53

while the

peak around 630 cm-1 was associated with the out of plane vibration of the Al-O group.54,55
Complementarily, UC900 had an additional peak around 640 cm-1 presumably due to Si-O-Si
bending53 while CC900 no longer retained the peaks normally present in its CC form at 2920,
2850, and 720 cm-1 respectively, thus confirming the degradation of the organic modifier.56 Such
peaks were likely resulted from the asymmetric or symmetric stretching of the C-H groups
included in methylene groups or alkane rock of CH2 for alkanes with 7 or more carbons,
respectively29,53 as resulted from the incorporation of the methyl, tallow, bis-2-hydroxyethyl,
quaternary ammonium organic modifier during the nanoclay processing.29,53 Molecular
composition of UC, CC, and their thermally degraded counterparts was not changed after UV
sterilization (Figure S1).
Scanning Electron Microscopy (SEM) allowed surface morphologies analyses of the asreceived and end of life cycle samples (Figure 2). Generally, UC appeared to have less layering
and smoother edges relative to CC (Figure 2a,b); similarly, UC900 and CC900 existed in
agglomerated forms however, they displayed a fairly uniform surface with smooth edges for
UC900 (Figure 2c) and a more fragmented surface with platelets jutting out for CC900 (Figure
2d). The observed changes in morphology from pristine nanoclay to thermally degraded nanoclay
could be due to both the dehydroxylation of the crystal lattice structure of montmorillonite that
occurs around 700 °C 56 as well as from the presence of the organic modifier which causes an
increase in the nanoclay’s basal spacing57 and thus possible differences in the platelet structure
breakdown during thermal degradation. UV sterilization did not produce significant changes in the
surface morphology of UC, CC, or their thermally degraded byproducts (Figure S2a-d).
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(a)

(b)

(c)

(d)

(e)

Figure 2: Surface morphology of (a) UC, (b) CC, and thermally degraded (c) UC900, and (d)
CC900 as determined by SEM. (e) Elemental composition of as-received nanoclay and their
thermally degraded byproducts as determined by EDX at 1 µm (n=5). The symbols * and ~ indicate
significant differences between UC and CC and between as received nanoclay and its thermally
degraded byproduct, respectively.
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UC and CC differed significantly in their elemental composition as determined by energy
dispersive X-ray (EDX) spectroscopy (Figure 2e). Specifically, CC showed a higher weight
percent of carbon and a lower weight percent of sodium, both relative to UC, thus confirming the
modification with the organic modifier.58 After thermal degradation however, the weight percent
of carbon decreased significantly for CC900, while the weight percent of magnesium, aluminum,
and silicon increased; further, no sodium was observed. Complementarily, no significant
differences were observed between the elemental composition of UC and its thermally degraded
byproduct, UC900. The lower amount of carbon present in CC900 versus CC, as well as the fact
that there was no longer a carbon difference between the two forms of thermally degraded clay is
consistent with the previous studies and confirms the loss of the organic modifier after thermal
degradation56 Analyses also showed that the elemental composition of UC, CC, and their thermally
degraded counterparts was not affected by UV sterilization (Figure S2e).
All of the samples displayed size distributions in the micrometer range upon sonication in
either cellular media (Table 2) or phosphate buffer saline (PBS; Table 3), indicating that samples
formed agglomerates. Agglomerate’s size distribution was a function of the sample’s chemical
signature (Figure 3), with cell culture media with 5% serum containing appropriate cell growth
proteins favoring larger agglomerates formation than PBS alone, likely due to the interactions of
the clays with the proteins in the media forming coronas.59,60 Interestingly, analyses showed that
CC displayed smaller diameter sizes in both media and PBS relative to the other three samples,
likely due to the presence of the organic modifier (Figure 3a,c). Contrary, thermally degraded
samples of CC900 formed larger conglomerates relative to their non-degraded counterparts
presumably due to their reduction of OH contents, with a 35 % and 36 % increase in size for CC900
in media and PBS, respectively, relative CC (Figure 3b,d). Table S1 and S2 and Figure S3a-d (both
in Supplementary Information) display particle diameter sizes based upon % volume, with results
confirming that while there were a greater number of small sized particles, the larger sized particles
were taking up more volume. Sedimentation analysis showed that all of the samples had around
85% or more particles settled by 6 h ((Supplementary Information Figure S4), with the samples
experiencing the greatest sedimentation within the first 3 h.
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Table 2: Average particle diameter distribution sizes (µm) in solutions of media relative to the
number of particles.
<10%
<50%
<90%

UC
4.66 +/- 0.25
7.70 +/- 0.40
13.91 +/- 0.48

CC
2.63 +/- 0.06
3.85 +/- 0.17
7.23 +/- 0.36

UC900
3.58 +/- 0.08
5.50 +/- 0.18
10.86 +/- 0.24

CC900
3.75 +/- 0.13
5.89 +/- 0.23
11.22 +/- 0.29

Table 3: Average particle diameter distribution sizes (µm) in solutions of PBS relative to the
number of particles.
<10%
<50%
<90%

UC
3.88 +/- 0.16
6.16 +/- 0.26
11.02 +/- 0.30

CC
2.66 +/- 0.06
3.99 +/- 0.12
7.86 +/- 0.23

UC900
3.32 +/- 0.01
5.41 +/- 0.02
11.28 +/- 0.04

CC900
3.75 +/- 0.01
6.23 +/- 0.00
11.88 +/- 0.02

Figure 3: Average particle diameter size distribution of UC, CC, UC900, and CC900 in solutions
of (a and b) media or (c and d) PBS.
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The measured clay or thermally degraded byproducts sizes were similar to those found in
manufacturing and disposal environments.61 Specifically, manufacturing workplaces showed
particle sizes from around 2.3 nm to 50 µm.62,63 Further, the fly ash from incinerators was shown
to display particles of size distributions ranging from 1 nm to 1000 µm, with a large fraction of
such particles being under 100 µm.37,64,65 This is in contrast with bottom ash64,65 which was
generally shown to contain larger particles normally ranging from around 250 µm to more than 8
mm, though the majority of the bottom ash was around 2-8 mm.65
Evaluate Cellular Behavior upon Exposure to Nanoclays or Thermally Degraded Byproducts
Changes in cell-induced impedance signals’ were used to evaluate the characteristics of
epithelial lung cells before and after exposure to as-received pristine, organically modified and
end of life cycle nanoclay byproducts, as well as cellular ability to recover from any potential
deleterious effects. Specifically, electric cell-substrate impedance sensing (ECIS) quantified
changes in cell-substrate interactions and cell morphology, in real-time and non-invasively, all
after exposure of human bronchial epithelial cells (BEAS-2B) to 100 µg/ml doses of the abovecharacterized samples. ECIS was previously used to monitor the morphology, attachment, and
movement of cells,51,46 while BEAS-2B’s were previously used as model systems66 to mimic
inhalation toxicity. Previous studies have showed that the size of particles greatly influences their
translocation in biological systems, with particles below 2.5 µm reaching the alveoli42 and larger
ones likely affecting cells in the upper airways.42 Another study showed that the platelet-shaped
particle with a projected area diameter up to 25 µm and thickness up to 0.1 µm is able to be respired
and deposited in the lungs.67 BEAS-2B epithelial cells were shown to serve as the first line of
defense when a material is introduced into the human lung by respiration. The dose was chosen to
represent a 6-year working lifetime, based on 8 h/day and 50 weeks/year as derived from particle
deposition studies in rat lungs or computer modeling involving variables related to particle
characteristics and lung characteristics of humans respectively.48,68
For analysis, the BEAS-2B cells were seeded onto the ECIS electrodes and exposed to
clays or end of life cycle clay-based byproducts for 24 h (Figure 4, Region A and Region B
respectively). To assess cellular recovery after clay or byproduct-based treatment, the clays and
byproducts were removed and cellular behavior was recorded in real-time for another 48 h, using
4000 Hz, (Figure 4, Region C). The chosen frequency allows for resistance evaluation without
effects on cell’s plasma membrane.69 Further, at this frequency, previous analyses have showed
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that the impedance is dependent on the cell bodies, whereas at the lower or higher frequencies,
parameters such as impedance of the electrode/electrolyte interface or the medium, and the
constriction resistance of the working electrode dominate the impedance measurements.70
Our results showed that the resistance of cells treated with the clay or byproduct dropped
when compared to the control (Figure 4a); in particular, CC showed the greatest drop in resistance,
with an almost complete loss after 6 h of treatment (Region B). Upon 24 h of treatment and removal
of the clays or end of life cycle byproducts, cells treated with UC, UC900, and CC900 were able
to regain/maintain their resistance values (Region C). Further, the trends in resistance were similar
for both UC and UC900, and slightly lower for CC900; no regain in resistance was however
recorded for cells exposed to CC.

(a)

(b)

Figure 4: (a) Representative real-time measurements of normalized resistance for BEAS-2B cells
before (Region A), during (Region B), and after treatment (Region C) with as-received and
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thermally degraded nanoclays. (b) Real-time measurements of normalized alpha (α) parameter for
BEAS-2B cells before (Region A), during (Region B), and after treatment (Region C) with asreceived and thermally degraded nanoclays.

Mechanisms Responsible for Nanoclays or Thermally Degraded Byproducts Cellular Changes
Previous analysis have showed that a drop in resistance could be associated with changes
in cell-substrate interactions,71 in cell viability and proliferation,72 or in cell shape as resulted from
cell death, since flatter, more spread cells are responsible for higher resistance than rounder or
apoptotic cells.51,46 Complementary, complete loss in resistance was shown to be due to cell death
and detachment from the electrode.71
To evaluate the first, namely whether cells exposed to nanoclays show changes in cellsubstrate interactions, we used the α parameter which details the current through the ventral
surfaces of the cells and electrodes73 (Figure 4b). Indeed, while CC showed a complete loss in cellsubstrate interaction within the course of the study time, cells treated with UC showed a decrease
in α relative to the control cells within Region B, however, after clay removal, they maintained
their cell-substrate interaction (Region C). Complementary, UC900 and CC900 had similar α
values relative to the control, thus indicating that interactions between the cells and the substrate
were maintained; however, resistance was lower for both relative to the control, possibly indicating
that changes to the cell morphology had occurred. CC900 also showed an increase in the α
parameter within the 48 h post treatment removal (Region C) confirming cell recovery.
To evaluate the second, namely whether changes in resistance are due to decreases in
cellular viability and proliferation, we used cellular assays. Indeed, analyses showed that UC and
CC displayed significant decreases, with CC causing a time-dependent decrease in cellular
proliferation and viability over 72 h of exposure, relative to the control, UC, and the thermally
degraded byproducts. Similar results were obtained by Maisanaba et al. who showed decreases in
cellular viability in a time dependent manner at doses above 3.91 µg/ml upon treatment with CC
of the human colon cell line, Caco-2.30 UC900 and CC900 showed a more varied response in both
live cell counts and cellular viability relative to their non-degraded counterparts. In particular,
UC900 had a significant decrease in live cell count (Figure 5a), while no significant decreases in
cellular viability were obtained for the thermally degraded clays, both relative to the control
(Figure 5b). CC900 displayed an increase in cellular proliferation at 72 h relative to 48 h and
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further confirmed the observed Region C changes in the α parameter. The ability of CC900 to
display increased proliferation, may hint at its potential to produce effects similar to carcinogen
carbon black; complementary study noted for instance that carbon black caused an increase in
epithelial cell proliferation, as well as increases in mutation frequency in these cells, therefore
hinting at an increased prevalence of cancer incidence upon such exposures.74 No significant
differences were obtained between UC and UC900 and overall there were no major differences
between sterilized and unsterilized nanoclays (Figure S5a,b). Verma et al. complement our results
on as-received nanoclays by showing differences in toxicity in A549 cells based on the clay
morphology, with platelet type nanoclays showing lower cell numbers relative to the tubular type,
as well as varying toxicity between the platelet types.31

(a)

(b)

Figure 5: Toxicity of as-received and thermally degraded nanoclays determined by (a) live cell
count and (b) cellular viability via WST assay, for unsterilized nanoclay (n=6). The symbols * and
~ indicate significant differences between the control and nanoclay treatments and between asreceived nanoclay and thermally degraded byproducts, respectively.
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To evaluate the last, namely whether changes in cell shape were correlated with the ECIS
results, cellular imaging was used. Indeed, analysis showed that all of the clays and thermally
degraded byproducts altered cellular shape and size, as well as cells confluence (Figure 6a-e). For
instance, the treated cells displayed abnormal cell shapes with a more stretched and altered profile
away from the more oval shape of the control cells. Further, the membranes of the cells exposed
to UC900 and CC900 did not appear as distinct as those of the control cells and further, the
integrity of the exposed cell monolayer seemed compromised. Moreover, treatment with UC and
CC caused significant decreases in the area of the cells relative to the control therefore further
confirming the ECIS results (Figure 6f); i.e., smaller cells would be taking up less room on the
electrode, causing for more current to pass through and thus a lower resistance as shown by ECIS.
Further, the dramatic loss of resistance and α shown for cells treated with CC along with the
circular shape observed in cell imaging, show that alterations are likely occurring in these cells
morphology as a first step towards cell transformation.
The larger effect observed for CC is presumably due to the presence of its organic modifier
known to induce toxicity33,30,35 through decrease in cellular proliferation,31 as well as membrane
changes29,32 and DNA damage.33,34,35 It is our hypothesis that the route of the displayed toxicity of
cells treated with CC could be through alteration of the cytoskeleton, causing for the observed
decreases in resistance and α. Specifically, previous analysis for instance have shown that circular
cells have lost their ability to attach to the substrate (electrode), as well as to other cells eventually
leading to and/or serving as a signal of cell death.75,76 Such changes in morphology are known to
be occurring due to cytoskeleton reorganization76 with alteration in cytoskeleton44 leading to
changes in cell mechanics,77 migration,78 differentiation,79 and organization.80 Further, it is likely
that cells exposed to UC are also experiencing alterations of their cytoskeleton. While UC900 and
CC900 did not experience as much a loss in the α parameter relative to the as-received clays, they
still showed decreases in resistance, possibly associated with reduced membrane integrity as
observed in cellular imaging. Such changes in cell morphology, structure, and cell-substrate
interactions may eventually lead to loss of cell-cell signaling.76,81
Similar to our results, the presence of the organic modifier in clays was associated to greater
toxicity.29,30,35,82 Janer et al. for instance tested dose-response (<500 µg/ml) of 5 cell lines and 1
primary cell line and found that clays organically modified with dimethyl dihydrogenated tallow
ammonium and dimethyl benzyl hydrogenated tallow ammonium respectively had higher
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cytotoxicity relative to pristine clays.82 When testing the modifier, quaternary ammonium
compound (QAC), Sharma et al. found that the QAC had the same effect as the coated clay on the
genotoxicity of Caco-2 cells, suggesting that the toxic effects were due to QAC.35 Further, one
study by Yoshida et al. found that organically modified silica particles coated with amine or
carboxyl groups reduced the amount of reactive oxygen generation in HaCaT and TLR-1 cells.
They also observed reduced DNA damage in HaCaT cells all relative to the unmodified silica
particle, showing that the type of organic modifier and not just its presence plays a key role in
toxicity.83

Figure 6: Fluorescent images of the cell membrane (red) and nucleus (blue) for (a) control cells
and cells treated with (b) UC, (c) CC, (d) UC900, and (e) CC900 after 24 h. (f) Cell area (µm)
after 24 h of treatment with nanoclays (n=3).

While the full picture of the mechanistic toxicity of the nanoclays or end of life byproducts
is still undergoing, to our knowledge, these are the first studies to identify toxicological profiles
associated with cellular exposure to thermally degraded byproducts using a non-invasive and real51

time cellular based platform. Further, while in our study we evaluated 4 different samples, one
could envision creating a combinatorial assay to allow for profiles identification based on both
sample as well as cellular characteristics thus extending the flexibility of this experimental set-up
for toxicity evaluation of a large variety of nanomaterials, all in real-time and in a high-throughput
manner.

Conclusions
The ECIS provided new means to identify the toxicity profiles of the clays or byproducts,
in a non-invasive, high-throughput, and real-time manner. Specifically, the morphological,
behavioral, and viability changes observed in BEAS-2B cells after treatment with as-received clay
or thermally degraded byproducts show that such samples have the potential to produce toxic
effects when used both in manufacturing or disposal environments. Organically modified
nanoclay, CC, had the greatest toxic effects, with large losses in cell-substrate and cell-cell
interactions and near maximal cell population loss by 72 h. Contrary, its thermally degraded
byproduct, CC900, induced cell proliferation possibly hinting to similar toxic profiles to known
carcinogen carbon black. UC, and its thermally degraded counterpart, UC900, displayed less
significant toxic effects.
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Supporting Information
Chapter 2: Toxicity Evaluations of Nanoclays and Thermally Degraded Byproducts
through Spectroscopical and Microscopical Approaches

Materials and Methods
Material Characterization
In order to determine if UV sterilization caused changes in molecular composition, samples
of UC, CC, UC900, and CC900 were sterilized for 30 min under UV light and examined via
Fourier Transform Infrared Spectroscopy (FTIR, Digilab FTS 7000) equipped with diamond
Attenuated Total Reflection (ATR). Scans were collected in the range of 4000-400 cm-1 at a
resolution of 4 cm-1; a total of 100 scans were co-added to form the final spectrum of each one of
the samples being analyzed. Samples were used as dry powders.
In order to determine if UV sterilization caused changes in surface morphology and
chemical composition, samples of UC, CC, UC900, and CC900 were sterilized for 30 min under
UV light and examined using a Hitachi S-4700 Field Emission Scanning Electron Microscope
(SEM, Hitachi High-Technologies Corporation) equipped with an energy dispersive X-ray
spectrographic detector (EDX). Surface morphology was examined at 5.0 kV while elemental
composition was determined at 20.0 kV. For the analyses, the samples (dry powder forms) were
mounted onto a carbon tape and then sputter coated for 10 s in vacuum injected with argon using
a gold/palladium target.
Sedimentation over 6 h of the clays was performed by measuring absorbance via the
spectrophotometer. Briefly, a concentration of 100 µg/ml of the two clays and their thermally
degraded byproducts was prepared in media. The maximum absorbance of each clay was obtained
by scanning the absorbance of each solution from 400-1100 nm. Sedimentation was determined
by measuring the absorbance of each solution at the obtained maximum absorbance of 560 nm for
0, 0.5, 1, 2, 3, 4, 5, and 6 h with media serving as the blank at each time point.
Toxicity Analyses
UC, CC, and their thermally degraded byproducts were sterilized under UV light for 30 min
in order to verify that the toxic effects obtained from the clay were due to the clay and not due to
contaminants on the clay before sterilization. Therefore, live cell counts and cellular viability via
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the WST assay were also performed with UV sterilized clay samples. Live cell counts were
performed by seeding BEAS-2B cells in a 12 well plate (Thermo Scientific, USA) at a density of
2.0E+05 cells/ml. After 24 h, the cells were treated with UC(UV), CC(UV), or UV sterilized
thermally degraded byproducts at a dose of 100 µg/ml. Before addition to the respective wells, the
samples were sonicated for 8-10 min in media. Cells in only media served as controls. After 24,
48, and 72 h post exposure to UC(UV), CC(UV), UC900(UV) or CC900(UV), the cells were
trypsinized and stained with 0.4% trypan blue solution (Invitrogen, USA). Subsequently, 10 µl of
the sample containing the stained cells was added to a hemocytometer, and the number of cells in
the four outer grids was counted through the use of the Leica DM IL optical microscope (Leica
Microsystems) at 100X magnification. Cellular viability of cells treated with UV sterilized clays
was performed by seeding BEAS-2B cells in a 96 well plate (Thermo Scientific, USA) at a density
of 2.0E+05 cells/ml. After 24 h, 100 µg/ml of UC(UV), CC(UV), UC900(UV), or CC900(UV)
dispersed in media was added to their respective wells; cells in media served as control samples.
After 24, 48, and 72 h of exposure, 10 µl of WST was added to the wells. The cells were incubated
for 2.5 h and then read by a FLUOstar OPTIMA plate reader (BMG LABTECH) at 485 nm
absorbance.

Media,

UC(UV)+media,

CC(UV)+media,

UC900(UV)+media,

and

CC900(UV)+media served as blanks and their obtained absorbance values were subtracted from
their cellular counterparts.
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Results

Table S1: Average particle diameter distribution sizes (µm) in solutions of media relative to %
volume.
<10%
<50%
<90%

UC
7.93 +/- 0.27
14.41 +/- 0.46
24.21 +/-1.08

CC
4.25 +/- 0.16
9.76 +/- 0.08
21.73 +/- 1.32

UC900
6.25 +/- 0.01
13.53 +/- 0.21
25.81 +/-0.76

CC900
6.36 +/- 0.20
12.71 +/- 0.30
23.05 +/- 1.11

Table S2: Average particle diameter distribution sizes (µm) in solutions of PBS relative to %
volume.
<10%
<50%
<90%

UC
6.29 +/- 0.16
11.68 +/- 0.12
21.27 +/- 0.60

CC
4.68 +/- 0.12
11.12 +/- 0.12
23.00 +/- 0.15

UC900
6.69 +/- 0.03
14.64 +/- 0.05
28.14 +/- 0.09

CC900
6.79 +/- 0.01
13.16 +/- 0.03
23.53 +/- 0.07

Figure S1: FTIR spectrum of as-received and thermally degraded nanoclay sterilized by UV light
for 30 min (n=2).
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(a)

(b)

(c)

(d)

(e)

Figure S2: Surface morphology of sterilized (a) UC(UV), (b) CC(UV), and thermally degraded
(c) UC900(UV), and (d) CC900(UV) as determined by SEM. (e) Elemental composition of asreceived and thermally degraded nanoclay sterilized by UV light for 30 min determined by EDX
at 1µm (n=5). The symbols * and ~ indicate significant differences between UC and CC and
between as-received nanoclay and thermally degraded byproducts, respectively.
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Figure S3: Average particle diameter size distribution of UC, CC, UC900, and CC900 in solutions
of (a-b) media or (c-d) PBS based on % volume (n=3).

Figure S4: Sedimentation of as-received and thermally degraded nanoclays over 6 h as determined
via spectrophotometer (n=4).
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(a)

(b)

Figure S5: Toxicity of as-received and thermally degraded nanoclays sterilized by UV light for
30 min determined by (a) live cell count and (b) cellular viability via WST assay. The symbols *
and ~ indicate significant differences between the control and nanoclay treatments and between
as-received nanoclay and thermally degraded byproducts, respectively. The symbol ¤ indicates
significant differences between unsterilized nanoclay and its sterilized counterpart.
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CHAPTER 3
Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical
and Chemical Properties
Abstract
Nanoclays’ functionalization with organic modifiers increases their individual barrier
properties, thermal stability, and mechanical properties and allows for ease of implementation in
food packaging materials or medical devices. Previous reports have showed that while organic
modifiers integration between the layered mineral silicates leads to nanoclays with different
degrees of hydrophobicity that become easily miscible in polymers, they could also pose possible
effects at inhalation or ingestion routes of exposure. Through a systematic analysis of 3 organically
modified and one pristine nanoclays, we aimed to relate for the first time the physical and chemical
characteristics, determined via microscopical and spectroscopical techniques, with the potential of
these nanoclays to induce deleterious effects in in vitro cellular systems, i.e. immortalized and
primary human lung epithelial cell lines. In order to derive information on how functionalization
could lead to toxicological profiles throughout nanoclays’ life cycle, both as-received and
thermally degraded nanoclays were evaluated. Our analyses showed that the organic modifiers
chemical composition influenced both the physical and chemical characteristics of the nanoclays,
as well as their toxicity. Overall, nanoclays with organic modifiers containing bio-reactive groups
displayed lower cellular numbers as well more elongated cellular morphologies relative to the
pristine clay and the nanoclay containing a modifier with long carbon chains. Additionally, thermal
degradation caused for loss of the organic modifiers, as well as changes in size and shape of the
nanoclays, which led to changes in toxicity. Our study provides insight into the synergistic effects
of chemical composition, size, and shape of the nanoclays and their toxicological profiles in
conditions that mimic exposure in manufacturing and disposal environments respectively, and can
help aid in safe-by-design manufacturing of nanoclays with user-controlled functionalization and
lower toxicity levels when food packaging applications are considered.
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Introduction
With an estimated growth rate of about 25% annually,1 nanocomposites or composites
containing nanoclays incorporated into polymers, are expected to have wide implementation in
commercial and industrial products,2 from food packaging materials3 to automotive4 and medical
devices.5 In food packaging for instance, nanoclays are organically modified to allow for better
exfoliation within the polymer matrix4 at a low silicate weight percent,6 leading to commercial
applications of almost 70% of the market volume.7 The organic modification generally occurs via
an ion exchange reaction with the positively-charged ions present between the nanoclay platelets4
and directly impacts the type of polymer the clay can be exfoliated in, as well as the properties of
the resulting nanocomposite. The increased implementation of nanoclays is a result of the
improved mechanical strength,8 barrier properties,8 UV dispersion,9 and fire resistance,10 that they
inflict to the polymeric packaging materials thus reducing gas and moisture permeability,11
allowing for a longer shelf life4 while still producing a lightweight,12 transparent13 material capable
of withstanding physical manipulation12 and other environmental elements, such as light and
heat.12
Some of the most common nanoclays used in food packaging are Nanomer I.31PS,
Nanomer I.34TCN, and Nanomer I.44P respectively. These nanoclays, belonging to the
montmorillonite (MMT) clay ”family”, are made up of 2:1 phyllosilicates consisting of 2 silicateoxygen tetrahedral sheets bounding an aluminum octahedral sheet,14 with each of the clays
containing a different organic modifier that tailors its name as well as its exfoliation ability in the
specific types of polymer matrices.12 Specifically, Nanomer I.31PS is modified with
aminopropyltriethoxysilane and octadecylamine, while Nanomer I.34TCN and Nanomer I.44P are
modified with methyl dihdroxyethyl hydrogenated tallow ammonium and dimethyl dialkyl amine
respectively. Previous results showed that upon such modifications, Nanomer I.31PS and Nanomer
I.44P can be exfoliated in polyethylene15 and polypropylene16 to result in composites with
increased Young’s15,17 and storage moduli,15 thermal stability,17 and tensile strengths17 that
ensures enhanced shelf life of food packaging products. Complementary, addition of Nanomer
I.34TCN into polylactide acid18,13 has resulted in nanocomposites with increased barrier
properties,18,13 thermal stability,18 and tensile modulus,18 along with high transparency13 thus
making Nanomer I.34TCN a good candidate for the green food packaging area, i.e., using
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biodegradable polymers from renewable resources to allow for a more environmental friendly food
packaging material formation.
Previous reports showed that manufacturing and disposal of nanocomposites used in food
packaging applications could possibly lead to nanoclays being released from their polymer
matrix,19,20 which can pose health concerns if the exposure is via inhalation or ingestion routes.
General in vitro assessment has found that both pristine and organically modified nanoclays cause
decreased cellular proliferation,21 mitochondrial damage,22 reactive oxygen species (ROS)
generation,22 membrane22 and DNA damage,23 micronuclei induction,24 and changes in mRNA
expression,24 in lung epithelial cells,21,25 liver cells,22 colon cells,23 or skin cells,25 with the degree
of toxicity dependent on the cell type, dosage, and the organic modifier itself. Complementary, in
vivo results revealed significant toxic effects through alteration of protein expressions after
organically modified nanoclay was administered orally to rats,26 as well as robust inflammatory
responses characterized by transient neutrophilia for instance.27
However, while such reports hint at varying degrees of toxicity, minimal information is
available to compare and contrast the effects of the unique physico-chemical properties of the
nanoclays across their lifecycle and their effects on biological responses which may differ in
degree and mechanism of toxicity due to each clay’s unique properties and organic
functionalization. During their as-received usages in free forms in manufacturing environments,
workers could potentially be exposed to elevated levels of the airborne nanoclays.28, 29 In addition,
high temperatures and the oxidative environment present during the incineration process
associated with their disposal19 can lead to changes in both chemical composition and surface
morphology of nanoclays,20,30 that could potentially change their toxicological effect. Establishing
life cycle toxicity assessment profiles are essential to prevent deleterious effects associated with
inhalation of such particles by workers in both manufacturing and disposal environments.
Specifically, Yuwen et al, observed DNA damage in blood cells for workers exposed to high levels
of bentonite particles in factories producing such particles.29
We designed a systematic study to help determine the potential for inhalation toxicity of
the three organically modified Nanomer nanoclays currently used for food packaging applications.
Our study uses human immortalized bronchial epithelial cells (BEAS-2B), and primary small
airway epithelial cells (SAECs), as established cell lines for assessing toxicity induced via
inhalation since they have previously helped assess toxicity of graphene nanoparticles,31 asbestos32
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and carbon nanotubes.33 The SAECs model expands the impact of our study to a more humanrelated biological platform as primary cells more closely mimic their tissue of origin and further,
reduce misidentification, contamination,34 general genetic instability,35 or lack of functions and
markers often encountered with immortalized cellular systems. Additionally through the use of
two epithelial lung cell lines we will be able to further assess the potential toxicity of nanoclays
when they deposit in both the bronchioles and distal airways near the terminal bronchiole and
alveolar duct. Our systematic assessment will map and correlate the physical and chemical
properties of nanoclays at two points in their life cycle (i.e. production/manufacturing or the end
of their life cycle) with their potential to induce toxicity for a better understanding of how
nanoclays’ deleterious interactions with the cellular systems can be reduced so safe, yet effective
materials can be produced and implemented in commercial sectors.

Materials and Methods
Nanoclay Preparation
Four types of commercially available, raw (as-received), montmorillonite (MMT) clays,
were obtained from Sigma-Aldrich. Per the manufacturer specifications, Nanomer PGV (PGV) is
an unmodified, hydrophilic bentonite, Nanomer I.31PS (I.31PS) is surface modified with
aminopropyltriethoxysilane at 0.5-5 wt. % and octadecylamine at 15-35 wt. %, Nanomer I.34TCN
(I.34TCN) is surface modified with methyl dihdroxyethyl hydrogenated tallow ammonium at 2530 wt. % and, Nanomer I.44P (I.44P) is surface modified with dimethyl dialkyl amine at 35-45 wt.
%. All the modifications were done at the manufacturing site.
Thermal Degradation
Samples of PGV, I.31PS, I.34TCN, and I.44P were thermally degraded using a TGA701
Thermogravimetric Analyzer from LECO; degradation was used to mimic the disposal generation
in municipal solid waste plants.19 Differences in mass from unheated samples were monitored as
a function of temperature and used to calculate % content change. Moisture content of the samples
(around 0.5 g each) was determined in the 25 ºC to 105 ºC range, in nitrogen, at a rate of 6 ºC/min,
while high temperature volatile content was determined in the 105 ºC to 950 ºC range, in nitrogen,
at a rate of 43 ºC/min. Finally, ash content was determined in the 550 ºC to 900 ºC range, in oxygen,
at a rate of 15 ºC/min (Table S1). The resulting individual byproduct was collected to serve as the
end of life cycle sample assessment, i.e., thermally degraded Nanomer PGV (PGV900), thermally
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degraded Nanomer I.31PS (I.31PS900), thermally degraded Nanomer I.34TCN (I.34TCN900),
and thermally degraded Nanomer I.44P (I.44P900) respectively.
Material Characterization
Molecular composition of the samples and their thermally degraded byproducts in dry,
powder forms, was determined via Fourier Transform Infrared Spectroscopy (FTIR, Digilab FTS
7000) equipped with diamond Attenuated Total Reflection (ATR). For each of the samples, a total
of 100 scans in the range of 4000-400 cm-1 at a resolution of 4 cm-1 were co-added/ averaged to
form the final spectrum.
Surface morphology and elemental composition of the samples were investigated using a
Hitachi S-4700 Field Emission Scanning Electron Microscope (SEM, Hitachi High-Technologies
Corporation) equipped with an energy dispersive X-ray spectroscopy (EDX) unit. For the analyses,
dry individual powders were mounted on carbon tape and their surface morphology was examined
at 5.0 kV, while their elemental composition was evaluated at 20.0 kV. For surface morphology,
samples were also sputter coated for 10 s in vacuum injected with argon using a gold/palladium
target. The argon atoms were ionized and collided with the gold/palladium target, causing the
metal ions to deposit on the sample in a thin conductive layer of about 3 nm as calculated using
the equation d=KIVt, where d is thickness, k is a constant value of 0.17, I is plasma current, V is
voltage, and t is the time.
The size distribution of the nanoclays and thermally degraded byproducts was determined
by dynamic light scattering (DLS) via the Mastersizer 2000 with a Hydro 2000S accessory
(Malvern Instruments). For this, samples of PGV, I31PS, I.3TCN, I.44P, PGV900, I.31PS900,
I.34TCN900, or I.44P900 were dispersed either in Dulbecco’s Modified Eagle Medium (DMEM,
Life Technologies) containing 5% fetal bovine serum (FBS), or in Small Airway Growth Medium
(SAGM, Lonza) with SingleQuots Kit (Lonza) containing bovine pituitary extract, hydrocortisone,
human Epidermal Growth Factor, epinephrine, transferrin, insulin, retinoic acid, triiodothyronine,
gentamicin/amphotericin-B, and 1 % bovine serum albumin (BSA). Also, the nanoclays and
byproducts were dispersed in a control, phosphate buffered saline (PBS, Lonza) and in distilled
water containing 0.15 mg/ml Survanta®, a pulmonary surfactant.36 The solutions were then bath
sonicated and dropped into the Hydro 2000S until laser obscuration was within 10-20%. The size
analysis was performed 3 consecutive times with a stirrer speed of 1750 rpm and under continuous
sonication in the Hydro 2000S accessory.
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Cell Culture
Immortalized human bronchial epithelial cells (BEAS-2B) from American Type Culture
Collection (ATCC) were cultured in 100 mm dishes (Corning, Inc.) in DMEM containing 5% FBS,
1 % L-glutamine, and 1 % penicillin-streptomycin (all reagents were purchased from Life
Technologies). The cells were incubated at 37 ⁰C, 5 % CO2, and in an 80 % relative humidity;
consistent sub-culturing took place using 0.05 or 0.25 % trypsin (Invitrogen). Before each
experiment, cells were grown to a monolayer of 90-100% confluency and cells in the 3rd-6th
passage were used.
Additionally, small airway epithelial cells (SAECs) were cultured in SAGM with
SingleQuots Kit and 1 % penicillin-streptomycin (Life Technologies). Cells were seeded into T25 flasks (Corning, Inc.), grown to 75-80% confluency and subsequently split (5 passages total).
All experiments completed with SAECs were performed using the same passage number.
Half Maximal Inhibitory Concentration (IC50)
BEAS-2B cells and SAECs were seeded into 12 well plates (Thermo Scientific) at densities
of approximately 1.5x105 and 2.0x105 cells/ml, respectively. After 24 h, the cells were treated with
PGV, I.31PS, I.34TCN, I.44P or their thermally degraded byproducts at various doses ranging
from 0 to 197 µg/cm2 (i.e. 0, 0.03, 0.3, 13, 26, 66, 132, and 197 µg/cm2). To ensure an effective
dose metric and uniform dosage distribution per well, the dose is reported in µg/cm2 with the
analysis considering the area of the specific well into which the cells were seeded and the initial
dilution of nanoclays to form µg/ml solutions. Before addition to the respective wells, each
nanoclay or byproduct sample was sonicated for 10 min in a bath sonicator (2510 Branson; 100
W) with the concentrations used for exposure being serial dilutions from the original stock; cells
in only media served as controls. After 24 h of exposure to individual treatment, the treated cells
(as well as the controls) were washed to remove the nanoclays and byproducts, trypsinized, and
stained with 0.4% trypan blue solution (Invitrogen). Subsequently, 10 µl of the sample containing
the stained cells was added to a hemocytometer, and the number of cells in the 4 outer grids was
counted through the use of the Leica DM IL optical microscope (Leica Microsystems) and a 10X
objective. Analyses of the cellular proliferation post-exposure were used to extrapolate IC50 values
that would also be used in the remaining cellular assays. At least 6 replicates were performed for
BEAS-2B cells at each dose and 4 replicates for SAECs at each dose.
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Cellular Imaging
To evaluate changes in cell morphology, BEAS-2B cells and SAECs were seeded at
densities of 1.5x105 and 2.5x105 cells/ml, respectively, in 24 well plates. After 24 h the cells were
treated with the as-received nanoclays and thermally degraded byproducts, dispersed in media via
a bath sonicator, at their respective, determined IC50 dose. After 24 h of treatment the cells were
imaged through use of a Leica DM IL optical microscope (Leica Microsystems) with a 10X
objective. Two replicates were performed with 10 images, per replicate, taken at random spots
within the well for each control and treatment.
Extracellular Reactive Oxygen Species (ROS)
BEAS-2B cells were seeded into 24 well plates at a density of approximately 1.5x10 5
cells/ml. After 24 h, the cells were treated with nanoclays and byproducts dispersed in media
through use of a bath sonicator at their respective, determined IC50 value; cells exposed to only
media served as control samples. After 24, 48, and 72 h of treatment, 50 µl of the media was
transferred from the 24 well plate to its respective well in a black-bottomed 96 well plate (Corning,
Inc.). Subsequently, 50 µl of PBS was added to each well in the 96 well plate. Fifty µl of the
extracellular reactive oxygen species (ROS) assay reagent, Lumigen ECL Plus (Lumigen, Inc.),
was also added to each well. The samples were subsequently incubated at room temperature for 5
min, in the dark before luminescence was evaluated using a FLUOstar OPTIMA plate reader
(BMG LABTECH) at 600 nm. Media and treated media containing nanoclays or byproducts
suspended in solution served as blanks. Respective cellular measurements of the samples were
evaluated after subtracting the blanks in order to determine the effect treatment had on extracellular
ROS. It has been determined that Lumigen reagent assays generate chemiluminescent responses
specific to extracellular ROS.37 Four replicates were performed for each treatment.
Statistical Analyses
The cellular experiments were repeated at least 4 times for each one of the samples (with
the exception of cellular imaging). All tables are presented as the average value (+/-) standard
deviation (SD) values. All graphs are presented as the mean value of the number of indicated
replicates with (+/-) standard error (SE) bars. Excel and Origin (OriginLab) were used to determine
the IC50 value for each of the nanoclays and thermally degraded byproducts, through use of a bestfit line (either logistic, exponential, or logarithmic) for each individual replicate with each
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nanoclay or byproduct treatment containing at least 4 replicates. Significance was determined by
one-way analysis of variance ANOVA with p<0.05* indicating significance.

Results and Discussion
We

aimed

to

provide

insights

into

the

toxicity

mechanisms associated with human exposure to nanoclays in both manufacturing and disposal
areas. For this, we first selected a regiment of four nanoclays, namely one pristine (PGV) and
three organically modified nanoclays, (I.31PS, I.34TCN, and I.44P), with different physicochemical properties and with relevant implementation in current food packaging applications.7
Specifically, the modifier for I.31PS consists of a long alkyl tail and a silane coupling agent (Figure
1a).17 I.34TCN’s modifier consists of a long alkyl chain and 2 hydroxyl molecules,17 while, the
modifier for I.44P consists of 2 long alkyl chains.17 Secondly, we thermally degraded these
nanoclays in conditions aimed to mimic their disposal at the end of their individual life cycles and
created resulting byproducts. To assess possible deleterious pulmonary effects, two in vitro cellular
models were exposed to as-received nanoclays and their incinerated byproducts. Immortalized
human bronchial epithelial cells (BEAS-2B) and small airway epithelial cells (SAECs), previously
used for pulmonary toxicity in occupational studies, provide sensitive models for known nanoclay
deposition areas in the lung38 and serve as validation tool, as toxicity of nanoclays has shown to
differ based on cell line. The results are included below.
Materials Preparation and Characterization
To help evaluate the physico-chemical characteristics of the samples being assessed, we
compared nanoclays and their byproducts. Specifically, the thermally degraded byproducts of the
pristine (PGV) and the three organically modified nanoclays (I.31PS, I.34TCN, and I.44P) were
obtained at temperatures up to 950 °C, in three different temperature regimes known to mimic
incineration conditions at the end of food packaging product lifecycle19 (Figure 1b). The moisture,
high temperature volatiles, and ash contents of the resulting byproducts were determined in the
range of 25 °C to 105 °C and 105 °C to 950 °C in nitrogen for moisture and volatile contents, while
ash content was assessed in the range of 550 ⁰C to 900 °C in oxygen respectively.
Analyses showed that all the modified nanoclays had significantly lower amount of
moisture relative to the pristine nanoclay (Table 1), presumably a result of their greater
hydrophobicity resulted from individual chemical functionalization with an organic modifier
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known to replace adsorbed water normally found in pristine clays,39 therefore minimizing the
overall amount of free water to be released.40,41 The modified nanoclays also showed a
significantly higher amount of high temperature volatile content and a significantly lower amount
of ash content relative to the pristine nanoclay. This is also presumably due to the degradation of
the organic modifier which has previously been shown to be released within the 200-500 °C
temperature range.40,41 Further, out of the modified nanoclays themselves, I.44P seemed to have
the highest amount of high temperature volatile content of around 39 %, along with the lowest
amount of ash content of around 59 % respectively, presumably due to the chemical structure of
its organic modifier which is made up of 2 long alkyl chains which differs from the one of I.31PS
and I.34TCN, each only having one long alkyl chain.17

Table 1: The percent amount of moisture, high temperature volatiles, ash, and fixed carbon present
in the Nanomer nanoclays as determined by TGA. The symbol * indicates a significant difference
between PGV and the organically modified nanoclays (n=2).
Moisture

High Temperature Volatiles

Ash

Fixed Carbon

PGV

13.51 +/- 0.71

6.41 +/- 0.06

79.78 +/- 0.67

0.31 +/- 0.10

I.31PS

0.66 +/- 0.05*

30.53 +/- 0.01*

68.50 +/- 0.05*

0.32 +/- 0.08

I.34TCN

2.25 +/- 0.27*

26.50 +/- 0.08*

70.69 +/- 0.18*

0.58 +/- 0.16

I.44P

1.48 +/- 0.13*

39.23 +/- 0.12*

59.20 +/- 0.06*

0.10 +/- 0.06

The modified nanoclays also experienced a greater weight loss when compared to pristine
PGV, all within the temperature range of 400-800 °C (Figure 1b), with I.31PS and I.34TCN
experiencing similar amounts of weight loss of about 32 and 30 % respectively, while I.44P
experienced a greater weight loss of around 40 %. The observed differences are presumably due
to the weight percentages (wt. %) and chemical composition of the individual organic modifiers
used during functionalization, as well as their roles in the individual nanoclay’s degradation
profile,41 with I.44P’s organic modifier being added at 45 wt. %, while the organic modifiers of
I.31PS and I.34TCN were reported to be added up to 40 and 30 wt. %, respectively, via
manufacturer specifications. Our analyses are supported by Xie et al. that showed that the amount
of organic modifier released in degradation studies is dependent on the interlayer spacing and
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architecture of the modifier and its integration during nanoclay functionalization. 42 Lastly, PGV
seemed to have a more gradual weight loss in the 400-800 °C range when compared to the
functionalized nanoclays, which is probably associated with the MMT structure breakdown in
which hydroxyl groups incorporated within the crystal lattice are being dehydrated within the
temperature range of 500-800 ºC.41
Physico-chemical characterization of the nanoclays and their thermally degraded
byproducts was performed via Fourier Transform Infrared Spectroscopy (FTIR), scanning electron
microscopy (SEM) and elemental composition via energy dispersive X-ray spectroscopy (EDX).
Results of the thermally degraded byproducts are reported relative to the representative nondegraded form of the respective nanoclay being investigated. Specifically, FTIR analysis of the
characteristic peak of montmorillonite (MMT) at 1000 cm-1, indicative of Si-O-Si stretching
vibration of silicates,22,40 was observed for all the nanoclays. However, the peak was shifted to a
higher wavelength for the thermally degraded byproducts (Figure 1c,d,e) when compared to their
as-received counterparts. Further, all of the as-received nanoclays also displayed a peak at 900 cm1

indicative of Al-OH-Al deformation of aluminates,22,40,43 while the organically modified as-

received nanoclays displayed a peak at 840 cm-1 presumably resulted from the deformation of OH
linked to Al3- and Mg2- respectively.43 Previous analysis showed that peaks at 790 and 630 cm-1
are associated with Si-O groups43 and out of the plane vibration of Al-O group,44 respectively.
Additionally, the three, as-received, organically modified nanoclays also had peaks at 2920,
2850, and 720 cm-1 respectively, presumably resulting from the asymmetric and symmetric
stretching of their C-H groups included in methylene or alkane rock of CH2 for alkanes with 7 or
more carbons, respectively,22,40,43 and indicative of the incorporation of their respective organic
modifiers. The 3 peaks were however no longer present in the spectra of the thermally degraded
byproducts of these nanoclays, confirming their organic modifiers degradation.40 Additionally, the
peak around 3600 cm-1 with small repeated peaks moving out towards 3800 cm-1 for the as-received
clays, indicative of silanol groups on the SiO2 tetrahedral sheets,45 was no longer present for the
thermally degraded byproducts. Along with the shift recorded for 1000 cm-1 peak, the only other
peaks remaining for the thermally degraded byproducts were at 780 and 640 cm-1 respectively, and
are presumably associated with Si-O groups43 and Si-O-Si bending.43 Moreover, the peaks associated
with Al-OH-Al deformation and OH linked to Al3- and Mg2- were no longer present for any of the
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byproducts, again showing the degradation of the alumino-silicate lattice due to the loss of structural
water.40,41,42

(a)

(b)

(c)
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(d)

(e)

Figure 1: (a) Chemical structures of the organic modifiers present in I.31PS, I.34TCN, and I.44P
(b) Thermal degradation profile of PGV and the 3 organically modified nanoclays (n=2). FTIR
spectrum for (c) I.31PS, (d) I.34TCN, and (e) I.44P along with their thermally degraded
byproducts, all relative to PGV and PGV900 (n=2).

SEM surface morphology analyses revealed layered platelet surfaces (Figure 2a-d) for all
the nanoclays being investigated, with I.44P appearing to have a sharper, more defined plateletlike geometry when compared to the other nanoclays being investigated. PGV and I.34TCN
displayed similar morphologies in that their platelet edges seemed smoother, i.e., more rounded,
relative to I.31PS and I.44P. Also, while I.31PS had a similar morphology to I.44P. It did not seem
to contain as many platelets, thus revealing a slightly smoother aspect of its surface.
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The observed SEM differences are attributed to the presence of the organic modifiers and
their individual integration since previous analyses have showed that functionalization of pristine
nanoclays could influence their basal spacing.46 In particular, basal spacing was shown to increase
with increasing cation exchange capacity of a modifier46 or with increasing its alkyl length.42 Such
increases are presumably due to lowering of the surface energy of the platelets upon introduction
of the modifier, thus allowing for their easier separation and better mixing within polymer matrices
during manufacturing of composites.12 The easier dispersion also was shown to allow for better
exfoliation within such polymer matrices,4 thus resulting in nanocomposites with enhanced
properties, such as increased mechanical strength8 and barrier properties,8 when compared to the
neat polymer.8 Further, previous analysis showed that structure of the nanoclay is influenced by
the lateral layer arrangements of the modifiers,46 and is also dependent on the concentration of the
modifier used as well as the degree into which the organic molecules are able to fit/adsorb into the
nanoclay individual platelet surface.46
Thermal degradation caused for a loss in the platelet morphology for all the byproducts
but I.44P900 which seemed to display platelets with smoother edges, relative to its non-degraded
form (Figure 2e-h). PGV900 also displayed a smoother surface, while both I.31PS900 and
I.34TCN900 displayed a fragmented surface, with platelets jutting out, potentially due to slower
degradation due to the organic modifier. The loss in platelet structure recorded upon thermal
degradation was most likely caused by the high temperatures encountered which could cause their
breakdown likely by dehydroxylation of their aluminosilicates’ lattice.42,46 This is supported by
previous study by Ounoughene et al., who also observed a change in morphology of halloysite
nanotubes (HNTs) after their exposure to high temperatures (beyond 1000 ºC).20
Elemental composition analyses (EDX) showed that the as-received organically modified
nanoclays had significantly higher amount of carbon, relative to their pristine counterparts (Figure
3a). Additionally, they also had significantly lower amounts of oxygen, sodium, magnesium,
silicon, and calcium, relative to PGV. These changes in elemental composition further confirmed
the individual organic modifier functionalization.39 Moreover, EDX analyses showed that
I.34TCN had a lower amount of carbon and higher amount of oxygen relative to I.44P and I.31PS,
again, indicative of the presence of the 2 hydroxyl moieties associated with the functionalizing
modifier.17 Additionally, I.31PS had a higher amount of oxygen relative to I.44P, likely due to the
presence of the silane coupling agent which contains carbon and oxygen.17
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After thermal degradation, all of the nanoclays experienced decreases in their respective
carbon contents (up to 40-60 % loss) and increases of their oxygen (up to 40-85% increase),
magnesium, aluminum, and silicon contents respectively (Figure 3b). These changes were only
significant for the organically modified nanoclays, most likely due to the loss of their individual
organic modifiers. Lastly, the organically modified clays had around 40% decrease in their iron
contents after thermal degradation. The general trends in elemental composition between PGV and
the modified nanoclays also persisted after thermal degradation, relative to the as-received forms
(Table S2). Further, the only significant difference between PGV and PGV900 was an increase in
magnesium, showing that the organic modifiers played a large role in the changes observed in
elemental composition due to thermal degradation.

Figure 2: Surface morphology of (a) PGV, (b) I.31PS, (c) I.34TCN, and (d) I.44P and thermally
degraded (e) PGV900, (f) I.31PS900, (g) I.34TCN900, and (h) I.44P900 as determined by SEM.

Dispersity Analysis of Nanoclays and Byproducts
Considering that particle size and distribution have been demonstrated to influence the
toxicity of materials,47 as well as internalization into exposed cells,47 we first assessed nanoclays
and byproducts dispersion in cellular media. Such analyses were also expected to provide insights
into any sedimentation and/or possible diffusion of the materials thus helping ensure that there are
no-mass transfer limitations when exposure to cells is attempted thus limiting an uneven exposure
and localized toxicological effects.
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Size distributions of the nanoclays and byproducts were assessed by dynamic light
scattering (DLS); for this, samples were dispersed in their cell-specific media. A pulmonary
surfactant (Survanta) of 90 % lipid and 10 % protein was also used, to provide a model of similar
consistency to the pulmonary surfactant environment of humans.48 How a particle interacts with a
pulmonary surfactant will affect its deposition on and interaction with lung cells, its clearance, and
overall alveolar surface tension.49 Analyses are reported relative to control buffer solution
(phosphate buffered saline: PBS) normally used for cellular studies.
Overall, the organically modified nanoclays (with the exception of I.44P) had smaller sizes
in PBS and DMEM, whereas larger sizes were observed when the modified nanoclays were placed
in SAGM and Survanta respectively, all relative to the pristine nanoclay (PGV; Table S3).
Specifically, analyses showed that 90 % of the I.44P dispersed in either PBS, DMEM, SAGM, or
Survanta all had similar sizes and were smaller than 8 µm (Figure 3c). Moreover, 90 % of the
I.31PS and I.34TCN clays dispersed in either control PBS, DMEM, or SAGM were smaller than
0.9 µm. Both I.31PS and I.34TCN displayed an increase in size when in Survanta, with 90 % of
these nanoclays being under 8 µm. Lastly, 90% of the PGV dispersed in either SAGM or Survanta
were smaller than 0.15 µm. Particle size increased when the nanoclay was placed in PBS and
DMEM, with 90 % of it ranging under 9 µm for both solutions respectively. The specific
distribution ranges are summarized in Tables S4-7.
The observed differences are likely due to the complex interactions of nanoclays with
proteins and lipids in the media they were dispersed in,50,51 formations of protein corneas,50 or/and
particle repulsion.52 Specifically, particles that contain long hydrophobic chains, such as I.44P,
have been previously shown to have increased protein-binding sites53 relative to their more
hydrophilic counterparts, likely leading to an increased agglomeration via inter-particle-protein
bridges.54 Additionally, the hydrophobic portions of the proteins may associate with the more
hydrophobic nanoclays like the I.44P, to further cause for agglomeration.51
In the case of PGV, the hydrophilic portions of the proteins may also bind strongly to the
nanoclay’s hydrophilic surface,51 also causing for particle agglomeration as seen in DMEM.50
However, PGV, had a large decrease in size when placed in SAGM (relative to DMEM), signifying
the influence of media composition.55 Specifically, since SAGM has a greater variety of proteins
and growth factors present relative to the DMEM, it could possibly allow for a more varied protein
adsorption profile to this nanoclay and thus an increase in its dispersity. Similarly, I.34TCN and
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I.31PS likely had less agglomeration in both DMEM and SAGM due to their relative intermediate
hydrophobicity relative to PGV, resultant from their organic modifiers functionalization which
could presumably cause for heterogeneous51 or less protein adsorption55 and thus a better
dispersion.55 Additionally, their organic modifiers containing hydroxyl (I.34TCN) and amine
(I.31PS) groups could be more prone to interaction with proteins via hydrogen bonding, van der
Waals forces, and electrostatic interactions respectively, causing for clay repulsion52 to be recorded
as an increase in their individual dispersity.
Overall, solution type did not appear to largely influence the size distributions of the
dispersed byproducts however it did cause for an increase in the individual particle size
distributions (Figure 3d). For instance, 90 % of the I.44P900 dispersed in DMEM, SAGM,
Survanta and PBS were smaller than 9, 10, 11, and 11 µm, respectively. I.31PS900 displayed
similar size distributions in all 4 solutions, with 90 % of its particles smaller than 9 µm in PBS,
DMEM, and Survanta and 90 % of its particles smaller than 7 µm in SAGM only. Ninety % of the
I.34TCN900 dispersed in DMEM, SAGM, or Survanta were smaller than 10, 9, and 11 µm,
respectively; 90 % of the particles in PBS were smaller than 10 µm. Finally, 90 % of the PGV900
dispersed in DMEM, SAGM, or Survanta were smaller than 12, 9, and 8 µm, respectively.
Additionally there was no longer any differences between the organically modified nanoclays (i.e.
difference in size for I.31PS and I.34TCN relative to I.44P in DMEM, SAGM, and PBS) after
thermal degradation, further confirming that once the organic modifier was removed and the
platelet structure was melted and fused, no platelet exfoliation or breakup of loose agglomerates
might have taken place, thus, the surface chemistry and resulting molecular interactions might
have changed. In particular, since the byproducts no longer have their organic modifiers present,
this would likely decrease the amount of adsorbed protein and, dependent on the modifier, the
variety of proteins being adsorbed, thus in turn decreasing the stability of the suspensions 56 and
resulting in the recorded larger sizes.
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Figure 3: Elemental composition of (a) as-received nanoclay and (b) their thermally degraded
byproducts as determined by EDX at 1 µm (n=10). The symbol * indicates significant differences
between the unmodified clay (PGV/PGV900) and the organically modified clays. Average size of
<90% of (c) the as-received nanoclays in solutions of PBS, DMEM, SAGM, or Survanta (d) as
well as their byproducts (n=3).

Lastly, the different size distributions observed for nanoclays or byproducts in Survanta
could be a result of Survanta’s high content of phospholipids,49 which could largely change the
agglomeration states of the dispersed materials. Specially, the increased hydrophobicity of the
modified nanoclays relative to PGV, likely caused for an increased agglomeration and higher
interactions with the hydrophobic tails of the phospholipids.48 Sauer et al. found similar results for
hydrophobic nanoparticles that generally seemed to agglomerate more when in the presence of
lipids and proteins relative to their more hydrophilic counterparts.57
Toxicity Screening Based on Nanoclays’ Physico-chemical Properties
Upon dispersity analysis, nanoclays and byproducts dispersed in the complementary media
were used in different concentrations (i.e., 0-197 µg/cm2) and exposed to human bronchial
epithelial (BEAS-2B) cells and small airway epithelial cells (SAECs) respectively, for 24 h. The
dose range was chosen to mimic exposure in manufacturing and disposal condition areas, with
light exposure being defined as minimal concentration that could lead to inhalation in a
manufacturing or disposal environment and acute exposure being defined as a 45-year working
lifetime exposure based on 8 h/day and 50 weeks/year taking into account particle and lung
characteristics.58 The resulting IC50 values (concentration of the nanoclays or byproducts that
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inhibit cell growth by 50%) were extrapolated from the dose response trend lines derived from raw
data (Table S8). IC50 is an acceptable mean for early measure and comparison of particle
cytotoxicity,59 and could help identify early deleterious mechanisms associated with nanoclays
exposure to cellular systems.
Overall, the as-received nanoclays, with the exception of I.44P in SAECs, displayed a
greater cytotoxicity relative to their thermally degraded byproducts when exposed to both BEAS2B cells and SAECs respectively (Figure 4a). In addition, organically modified nanoclays showed
higher toxicity than their pristine counterpart (PGV), again, with the exception of I.44P in SAECs.
The byproducts showed similar toxicity with the PGV900 for the BEAS-2B cells (with PGV900
being the least toxic), while all the byproducts had a similar toxicity to each other for the SAECs.
The highest degree of toxicity was observed for I.34TCN (which has a long alkyl chain and 2
hydroxyl molecules),17 followed by lower degrees of toxicity for I.31PS (which has a long alkyl
tail and a silane coupling agent), and finally I.44P (which has 2 long alkyl chains), in both cell
lines being investigated. Lastly, SAECs showed a greater sensitivity relative to BEAS-2B cells for
all the nanoclays and byproducts, with the exception of I.44P.
We hypothesize that the cytotoxicity differences are based on the different interactions of
the organic modifiers-functionalized nanoclays that could influence particle’s degree of
hydrophobicity. Previous studies have showed that such chains could interact with the cell
membrane lipids to cause for changes in membrane integrity.60 For instance, Farcal et al. showed
that TiO2 nanomaterials with a hydrophobic coating were more toxic than their hydrophilic
counterpart in murine alveolar macrophages.60 Additionally, the increased toxicity of I.34TCN
relative to I.31PS and I.44P was likely due to the presence of bio-reactive groups, such as hydroxyl
present in its organic modifier. Previous studies on particles containing bio-reactive groups have
showed similar results,61,62 with analysis showing that such particles could interact with biological
macromolecules61 such as phospholipids and proteins62,63 via hydrogen bonding and electrostatic
interactions,63 disrupt the cell membranes62,63 and initiate apoptosis.63 For instance, Zhang et al.
showed a decrease in BEAS-2B cell viability upon their exposure to amorphous silica
nanoparticles with increased hydroxyl contents.62 Das et al. found that graphene sheets containing
reactive hydroxyl functional groups were more toxic than sheets without these groups and of the
same sizes,61 while Zhang et al. showed that hydroxyl groups can generate reactive oxygen species
(ROS)62 to be responsible for damage to macromolecules, such as nucleic acids, proteins, and
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lipids, and for deregulation of cellular signaling pathways associated with cell proliferation,
survival, and mitochondrial oxidative stress.64
While I.31PS did not contain hydroxyl groups, it did contain a silane coupling agent 17 and
an amine group which were shown to also be capable of binding to both organic and inorganic
compounds,65 to allow for interactions with biological molecules containing hydroxyl groups66 as
well as the negatively charged cell membrane.67 Positively charged particles such as the silane
terminated amine groups in I.31PS will also have a better cell internalization68 which could further
contribute to its observed increased toxicity.63 While the interchange of bio-reactive groups with
long alkyl chains has showed a decrease in toxicity, as observed by the reduction in toxicity of
I.44P relative to the other two organically modified nanoclays and by previous studies, 68 their
presence on particles still caused toxicity most likely because of disturbances of hydrophobic
interactions between the lipids and proteins and possibly induced changes in cell signaling.69
The byproducts were less toxic relative to their as-received counterparts in both cell lines
(except for I.44P/I.44P900 in SAECs). This is presumably due to the recorded loss of their organic
modifiers,25,23,22 reduction of their iron contents, and changes in their platelets morphology21 as
demonstrated by the SEM and EDX analyses or to the loss of the silanol groups on the SiO2
tetrahedral sheets of the nanoclays45 as demonstrated by the FTIR analysis. Specifically, our EDX
analysis confirmed that iron decreased by around 40% in the byproducts thus causing for lower
toxicity as supported by previous analysis that showed that high levels of iron promote cell death,70
and decrease ATP production.71 Complementary, silanol groups (especially the disorganized
silanols) have been previously hypothesized to contribute to SiO2 toxicity.72
Along with the presence of the organic modifiers, the size and general solubility of the
nanoclays and byproducts may also be contributing to the observed differences in cytotoxicity. As
seen by the DLS measurements, smaller sized nanoclays (I.34TCN and I.31PS) seemed to show
an increase in cytotoxicity relative to the larger as-received nanoclays (PGV and I.44P) as well as
their byproducts presumably due to a resultant higher surface area73 or higher degree of uptake.74,75
Results are consistent with previous analysis;74 specifically, Napierska et al. found that smaller
sized particles (14-16 nm diameter) were more toxic relative to their larger sized counterparts (19335 nm), as well as were internalized by human endothelial cells at a faster rate.74 Additionally,
Lin et al. found that smaller Stöber silica nanoparticles had higher hemolytic activity than larger
counterparts, most likely resulting from a larger surface area of such particles.75 However, PGV
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displayed the smallest size distribution in SAGM (media for SAECs), yet still had a lower degree
of toxicity relative to I.34TCN and I.31PS, showing that the chemical composition of the organic
modifiers also plays a large role in the toxicity profiles of these nanoclays, as detailed above. The
resultant smaller size of PGV could have attributed to it having a higher degree of toxicity relative
to I.44P though in SAECs, which was not observed in the BEAS-2B cells when I.44P and PGV
had a similar size distribution.
Overall, SAECs showed a greater sensitivity (of about 4 to 5 times) for all the clays (except
I.44P), while the sensitivity of the primary cells exposed to byproducts was only about 2 to 4 times
higher relative to BEAS-2B cells. This is presumably due to the fact that primary cells more closely
mimic their tissue of human origin; contrary, their immortalized counterparts can undergo
mutations as well as contain viral genes to influence their overall stability thus reducing their
susceptibility to external agents used for toxicity analysis.34 Further, immortalized cell lines
generally are not as genetically stable as primary cells and lack function and markers often seen in
vivo.35 Our results confirm previous experiments in which primary cells displayed a higher degree
of toxicity when compared to immortalized cell lines upon exposure to nanoparticles with similar
aspect ratios.38 Moreover, the general trends in our experiments remained the same between the 2
cell lines showing validation of the obtained results and overall confirming that such cell-based
systems are suitable models for assessing inhalation toxicity in vitro.
Changes in IC50 were complemented by the changes in cell morphology (Figure 4b) which
is known to be an indicator of overall cell health.76,77 Specifically, treatment with the nanoclays
and byproducts caused for changes in the cellular shape of both cell types relative to the control,
more so for the BEAS-2B. These cells were more stretched, thin-like structures relative to the more
oval shapes displayed by the controls (especially in regards to their exposure to the byproducts).
When comparing BEAS-2B with the primary cells, there was observed that the immortalized cells
had a more stretched profile. Generally, treatment with PGV produced more circular cells than any
of the other treatments, in both cell lines and also a lower cell confluence especially in primary
cells, likely serving as a signal of cell death and thus complementing our IC50 values as well as
possibly indicating a different mechanistic-based cytotoxic effect.77 A difference in cytotoxic
mechanism is also supported by different slopes of the dose response curves for PGV compared to
organically modified nanoclays. For SAECs, exposure seemed to also cause changes in the cell
membrane, which could then influence cell-cell and cell-substrate interactions.76 Additionally,
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there were changes in the cell monolayer with all of the treatments causing for a loss of monolayer
integrity relative to controls for both cell lines being investigated and over 72 h time period
(Figures S1 and S2). Such changes can further provide insights into the integrity of the tight
junctions of the epithelial cells and mechanisms of toxicity since it is known that in the lung, the
epithelial cells serve as a barrier to prevent the entrance of inhaled particles and pathogens.78
Our results overall hint that treatment with nanoclays or byproducts may cause
cytoskeleton alterations76 which may eventually lead to changes in cell mechanics,79
differentiation, and organization.80 Similarly, Snyder et al. showed changes in cellular morphology
of primary human bronchial epithelial cells, from a cuboidal shape to a spindle-shaped,
fibroblastoid appearance upon treatment with multi-walled carbon nanotubes.78 Further, our
systematic analysis showed that the observed differences in cytotoxicity are most likely due to
synergistic effects resulting from (1) the presence of the organic modifiers and their surface
chemistry, and/or (2) the individual nanoclay or byproduct particle size and surface area and
general dispersibility. Synergism has been previously reported for other materials where the
combined effects of size, shape, solubility, and/or surface functionalization all contributed to the
toxicity profile of the material.81,82 For instance, Tarantola et al. found that cetyl-trimethylammonium bromide (CTAB)-coated spherical particles were more toxic than rod-shaped ones, due
not only due to the shape, but also due to the way such shape influenced cluster formation and
release of the CTAB.81 Xia et al. found that the composition of metal oxide nanoparticles
influenced toxicity; however, the degree of toxicity of the metal oxide was also dependent on its
solubility in the media.82 Based on our results, it is likely that the chemical composition of the
organic modifier is influencing the degree of toxicity both directly and indirectly due to such
modifier composition and effect on the size and dispersibility of the nanoclays. Such toxic effects
were diminished when the cells were exposed to the byproducts.
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Figure 4: (a) IC50 values (µg/cm2) for BEAS-2B cells and SAECs treated with as-received
nanoclays and byproducts. The symbol * and ~ indicate significant differences between the
unmodified nanoclay (PGV/PGV900) and the organically modified nanoclays and between the asreceived nanoclay and its thermally degraded byproduct, respectively (n≥4 for each treatment). (b)
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Representative optical images of BEAS-2B cells and SAECs treated with as-received nanoclays
and byproducts at their respective IC50 dose after 24 h of exposure. (c) Extracellular ROS
production by BEAS-2B cells after treatment with as-received nanoclays and byproducts at their
respective IC50 dose over 72 h (n=4).

The observed synergism also implies that setting up rather simplistic platforms for toxicity
evaluation will not provide a realistic or viable assessment strategy. Extracellular quantitative
luminescence reactive oxygen species (ROS) assays,62 were previously shown to be reliable and
help provide information on oxidative stress and cellular metabolism64 or damage to
macromolecules.64 Indeed, our control analysis showed that when using the extracellular ROS
assay our results were inconclusive (Figure 4c). In particular, there was no significant trend
observed in the cell response with treatment and moreover, there was a large variability in the
extracellular ROS production. A similar response was also observed for doses above and below
the IC50 value for each clay and byproduct (Figure S3). This could be due to the interaction of the
nanoclays with the reagent. Our study accentuates the controversy of using such reagent for
toxicity screening, and adds to the bases of other studies that showed22 or did not show83 ROS
generation for cells exposed to nanoclays. In particular, Maisanaba et al. did not observe any ROS
generation for Cloisite Na+ and Cloisite 30B in HepG2 cells up to a dose of 88 µg/ml;83 however,
Lordan et al. found that Cloisite Na+ did cause ROS generation in HepG2 cells at doses 50 µg/ml
higher.22
Our study is the first to show that if one is to implement a platform for toxicity screening
of nanoclays during their lifecycle, the overall functionality of the material needs to be tested, with
functionality encompassing not only physico-chemical characteristics of the ‘as-produced’
material, but also its changes in a variety of conditions that reflect product implementation and
disposal. Further, our study shows that cellular systems complexity needs to be accounted for, as
differences in toxicity may be observed between cell lines and could be due to the different cell
lines sensitivity as well as any related cellular changes upon cell line transformation. Only through
such a dynamic interplay that could affect both the product “personality” as well as its shelf-life
and interactions, one would fully evaluate product safety characteristics and impose viable disposal
measures.
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Conclusions
Our study showed that the chemical composition of individual organic modifiers used for
nanoclays functionalization played large roles in their interactions with cellular systems.
Specifically, differences in organic modifiers caused differential size distributions in dispersion
cellular media and differential degrees of toxicity upon their or thermally degraded byproducts
exposure to lung epithelial cells. The organically modified nanoclays I.34TCN and I.31PS
displayed the highest degree of toxicity, followed by I.44P, all relative to the pristine PGV. Based
on the chemical structure of their modifiers, it can be determined that modifiers containing bioreactive groups, such as hydroxyl, are more toxic, relative to the modifiers containing long alkyl
chains, likely due to increased interaction with biological macromolecules. Further, the
composition of the bio-reactive group was shown to influence toxicity, as the modifier containing
hydroxyl (I.34TCN) was more toxic relative to the one containing amine and silane (I.31PS).
Finally, the byproducts displayed a loss in toxicity, likely due to the loss of their organic modifier,
changes in size, shape, and elemental composition. Such changes in toxicity profiles of the asreceived nanoclays relative to their byproducts emphasize the importance of examining such
materials at all stages in their life cycle where human exposure might occur. Understanding how
the physical and chemical properties of such materials influences toxicity can aid in safer design
functionalities, while still maintaining beneficial properties to make them miscible with polymer
matrices for food packaging applications.
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Supporting Information
Chapter 3: Early Assessment and Correlations of Nanoclay’s Toxicity to their Physical and
Chemical Properties

Materials and Methods
Dispersion analysis
The size distribution of the nanoclays and thermally degraded byproducts was determined
by dynamic light scattering (DLS) via the Mastersizer 2000 with a Hydro 2000S accessory
(Malvern Instruments). For this, samples of Nanomer PGV (PGV), an unmodified, hydrophilic
bentonite,

Nanomer

I.31PS

(I.31PS),

a

nanoclay

surface

modified

with

aminopropyltriethoxysilane at 0.5-5 wt. % and octadecylamine at 15-35 wt. %, Nanomer I.34TCN
(I.34TCN), a nanoclay surface modified with methyl dihdroxyethyl hydrogenated tallow
ammonium at 25-30 wt. % and, Nanomer I.44P (I.44P), a nanoclay surface modified with dimethyl
dialkyl amine at 35-45 wt. %, as well as their thermally degraded byproducts (PGV900, I.31PS900,
I.34TCN900, or I.44P900 respectively) were dispersed either in Dulbecco’s Modified Eagle
Medium (DMEM, Life Technologies) containing 5% fetal bovine serum (FBS), or in Small
Airway Growth Medium (SAGM, Lonza) with SingleQuots Kit (Lonza) containing bovine
pituitary extract, hydrocortisone, human Epidermal Growth Factor, epinephrine, transferrin,
insulin, retinoic acid, triiodothyronine, gentamicin/amphotericin-B, and 1 % bovine serum
albumin (BSA). Also, the nanoclays and byproducts were dispersed in a control, phosphate
buffered saline (PBS, Lonza) and in distilled water containing 0.15 mg/ml Survanta®, a pulmonary
surfactant. The solutions were then bath sonicated and dropped into the Hydro 2000S until laser
obscuration was within 10-20%. The size analysis was performed 3 consecutive times with a stirrer
speed of 1750 rpm and under continuous sonication in the Hydro 2000S accessory.
Cell Culture
Immortalized human bronchial epithelial cells (BEAS-2B) from American Type Culture
Collection (ATCC) were cultured in 100 mm dishes (Corning, Inc.) in DMEM, containing 5%
FBS, 1 % L-glutamine, and 1 % penicillin-streptomycin. The cells were incubated at 37 ⁰C, 5 %
CO2, and in an 80 % relative humidity; consistent sub-culturing took place using 0.05 or 0.25 %
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trypsin (Invitrogen). Before each experiment, cells were grown to a monolayer of 90-100%
confluency and cells in the 3rd-6th passage were used.
Additionally, small airway epithelial cells (SAECs) were cultured in SAGM with
SingleQuots Kit and 1 % penicillin-streptomycin (Life Technologies). Cells were seeded into T25 flasks (Corning, Inc.), grown to 75-80% confluency and subsequently split (5 passages total).
All experiments completed with SAECs were performed using the same passage number.
Half Maximal Inhibitory Concentration (IC50)
BEAS-2B cells and SAECs were seeded into 12 well plates (Thermo Scientific) at densities
of approximately 1.5x105 and 2.0x105 cells/ml, respectively. After 24 h, the cells were treated with
PGV, I.31PS, I.34TCN, I.44P, or their thermally degraded byproducts at various doses ranging
from 0 to 197 µg/cm2. Before addition to the respective wells, each nanoclay or byproduct sample
was sonicated for 10 min in a bath sonicator (2510 Branson; 100 W) with the concentrations used
for exposure being serial dilutions from the original stock; cells in only media served as controls.
After 24 h of exposure to individual treatment, the treated cells (as well as the controls) were
washed to remove the nanoclays and byproducts, trypsinized, and stained with 0.4% trypan blue
solution (Invitrogen). Subsequently, 10 µl of the sample containing the stained cells was added to
a hemocytometer, and the number of cells in the 4 outer grids was counted through the use of the
Leica DM IL optical microscope (Leica Microsystems) and a 10X objective. Analyses of the
cellular proliferation post-exposure were used to extrapolate IC50 values that would also be used
in the remaining cellular assays.
Cellular Imaging
BEAS-2B cells and SAECs were seeded at densities of 1.5x105 and 2.5x105 cells/ml,
respectively, in 24 well plates. After 24 h the cells were treated with the as-received nanoclays and
thermally degraded byproducts, dispersed in media via a bath sonicator, at their respective,
determined IC50 dose. After 24, 48, and 72 h of treatment the cells were imaged through use of a
Leica DM IL optical microscope (Leica Microsystems) with a 10X objective. Two replicates were
performed with 10 images, per replicate, taken at random spots within the well for each control
and treatment.
Extracellular Reactive Oxygen Species (ROS)
BEAS-2B cells were seeded into 24 well plates at a density of approximately 1.5x10 5
cells/ml. After 24 h, the cells were treated with nanoclays and byproducts dispersed in media
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through use of a bath sonicator at doses above and below their respective, determined IC 50 value;
cells exposed to only media served as control samples. After 24, 48, and 72 h of treatment, 50 µl
of the media was transferred from the 24 well plate to its respective well in a black-bottomed 96
well plate (Corning, Inc.). Subsequently, 50 µl of PBS was added to each well in the 96 well plate.
Fifty µl of the extracellular reactive oxygen species (ROS) assay reagent, Lumigen ECL Plus
(Lumigen, Inc.), was also added to each well. The samples were subsequently incubated at room
temperature for 5 min, in the dark before luminescence was evaluated using a FLUOstar OPTIMA
plate reader (BMG LABTECH) at 600 nm. Media and treated media containing nanoclays or
byproducts suspended in solution served as blanks. Respective cellular measurements of the
samples were evaluated after subtracting the blanks in order to determine the effect treatment had
on extracellular ROS. Four replicates were performed for each treatment.
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Results
Table S1: Equations used to determine the percent moisture, volatile, and ash present in the 4
Nanomer nanoclays upon thermal degradation via the TGA701 Thermogravimetric Analyzer.
Content
Moisture
Volatile
Ash

Equation
(([Initial Mass]-[Moisture Mass])/[Initial Mass])*100
(([Moisture Mass]-[Volatile Mass])/([Initial Mass])*100
([Ash Mass]/[Initial Mass])*100

Table S2: Elemental composition of as-received nanoclay and their thermally degraded
byproducts as determined by EDX at 1 µm (n=10). The symbol * and ~ indicate significant
differences between the unmodified nanoclay (PGV/PGV900) and the organically modified
nanoclays and between the as-received nanoclay and its thermally degraded byproduct,
respectively.
PGV
5.70 +/4.50
Carbon
39.67
+/- 2.62
Oxygen
1.77 +/0.54
Sodium
3.12 +/Magnesium 0.70
11.33
Aluminum +/- 0.76
32.93
+/- 4.20
Silicon
1.70 +/Calcium 0.77
3.79 +/1.18
Iron
0.00 +/Chlorine 0.00
0.00 +/Potassium 0.00

I.31PS
38.59 +/7.13*
28.49 +/3.59*
0.00 +/0.00*
1.37 +/0.27*
7.19 +/1.33*
21.21 +/4.34*
0.00 +/0.00*
2.27 +/0.69*
0.78 +/0.46*
0.12 +/0.38

I.34TCN I.44P
26.87 +/- 38.15 +/6.70*
2.95*
30.84 +/- 23.89 +/3.55*
3.76*
0.00 +/- 0.00 +/0.00*
0.00*
1.46 +/- 1.33 +/0.33*
0.31*
10.98 +/- 9.70 +/1.53
1.28*
26.52 +/- 24.07 +/4.34*
4.01*
0.00 +/- 0.00 +/0.00*
0.00*
3.62 +/- 2.86 +/1.00
0.73*
0.00 +/- 0.00 +/0.00
0.00
0.00 +/- 0.00 +/0.00
0.00

PGV900 I.31PS900
2.33 +/- 22.67 +/5.55
16.31*~
40.34 +/- 40.42 +/6.43
13.97~
2.11 +/- 0.00 +/0.41
0.00*
4.01 +/- 1.75 +/0.69~
0.57*
12.12 +/- 7.86 +/1.22
2.48*
33.14 +/- 22.22 +/4.29
7.87*
1.85 +/- 0.00 +/0.98
0.00*
4.02 +/- 1.29 +/2.83
0.51*~
0.00 +/- 0.00 +/0.00
0.00~
0.00 +/- 0.20 +/0.00
0.24*

I.34TCN900 I.44P900
13.68 +/14.88 +/13.41*~
13.92*~
44.28 +/44.33 +/4.63~
4.78~
0.00 +/0.00 +/0.00*
0.00*
1.74 +/1.84 +/0.47*
0.58*~
11.39 +/12.57 +/3.33
5.01
26.90 +/24.50 +/9.82
6.33*
0.00 +/0.29 +/0.00*
0.76*
2.02 +/1.59 +/1.30~
0.50*~
0.00 +/0.00 +/- 0.00 0.00
0.00 +/0.00 +/- 0.00 0.00
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Table S3: Average particle size (µm) of <90 % of the four as-received nanoclays and their
thermally degraded byproducts in solutions of PBS, DMEM, SAGM, or Survanta with +/- standard
deviation (n=3). The symbol * and ~ indicate significant differences between the unmodified
nanoclay (PGV/PGV900) and the organically modified nanoclays and between the as-received
nanoclay and its thermally degraded byproduct, respectively.

PGV

I.31PS

I.34TCN I.44P

PGV900 I.31PS900 I.34TCN900 I.44P900

PBS

9.17 +/- 0.71 +/- 0.75 +/1.59
0.05*
0.06*

7.83 +/- 3.72 +/- 8.28 +/0.44
5.70
0.19~

9.71 +/0.01~

10.99 +/0.15~

DMEM

8.55 +/- 0.85 +/- 0.92 +/1.0
0.04*
0.04*

7.69 +/- 11.54 +/- 8.23 +/0.02
0.09~
0.02*~

9.42 +/0.36*~

8.85 +/0.01*~

SAGM

0.15 +/- 0.85 +/- 0.85 +/0.02
0.01*
0.05*

7.73 +/- 9.02 +/- 6.71 +/0.05* 0.34~
0.01*~

8.55 +/0.01~

10.04 +/0.12*~

Survanta 0.12 +/- 7.79 +/- 7.46 +/0.01
0.12*
0.35*

8.12 +/- 8.03 +/- 8.87 +/0.17* 0.33~
0.21*~

10.33 +/0.65*~

10.86 +/0.33*~

Table S4: Average particle size (µm) distributions of the 4 as-received nanoclays and their
thermally degraded byproducts in PBS with +/- standard deviation (n=3). The symbol * and ~
indicate significant differences between the unmodified nanoclay (PGV/PGV900) and the
organically modified nanoclays and between the as-received nanoclay and its thermally degraded
byproduct, respectively.
PGV
I.31PS
I.34TCN I.44P
PGV900 I.31PS900 I.34TCN900 I.44P900
3.04 +/- 0.33 +/- 0.38 +/- 2.81 +/- 1.22 +/- 2.87
+/- 3.15
+/- 3.62 +/0.38
0.02*
0.03*
0.12
1.79
0.02~
0.00~
0.02~
<10%
4.78 +/- 0.44 +/- 0.49 +/- 4.11 +/- 1.88 +/- 4.30
+/- 4.91
+/- 5.81 +/0.03*
0.03*
0.22
2.82
0.06~
0.00~
0.06~
<50% 0.72
9.17 +/- 0.71 +/- 0.75 +/- 7.83 +/- 3.72 +/- 8.28
+/- 9.71
+/- 10.99 +/0.05*
0.06*
0.44
5.70
0.19~
0.01~
0.15~
<90% 1.59
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Table S5: Average particle size (µm) distributions of the 4 as-received nanoclays and their
thermally degraded byproducts in DMEM with +/- standard deviation (n=3). The symbol * and ~
indicate significant differences between the unmodified nanoclay (PGV/PGV900) and the
organically modified nanoclays and between the as-received nanoclay and its thermally degraded
byproduct, respectively.
PGV
I.31PS
I.34TCN I.44P
PGV900 I.31PS900 I.34TCN900 I.44P900
2.55 +/- 0.38 +/- 0.44
+/- 2.84 +/- 4.06
+/- 2.95
+/- 3.21
+/- 3.25 +/0.02*
0.02*
0.00*
0.01~
0.00*~
0.10*~
0.00*~
<10% 0.14
3.81 +/1 0.50 +/- 0.57
+/- 4.09 +/- 6.11
+/1 4.28
+/- 4.89
+/- 4.83 +/0.02*
0.02*
0.01
0.05~
0.00*~
0.20*~
0.01*~
<50% 0.27
8.55 +/- 0.85 +/- 0.92
+/- 7.69 +/- 11.54 +/- 8.23
+/- 9.42
+/- 8.85 +/0.04*
0.04*
0.02
0.09~
0.02*~
0.36*~
0.01*~
<90% 1.0

Table S6: Average particle size (µm) distributions of the 4 as-received nanoclays and their
thermally degraded byproducts in SAGM with +/- standard deviation (n=3). The symbol * and ~
indicate significant differences between the unmodified nanoclay (PGV/PGV900) and the
organically modified nanoclays and between the as-received nanoclay and its thermally degraded
byproduct, respectively.
PGV
I.31PS
I.34TCN I.44P
PGV900 I.31PS900 I.34TCN900 I.44P900
0.05 +/- 0.37 +/- 0.41 +/- 2.75 +/- 3.07
+/- 2.52
+/- 2.83
+/- 3.28
+/0.00*
0.01*
0.02*
0.08~
0.00*~
0.00*~
0.01*~
<10% 0.01
0.08 +/- 0.50 +/- 0.53 +/- 4.03 +/- 4.66
+/- 3.61
+/- 4.23
+/- 5.11
+/0.02
0.02*
0.02*
0.02*
0.19~
0.01*~
0.00*~
0.03*~
<50%
0.15 +/- 0.85 +/- 0.85 +/- 7.73 +/- 9.02
+/- 6.71
+/- 8.55
+/- 10.04 +/0.01*
0.05*
0.05*
0.34~
0.01*~
0.01~
0.12*~
<90% 0.02
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Table S7: Average particle size (µm) distributions of the 4 as-received nanoclays and their
thermally degraded byproducts in Survanta with +/- standard deviation (n=3). The symbol * and
~ indicate significant differences between the unmodified nanoclay (PGV/PGV900) and the
organically modified nanoclays and between the as-received nanoclay and its thermally degraded
byproduct, respectively.
PGV
I.31PS
I.34TCN I.44P
PGV900 I.31PS900 I.34TCN900 I.44P900
0.03 +/- 2.42 +/- 2.36 +/- 2.64 +/- 3.39 +/- 2.94
+/- 3.35
+/- 4.10
+/0.16*
0.11*
0.02*
0.19~
0.02*~
0.21~
0.10*~
<10% 0.00
0.06 +/- 3.78 +/- 3.63 +/- 3.99 +/- 4.94 +/1 4.44
+/- 5.49
+/- 6.34
+/0.25*
0.19*
0.05*
0.25~
0.04*~
0.41~
0.10*~
<50% 0.00
0.12 +/- 7.79 +/- 7.46 +/- 8.12 +/- 8.03 +/- 8.87
+/- 10.33
+/- 10.86 +/0.12*
0.35*
0.17*
0.33~
0.21*~
0.65*~
0.33*~
<90% 0.01

2

Table S8: IC50 values (µg/cm ) of BEAS-2B cells and SAECs treated with as-received nanoclays
and thermally degraded byproducts.
BEAS-2B

SAECs

60.3

13.2

I.31PS

4.5

1.3

I.34TCN

2.1

0.5

I.44P

13.7

14.2

PGV900

96.3

26.3

I.31PS900

43.2

21.8

I.34MN900

51.1

21.6

I.44P900

42.9

8.7

PGV
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(a) 24 h

(b) 48 h

(c) 72 h
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Figure S1: Representative optical images of BEAS-2B cells treated with as-received Nanomer
nanoclays and thermally degraded byproducts at their respective IC50 doses at (a) 24 h, (b) 48 h, and
(c) 72 h post-treatment (n=2).
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(a) 24 h

(b) 48 h

(c) 72 h

102

Figure S2: Representative optical images of SAECs treated with as-received Nanomer nanoclays
and thermally degraded byproducts at their respective IC50 doses at (a) 24 h, (b) 48 h, and (c) 72 h
post-treatment (n=2).
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(a)

(b)

Figure S3: Extracellular ROS production by BEAS-2B cells after treatment with (a) as-received
nanoclays above and below their respective IC50 dose and (b) thermally degraded byproducts above
and below their respective IC50 dose over 72 h (n=4).
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CHAPTER 4
Toxicity Assessment of Byproducts Resulted from Nanoclay Composite
Disposal by Incineration
Abstract
Addition of nanoclays into a biodegradable polymer matrix leads to nanocomposites with
increased mechanical strength, barrier properties, UV dispersion, and thermal stability to be used
in plastics for food packaging applications. Because of the plastics’ relatively high stored energy
values, such nanocomposites make good candidates for disposal via municipal solid waste plants,
with the plastics being combusted to allow for the recovery of energy and reduction of waste
volume of up to 90 %. However, upon nanocomposite disposal at the end of their lifecycle,
increased concerns related to their potential toxicity arise, especially considering that byproducts
resulting from nanocomposite incineration could escape disposal filters to cause worker inhalation
hazards. Herein, we investigated the deleterious effects that a biodegradable polymer polylactic
acid (PLA)-based nanocomposite containing methyl, tallow, bis-2-hydroxyethyl, quaternary
ammonium functionalized montmorillonite nanoclay could pose to human lung epithelial cells,
used as a model for inhalation exposure, at the end of its lifecycle. Chemical (elemental and
molecular compositions) and physical (morphology, mechanical and optical properties,
crystallinity and degree of exfoliation of nanoclay in PLA, and hydrodynamic diffusion versus
projected area of byproducts, respectively) properties were assessed and correlated with the
toxicological profiles of the end of lifecycle byproduct at different exposure doses. The byproducts
induced toxic responses, including reductions in cellular viability and proliferation, changes in
cellular morphology, and cytoskeletal alterations, but only at high doses. Further, the degree of
dispersion of nanoclays in the polymer matrix appeared to influence both the physical and
chemical characteristics, thermal degradation, as well as the toxicity. With toxicity of the
byproduct occurring at high doses, safety protocols should be considered, along with further
investigation into how the material characteristics of such nanocomposites and their disposal
profiles could be controlled to help aid in a safer, yet still effective disposal strategy.

114

Introduction
Biodegradable polymers such as linear aliphatic thermoplastic polyester1 polylactic acid
(PLA),2-4 made from renewable resources,2,3,5 have shown good biocompatibility6-8 and
applicability in food packaging2 and medical areas.7,8 Biodegradable polymers allow for the
reduction of environmental risks resulting from high greenhouse gas emissions and fossil fuel
energy usage5 otherwise encountered at the implementation of conventional petrochemical
polymers such as polyethylene (PE), polyethylene terephthalate (PET), polyvinylchloride (PVC),
polypropylene (PP), or polystyrene (PS).5,6,9 Additionally, since biodegradable polymers require
25-55 % less power at their production when compared to the power used to generate petroleumbased polymers,5 and because of their relatively low production cost resulting from
implementation of new processing techniques,6 it is expected that biodegradable polymers’ usage
will increase in the future especially when considering the amount of plastics being needed and/or
consumed daily.10,11 However, such biodegradable polymers, including PLA, are still brittle6,12,13
and lack the barrier,4,12 thermal,4,12 and impact resistance properties13 displayed by the
conventional petroleum-based polymers,6 thus limiting their consumer application.
Recent studies have showed that incorporation of nanoclays, i.e., layered mineral
silicates14,15 with a platelet thickness of about 1 nm and lengths and widths in the micron range,16,17
could enhance polymers’ mechanical strength,18-20 barrier,21,22 and thermal properties6,18,23 when
mixed at a low weight percent.16,18 When such incorporation is attempted, the nanoclays need to
be fully exfoliated within the polymer matrix6 to allow for increased interactions with the polymer,
thus minimizing chain mobility and creating reinforcement effects.18

For the increased

interactions, such nanoclays need to be functionalized with organic modifiers to allow for the
required miscibility within the polymer,24,25 as well as a better incorporation/exfoliation.19 One
example of a nanoclay isolated from the clay fraction of soil14,15 is montmorillonite (MMT) which
can be easily modified with methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium (to form
Cloisite 30B (CC)) for facile incorporation within PLA.1,19,26,27 The good miscibility observed
upon such nanoclay incorporation is presumably due to interactions of the C=O moieties present
in PLA with its modified hydroxyl groups.1 Due to the resulting increased barrier properties,20,28,29
UV dispersion,21,30 transparency,31 mechanical strength,28,32 and a longer shelf life,17 polymerbased nanoclay nanocomposites have shown increased implementation in food packaging with the
ability to withstand physical stresses associated with transportation and handling.33 Further, PLA115

CC nanocomposites were shown to provide a ”green” packaging material that has a lower
environmental impact and increased sustainability relative to conventional polymers.1,12,17 Upon
the end of their use, such nanocomposites are known to either be disposed in the landfills,
incinerated, or recycled.34,35 However, due to plastics relatively high stored energy values,11 the
PLA-based nanocomposites make good candidates for disposal via municipal solid waste (MSW)
plants, with the waste being combusted to allow for the recovery of energy and reduction of volume
of waste of up to 90 %.11
Considering the large implementation that is envisioned for such nanocomposites, recent
research is focused on determining whether they have toxicological profiles. The need to identify
possible deleterious pathways is driven by the minimal studies on their toxicity in both
manufacturing and disposal areas, with the available toxicity studies only considering the
migration extracts from such nanocomposites,36,37 and other numerous results showing that
nanoclays by themselves can induce toxic effects upon exposure to lung cells38-41 in such areas.4244

Specifically, Maisanaba et al. examined the toxicity of migration extracts from a PLA-Clay 1

(a nanoclay modified with hexadecyltrimethyl-ammonium bromide (HDTA)) and PLA-Clay 2 (a
nanoclay modified with HDTA and acetylcholine chloride) nanocomposite on Caco-2 and HepG2
cells and found no significant toxic effects.36 Similarly, Maisanaba et al. examined the toxicity of
a PLA-Clay 1 migration extract on Wistar rats and found no significant toxic effects.37 However,
Zia et al. examined the toxicity of nanocomposite films via investigation of cell attachment and
spreading of L-929 cells on a chitin based polyurethane-bentonite nanocomposite and found that
nanocomposites with increasing amounts of bentonite had adverse effects on the samples’
biocompatibility with less adhesion and dissimilar morphology of the cells relative to control
cells.45 Complementary, we and others showed that nanoclays by themselves decrease cellular
proliferation,38,40 cause mitochondrial46 and membrane damage,46,47 induce reactive oxygen
species (ROS) generation,46 and genotoxic effects, such as micronuclei induction48,49 and changes
in mRNA expression.48
Considering that ultrafine and fine-sized particles could result from disposal of
nanocomposites via MSW plants to potentially escape exhaust filters,42 and that the high
temperatures encountered in the MSW disposal42 could cause property changes of the incinerated
material50,51 and could potentially create a byproduct with its own toxicological profile,52,40 we
aimed to determine the toxicity of incinerated PLA-CC nanocomposites through the use of a model
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in vitro cell line, human bronchial epithelial cells (BEAS-2B).53 The toxicity of such thermally
degraded nanocomposites (i.e., herein called byproducts) is expected to allow for correlation
studies between the consumption/usage and disposal stages during the nanocomposite’s life cycle,
while also allowing the individual toxicological impacts and material characteristics of the
components themselves, i.e. PLA and nanoclay, as well as their associated byproducts, to be
explored. Such a study could potentially lead to mitigation strategies for worker protection and
controlled land field disposal of byproducts.

Materials and Methods
Nanocomposite and Incinerated Byproducts Preparation
Cloisite 30B (CC) was obtained from Southern Clay Products (Gonzales, TX) and, per the
manufacturer specifications, organically modified via an ion-exchange reaction with methyl,
tallow, bis-2-hydroxyethyl, quaternary ammonium (Scheme S1). Polylactic acid 6752 (PLA;
NatureWorks) was melt-mixed with CC loaded at a 5 wt. %, in a Thermo-Haake internal mixer
operating at 200 ºC and 80 rpm for 5 min. Thin films were then molded at 200 ºC using a
compression press to form PLA-CC nanocomposites (PLACC), as well as PLA films to be used
as controls.
Samples of PLA and PLACC (1 g per sample) were thermally degraded using a TGA701
Thermogravimetric Analyzer (LECO) to mimic their disposal. To determine the moisture content,
the samples were heated in nitrogen at a rate of 6 ºC/min and in a range of temperatures from 25
ºC to 105 ºC. To determine the volatile content, the samples were heated from 105 ºC to 950 ºC,
also in nitrogen and at a rate of 43 ºC/min. Finally, to determine the ash content, the samples were
heated from 550 ºC to 900 ºC in oxygen, at a rate of 15 ºC/min. The resulting ash was collected to
serve as a model of the byproducts resulted from incineration i.e., thermally degraded PLA-CC
nanocomposite (PLACC900).
Materials Characterization
Elemental composition and surface morphology of PLA, PLACC, and PLACC900 were
investigated using a Hitachi S-4700 Field Emission Scanning Electron Microscope (SEM, Hitachi
High-Technologies Corporation) equipped with energy dispersive X-ray (EDX) spectroscopy.
Surface morphology was examined at 5.0 kV while elemental composition was determined at 20.0
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kV. For the analyses, dry films or powder samples were mounted onto a carbon tape and then
sputter coated with gold/palladium for 10 s in vacuum injected with argon.
Molecular composition of the samples was determined using Fourier Transform Infrared
Spectroscopy (FTIR, Digilab FTS 7000) equipped with diamond Attenuated Total Reflection
(ATR). Scans were collected in the range of 4000-400 cm-1 at a resolution of 4 cm-1; a total of 100
scans were co-added to form the final spectrum for each of the samples.
The crystallinity of PLA and PLACC and the degree of exfoliation of CC in PLACC was
determined via X-ray diffraction (XRD): PANalytical X’Pert Pro XRD for crystallinity via a Cukα1 8047.2 eV source at 45 kV and 40 mA with a 10 sec/step in a 5-80 º 2θ range and Bruker D8
Discovery XRD for determination of the degree of exfoliation. For the Bruker XRD, thin films
were mounted on the sample holder and diffraction was obtained in the 2θ range of 1-10 º at an
increment of 0.02 º and scan speed of 10 sec/step via a Cu-kα1 8047.2 eV source at 40 kV and 40
mA. Basal spacing was determined by Bragg’s equation
nλ=2dsinθ,
where n is an integer, λ is the wavelength of the X-ray radiation (0.1546 nm), d is the spacing
between lattice planes, and θ is the measured diffraction angle.
The absorption spectra for PLA and PLACC was determined in the range of 200-800 nm
via the Shimadzu UV-Vis spectrophotometer (Shimadzu Scientific Instruments). UV barrier
properties of the film were determined by measuring transmission at 280 nm, and transparency of
the films was determined by measuring transmission at 660 nm, also via the Shimadzu UV-Vis
spectrophotometer.
The tensile strength, Young’s Modulus, and elongation at break for films of PLA and
PLACC were evaluated via the Instron E1000 (Instron Corporation) under a 2 kN load cell and
using the Bluehill 3 software. For this, rectangular films of PLA and PLACC, 5 mm in width x 32
mm in length x 0.3 mm in thickness, were placed in the Instron grips, and the experiments were
performed with a crosshead speed set at 5 mm/min. A specimen gauge length of about 25 mm was
used for each sample upon gripping in the crosshead.
The size distribution of PLACC900 was determined by dynamic light scattering (DLS) via
the Mastersizer 2000 with a Hydro 2000S accessory (Malvern Instruments). For this, solutions of
PLACC900 dispersed and bath sonicated in cell culture media (Dulbecco’s Modified Eagle
Medium: DMEM) containing 5% fetal bovine serum (FBS) or in phosphate buffered saline (PBS)
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were dropped into the Hydro 2000S until laser obscuration was within 10-20 %. The size analysis
was performed 3 consecutive times with a stirrer speed of 1750 rpm and under continuous
sonication.
Cell Culture
Immortalized human bronchial epithelial cells (BEAS-2B) were cultured in DMEM media
containing 5% FBS, 1 % L-glutamine, and 1 % penicillin-streptomycin (all reagents were
purchased from Life Technologies). The cells were passaged regularly using 0.25 % trypsin
(Invitrogen) and incubated at 37 ºC, 5 % CO2, and 80 % relative humidity. Before each experiment
cells were grown to a confluent monolayer.
Dose Response Curve (IC50)/ Cell Viability
BEAS-2B were seeded in a 12 well plate (Falcon) at a density of 2.0x105 cells/ml. After
24 h, the cells were exposed to PLACC900 from 0-750 µg/ml, with the doses obtained by serial
dilutions. For this, samples were first sonicated for 8-10 min in media by using a bath sonicator
(Branson). After 24 h of exposure to PLACC900, the cells were trypsinized and stained with 0.4%
trypan blue solution (Invitrogen). Subsequently, 10 µl of the sample containing the stained cells
was added to a hemocytometer (Hausser Scientific), and the number of cells in the 4 outer grids
was counted through use of the Leica DM IL optical microscope (Leica Microsystems) using a
10X objective. OriginPro (OriginLab Corporation) software was used to determine the IC50 value
via fit with a sigmoidal curve.
In another assay, BEAS-2B were seeded in a 96 well plate (CellTreat Scientific Products)
at a density of 2.0x105 cells/ml. After 24 h, the cells were exposed to PLACC900 at 100, 300, and
500 µg/ml dispersed in media following 8-10 min sonication. Cells in only media served as
controls. The 4-[3-(4-Idophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate
known as WST-1 assay (Roche, USA) was used to determine cellular metabolic activity since it is
known that changes in color of such reagent are produced when cellular dehydrogenases of
metabolically active cells reduce it to formazan.54 Twenty four, 48, and 72 h post exposure to
PLACC900, 10 µl of WST was added to the wells. Cells (exposed and control) were incubated for
2 h and absorbance was read at 485 nm using a FLUOstar OPTIMA plate reader (BMG
LABTECH). Media and PLACC900 byproduct dispersed in media served as blanks with their
absorbance values being subtracted from the cellular measurements counterparts.
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Extracellular Reactive Oxygen Species (ROS)
BEAS-2B were seeded in a 12 well plate at a density of 1.5x105 cells/ml. After 24 h, the
cells were exposed to 100 or 300 µg/ml of PLACC900 dispersed in media as previously described.
After 24, 48, and 72 h of exposure, 50 µl of media from each treatment was transferred to a blackbottomed 96 well plate (Corning, Inc.). Subsequently, 50 µl of PBS and 50 µl of Lumigen ECL
Plus (Lumigen, Inc.) were added to each well, and the samples were incubated for 5 min in the
dark. Luminescence was read at 600 nm via the FLUOstar OPTIMA plate reader. Media as well
as PLACC900 dispersed in media, at each dose, served as blanks. Extracellular reactive oxygen
species (ROS) was calculated by subtracting PLACC900 luminescence (determined via
subtraction of media from the PLACC900+media blanks) from the respective cellular
measurements.
Cellular Imaging
BEAS-2B were seeded on glass coverslips (15 mm diameter; Fisher Scientific) in a 12 well
plate at a density of 1.5x105 cells/ml overnight. The cells were subsequently exposed to 100, 300,
or 500 µg/ml PLACC900 dispersed in media as previously described. After 24 h, the media was
removed and the cells were washed two times with Hank’s Balanced Salt Solution (HBSS)
(Corning, Inc.), fixed with 4% formaldehyde (Sigma-Aldrich) for 15 min and at 37 ºC, and
subsequently washed 3 more times with HBSS to remove any remaining formaldehyde. The cells’
plasma membranes and nuclei were then stained with 3 µg/ml Alexa Fluor 594 wheat germ
agglutinin (WGA) and 2 µM Hoechst 33342 (Image-iT LIVE Plasma Membrane and Nuclear
Labeling Kit, Life Technologies), respectively, both dispersed in HBSS, for 10 min and at 4 ºC.
After incubation, cells were washed 2 times with HBSS, the cover slides were mounted on glass
coverslips, and imaged under a Nikon Inverted Microscope Eclipse Ti Series (Nikon) and a 40X
objective. The NIS-Elements BR 3.1 software was used to analyze the size and morphology of the
cells.
Electrical Cell-substrate Impedance Testing
Real-time measurements of BEAS-2B cellular resistance during and after exposure with
PLACC900 were performed using an electrical cell-substrate impedance sensing instrument
(ECIS-ZΘ, Applied Biophysics, NY). For such cellular studies, a 96 well plate (96W10idf) that
contained inter-digitated finger connection electrodes covering an area of about 4 mm2 of each
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well were used. Before addition of the cells, the electrodes were stabilized for 2 h with 200 µl of
media to minimize any drift during the experiment.
For exposure, BEAS-2B were seeded on the ECIS electrodes at a density of 2.0x105
cells/ml in a volume of 150 µl/well. After 24 h, the cells were exposed to 100, 300, or 500 µg/ml
of PLACC900, dispersed in media; cells in media served as controls. The resistance of the cells
was monitored continuously for 72 h. The recovery of the cells was also monitored for 72 h. For
this, parallel experiments were performed in which, after 24, 48, and 72 h of exposure, the cells
were trypsinized and counted so that 1.0x105 cells/ml could be added to its respective ECIS well
at a volume of 150 µl/well.
Cell Cycle
BEAS-2B were seeded in a 6 well plate (Corning, Inc.) at a density of 2.5x105 cells/ml;
cells in media served as controls. After 24 h, the cells were exposed to 1-100 µg/ml (1, 10, 25, 50,
and 100 µg/ml) of PLACC900 dispersed in media as previously described. After 24 h, the cells
were washed 2 times with PBS, trypsinized, pelleted, and washed again. The cells were then
resuspended and fixed with 70 % ethanol overnight at -20 ºC. Subsequently, the cells were pelleted
and the ethanol decanted. The cells were once again washed and resuspended in 0.2% Tween 20
(Fisher Scientific) for 15 min at 37 ºC. In another step, PBS was added and the cells were pelleted
and resuspended in 180 µg/ml Ribonuclease A-PBS (Sigma-Aldrich) for 15 min at room
temperature. Finally, the DNA of the cells was stained via a 15 min incubation with 75 µg/ml
propidium iodide solution (Sigma-Aldrich) at room temperature. After incubation, the volume was
brought up with 300 µl of PBS. The cells’ DNA content was then analyzed via the BD LSRFortessa
(BD Biosciences) and BDFACSDiva 8.0 software and knowing that the amount of DNA will
double in the G2 phase when compared with S phase of the cell cycle. There were 20,000 events
contained in the gated area of the live cell population per sample (formed via forward scatter and
side scatter) used for analysis.
Statistical Analyses
All cellular experiments were repeated at least 4 times for all samples, with the exception
of cellular imaging which was repeated 3 times. All tables are presented as the average value with
(+/-) SD values. All graphs are presented as the mean value of the number of indicated replicates
with (+/-) SE bars. Significance was determined by one- or two-way analysis of variance ANOVA
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with p<0.05* indicating significance. OriginPro software was used for determination of the IC50
value for PLACC900 by using a sigmoidal dose response fit on the average of the 5 replicates.

Results and Discussion
Considering that nanocomposites (or nanoclay melt-mixed within polymers) have seen
increased implementation in food packaging,55,56 with such products being disposed by
incineration because of their energetic costs reduction and cost recovery,11,57 we aimed to design
a platform for meaningful assessment of possible toxicity profiles. The need for toxicity studies is
driven by the recent reports that show that nanoparticles resulted from incineration have the
potential to escape filters in disposal areas42,58 and induce toxic effects on lung cells40,41 of the
workers present in such environments. However, no reports assess human exposures in such areas.
To demonstrate the feasibility of the designed platform, we used a model polylactic acid
(PLA)-based nanocomposite since PLA has seen a high consumer implementation in the food
packaging industry59,60 due to its known “green polymer” characteristics and granted approval by
the Food and Drug Administration.32,61 In the first part of the assessment strategy, we evaluated
the materials’ and byproduct resulting from incineration characteristics, while in the second we
assessed any induced deleterious effects of such byproducts on model human lung cells and
correlated any toxicological mechanistic profiles with the starting material or resulting byproducts
physico-chemical characteristics.
Materials Characterization
We first created the PLA-based nanocomposite (PLACC) by melt mixing Cloisite 30B
(CC) into PLA.62-65 Films formed from solely PLA served as controls. Consideration was given
to CC as a model nanoclay because of its good miscibility in PLA,4 large consumer
implementation,66,67 and the available reports on its toxicity on systems such as liver,68 colon,69
and lung,40 where it has shown both reductions in proliferation and viability,40,68,69 as well as
cellular membrane damages,68 changes in cellular morphology,40 and increased reactive oxygen
species (ROS) generation.70
We then aimed to mimic the route of disposal by incineration of such nanocomposites using
conditions encountered in MSW plants.42 Specifically for this, we thermally degraded both
PLACC and the PLA control films under temperatures ranging from 25 to 950 ºC and then
evaluated the resulting moisture, volatile, and ash contents. As expected, no ash was obtained upon
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PLA films incineration, indicating complete degradation of the polymer (Table S1). However,
PLACC had around 4 % of its weight remaining as ash, likely due to CC, which was added at 5
wt. %. Additionally, PLACC had a significantly lower amount of volatile content relative to PLA,
again, presumably due to the presence of such nanoclay. Such results are supported by Koh et al.
who also showed byproduct formation after degradation at up to 700 ºC of PLA containing either
Cloisite 15A or Cloisite 20A respectively.71 However, the ash content identified in our study was
larger when compared to the previous one, most likely because of a more prominent char resistance
of the CC relative to the other nanoclays71 as dictated by their different thermal stability as resulting
from their respective organic modifier composition (i.e. amount of volatile compounds present)
and the wt. % in which the organic modifier was added to them.41 Specifically the organic
modifiers for Cloisite 15A or 20A respectively are made up of 2 tallow groups when compared to
CC which is made up of only one tallow group (Scheme S1).71
Based on our analysis, both PLA and PLACC lost the majority of their weight in the range
of 300-600 ºC, with PLACC showing a slightly slower degradation rate relative to control PLA
(Figure 1a). Overall, the differences in degradation rate and onset degradation temperature were
fairly minimal between PLA and PLACC, showing that the addition of CC did not appear to
significantly influence PLA’s thermal stability. It is known that thermal stability of
nanocomposites is generally dependent on the degree of dispersion and wt. % of the nanoclays,
with a well exfoliated nanocomposite displaying increased stability.72,73 This is presumably due to
the thermal stability of inorganic materials,71 their interactions with the polymer substrate that
allow for the formation of char by hindering the release of volatile products,71,73,74 or/and to the
nanoclays themselves which could potentially be creating a protective barrier when on the surface
of the nanocomposite.72
The nanocomposites, control films, and their byproducts resulting from incineration were
subsequently investigated for their chemical (elemental and molecular compositions) and physical
(morphology, mechanical and optical properties, crystallinity and degree of exfoliation of CC in
PLA, and hydrodynamic diffusion versus projected area of byproducts, respectively)
characteristics.
For chemical characteristics specifically, the elemental composition of PLA, PLACC, and
PLACC900 was determined by energy dispersive X-ray (EDX) spectroscopy. Analysis confirmed
the presence of carbon and oxygen as the majority of the elements for PLA (Figure 1b), as well as
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a significant decrease in carbon content and increase in oxygen and silicon contents respectively
in the PLACC nanocomposite presumably resulting from the incorporation of the CC.14 Upon
thermal degradation, the amount of carbon was significantly decreased, confirming the loss of
PLA.75 Additionally, PLACC900 had a significantly higher amount of oxygen, magnesium,
aluminum, silicon, and iron, all relative to PLACC with such elements being associated with the
presence of the nanoclay itself,14,76 thus signifying that the ash content was made up mostly of the
nanoclay byproduct.

(a)

(b)
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(c)

Figure 1: (a) Thermal degradation profile of PLA and PLACC as determined by TGA (n=2).
Chemical characteristics analysis. (b) Elemental composition of PLA, PLACC, and PLACC900 as
determined by EDX (n=5). The symbol * and ~ indicate significant differences between PLA and
PLACC and between PLACC and its incinerated byproduct, PLACC900, respectively. (c) FTIR
spectra for PLA, PLACC, and PLACC900 (n=2).

Molecular composition of the nanocomposites, PLA control films, and PLACC900 was
determined by Fourier Transform Infrared Spectroscopy (FTIR). PLA and PLACC both displayed
similar spectra (Figure 1c), as previously reported for PLA itself.21,77-79 Specifically, both PLA and
PLACC displayed peaks at 1267, 1181, 1090, and 1045 cm-1, indicative of -C-O- stretching77,78
and at 1454, 1384, and 1362 cm-1, indicative of symmetric and asymmetric deformational
vibrations of C-H present in the CH3 groups of the PLA respectively.21,77-79 Additionally, the peaks
present at 2995 and 2944 cm-1 and 1747 cm-1 were indicative of -CH-

77-79

and C=O

stretching,21,78,79 respectively. Finally, the peak at 871 cm-1 was presumably due to -C-C bond
formation.77,78 Peaks specific for CC did not show up in PLACC likely due to the low concentration
at which this nanoclay was added when the nanocomposite was formed. Similar results were
obtained by Moo-Espinosa et al., when CC was exfoliated into segmented polyurethanes at
concentrations of 2, 6, or 10 wt. %.80
All of the peaks associated with PLA were no longer present for the byproduct,
PLACC900, confirming the degradation of the polymer upon nanocomposite’s incineration. The
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only 2 peaks remaining for PLACC900 were associated with Si-O-Si stretching vibration of
silicate as indicated by the peak around 1000 cm-1,46,81 and Si-O indicated by the peak observed
around 780 cm-1.82 Along with the loss of polymer, the nanoclay itself also lost its organic modifier
as confirmed by the absence of peaks at 2920, 2850, and 720 cm-1.46,81-83 Further, the loss of the
alumino-silicate lattice normally displayed by MMT was confirmed by the loss of peaks associated
with Al-OH-Al deformation (900 cm-1)46,81 and OH respectively which was previously linked to
Al3- and Mg2- (840 cm-1) (Figure S1a).82
For physical characteristics we considered that thermal degradation led to an ash
byproduct, as such we only investigated the crystallinity of PLA and PLACC, as well as the degree
of exfoliation of CC within the polymer, by using X-ray diffraction (XRD) in the 2θ ranges of 580 º and 1-10 º, respectively. In the context of our goal to design a platform for meaningful
assessment of toxicity, crystallinity was to be evaluated since it has been previously shown to
influence toxicity,84-86 with crystalline materials being known to produce more oxidant species
with pronounced deleterious cellular effects.84,86 Also, exfoliation of nanoparticles has previously
shown to influence toxicity, with studies showing that toxicity generally decreased when
nanoparticles were properly exfoliated versus when they were in agglomerate forms. 87,88 Further,
both crystallinity and exfoliation have been shown to influence degradation of materials, 65,88,89
which in itself could potentially cause for a differential influence in deleterious effects.90
Our analysis showed that in the 2θ range of 5-80 º, both PLA and PLACC displayed broad
peaks around 15.4 and 18.1 º, respectively (Figure S2a), which are characteristic of neat PLA 91
thus confirming the amorphous structure and low crystallinity of the samples80,92 likely induced
by the high cooling rates used during the molding process of the polymer.93
No peaks were observed for PLA in the 1 to 10 º 2θ range which was in contrast with CC
and PLACC which both displayed peaks within that range (Figure S2b). Specifically, CC displayed
a peak at around 4.8 º, presumably indicating a basal spacing of 1.85 nm.94 This peak was also
present for PLACC, however at a lower intensity, presumably demonstrating that a small amount
of the nanoclays were likely agglomerated within the polymer matrix.12 Additionally, PLACC
displayed peaks at smaller angles, i.e., around 1.8 º (basal spacing of 4.92 nm) and 2.5 º (basal
spacing of 3.54 nm) respectively, presumably due to the penetration of the polymer chains between
the nanoclay platelets and thus resulting in increased basal spacing to confirm intercalation or
exfoliation of the nanoclay within the PLA.12,95-97
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The CC did not seem to be completely surface exfoliated within PLA,97 as confirmed by
surface morphology analysis performed by scanning electron microscopy (SEM). Specifically,
results showed that PLACC displayed a slightly rougher morphology relative to PLA used as
control (Figure 2a,b). Complementary, upon nanocomposites degradation, the PLACC900
displayed generally two types of morphologies, namely one with a fragmented surface with
platelets jutting out, and a second one with a porous conformation (Figure 2c,d). Such different
morphologies may be due to differential distribution and degrading of the nanoclay within the
polymer matrix, interactions of the nanoclay with the polymer, and/or the different exfoliation
noted. Degree of dispersion can be controlled in the future by manufacturing parameters, such as,
temperature,98 time,22 and feed rate.99 Previous results by Stueckle et al., showed a porous
morphology if only CC was degraded, with the degraded CC’s (CC900) morphological changes
being attributed to the interactions of the organic modifier with Si-O and Al-O bonds in the pristine
clay and an increase in basal spacing of the nanoclay.52 The porous morphology of the degraded
nanocomposite, PLACC900, could also be attributed to the polymer increasing the basal spacing
between CC, with the fragmented morphology potentially due to agglomerated CC. Indeed, our
control experiments of thermally degraded CC (CC900) showed that the main difference between
the thermally degraded nanocomposite (PLACC900) and CC900 respectively, appeared to be
related to the physical properties and not changes in the elemental or molecular properties of the
two samples (Figure S1).
Additional physical characterizations of transparency and UV dispersion of PLA and
PLACC provided further insights into the exfoliation of CC into PLA. Both means of
characterizations have previously been shown to be contributing to overall samples’ physical
characterization and implementation as they allow for a consumer “to see the product” and for the
blocking of light/UV transmission to increase product’s shelf life100 by reduction in the UV driven
lipid oxidation and discoloration.101 Analysis showed that PLA and PLACC displayed similar
absorbance spectra with peaks around 245 and 270 nm, respectively (Figure S3a). PLACC also
had a significantly higher transparency than PLA (Table S2) which could indicate a better
orientation of the PLA upon addition of CC in the nanocomposite volume12,102 since previous
analysis showed that cast control films typically have a low degree of crystallinity and transparent
appearance due to the rapid cooling.75 Complementary, both PLA and PLACC generally displayed
good UV dispersion properties with around 4 and 3 % transmittance, respectively. The slight
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decrease in PLACC’s UV dispersion relative to PLA was most likely due to the presence of the
nanoclays which are known to enhance the scattering of the UV light. 103 Additionally, upon
incorporation of CC, PLACC displayed a color change (to a brown color, Figure S3b,c), further
known to be preferable for preventing UV transmission in food packaging.104

Figure 2: Surface morphology of (a) PLA, (b) PLACC, and (c), (d) the two morphologies
displayed by PLACC900 as determined by SEM.

Mechanical properties analysis of the nanocomposite showed that PLACC had a
significantly higher Young’s Modulus relative to PLA films, thus indicating that CC interacted
with the polymer within the volume of the nanocomposite (Table S3).72 However, both elongation
and tensile strength were lower for the nanocomposites when compared to control, presumably
due to an uneven dispersion of CC105 and resulting reduction in strength.106 Further, such
agglomerated nanoclays cause poor interfacial bonding, leading to the formation of
microcracks,105,107 as well as lower plasticity.108
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Lastly, the hydrodynamic diffusion versus projected area of byproducts was evaluated via
dynamic light scattering (DLS) since previous analysis have showed that the size of a particle
could influence its toxicity109 and internalization profiles.109 Specifically, spherical particles less
than 10 µm can be inhaled110,111 with particles smaller than 2.5 µm potentially reaching the
alveoli.110 Further, particles of up to 25 µm in diameter were shown to be deposited in ciliated
airways if they had a platelet like morphology and a thickness of less than 0.1 µm.112 Our analysis
showed that PLACC900 displayed size distributions in the micrometer range in both media and
control buffer, PBS (Figure S4). Specifically, 90 % of the particles were under 13 µm, with 50 %
of such particles being under 5 µm (Table S4) presumably due to the recorded loss of the organic
modifier from CC and the majority of the polymer matrix.41
Toxicity Evaluation
Thermally degraded PLACC byproduct (i.e., PLACC900) was exposed to model human
bronchial epithelial cells (BEAS-2B). BEAS-2B were chosen for inhalation toxicity assessment
due to their ease of handling and previous feasibility studies.113-116
A dose response curve was initially performed to identify the PLACC900 concentrations
that would create a differential effect on the cell viability. Specifically, cells were exposed to doses
of 0.1, 1, 50, 100, 250, 300, 500, and 750 µg/ml for 24 h (Figure 3a). The large number of doses
was chosen to mimic what a worker might inhale in areas of disposal, where it is known that
concentrations could vary based on the point of emission, time of day, the amount and
incorporation of the nanoparticle in the material being disposed, and the amount of the material
being disposed, respectively.43,117,118 Additionally, such doses represent different working
lifetimes by taking into account total work hours, and particle and lung characteristics of the
worker.119
Analysis showed that the IC50 value (i.e., concentration of PLACC900 required to inhibit
cell growth by 50%) of PLACC900 was 435 µg/ml. No significant decrease in cell viability was
observed for cells exposed to 100 µg/ml (below IC50) over the 72 h (Figure 3b). However, after 24
h of exposure a significant decrease in cellular viability (around 20 and 50 %) was observed for
cells exposed to PLACC900 at 300 and 500 µg/ml, respectively. This effect continued for BEAS2B exposed to 500 µg/ml PLACC900 throughout the 72 h of exposure. When examining the effect
of doses under the IC50 value of PLACC900 over time on cellular proliferation, there were not any
significant decreases even after 72 h of exposure (Figure S5).
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(a)

(b)

(c)

Figure 3: (a) Dose response curve (based on live cell counts) for BEAS-2B cells exposed to
PLACC900 from 0-750 µg/ml (n=5). (b) Cellular viability (based on WST assay) for cells exposed
to PLACC900 (n=6). The symbol * indicates a significant difference between the control cells and
exposed cells. The values are normalized relative to the controls. (c) Extracellular ROS of cells
exposed to varying doses of PLACC900 (n=4). The symbol * indicates a significant difference
between the control cells and exposed cells.
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The decrease in cellular viability could be due to the accumulation of reactive oxygen
species (ROS) and the effects that such accumulation could induce on the cells.120 In particular,
previous studies have showed that CC by itself could induce internal ROS70 to lead to cellular
membrane damage and cell morphology changes from an oval to a more circular profile.121,122 Our
results showed that the cells exposed to 300 µg/ml PLACC900 had a significant decrease in
external ROS after 72 h of exposure, indicating that ROS may be building up within individual
cells,120 to potentially cause damage to internal organelles or cell membrane and shape46 (Figure
3c). The observed error bars are attributed to the byproducts interaction with the reagent 123 or to
the variability in the surface morphology of the byproduct (Figure S6).38
Cellular imaging complemented the above results showing a dose-dependent behavior for
cells exposed to PLACC900 at 100, 300, and 500 µg/ml over a 24 h period (Figure 4a-d). Analysis
showed that at 24 h of exposure, the control and cells exposed to 100 µg/ml displayed a confluent
monolayer with oval cells. However, the cells were no longer confluent upon exposure to doses of
300 µg/ml and higher. Further, the cells seemed to assume irregular shapes, with stretched or
circular profiles being noted. Cells exposed to 500 µg/ml PLACC900 displayed the greatest loss
in cell monolayer.
The observed change in shape as well as the loss of the cellular monolayer and buildup of
ROS could indicate that cells may have begun to lose their ability to attach to substrates, as well
as to other cells, two mechanisms hinting at deleterious effects and potential toxicity121,122,124,125 of
the byproducts. Indeed, our electrical cell-substrate impedance sensing (ECIS) analysis indicated
that cells exposed to PLACC900 at 100, 300, and 500 µg/ml and subsequently monitored for 72 h
(Figure 5a) had changes in their resistance pathways which were both time and dose dependent.
ECIS is known to monitor changes in cell-cell and cell-substrate interactions, cell morphology,
and coverage in real time,126,127 with such changes being quantitatively analyzed, at a nanoscale
resolution, and in a non-invasive,123,128 and high-throughput manner.126,127,129,130 Specifically,
while cells exposed to 100 µg/ml had very similar resistance values relative to the control over the
whole exposure time, cells exposed to 300 and 500 µg/ml of the byproducts displayed an initial
increase in resistance, with the increase being more dramatic and longer for the 500 µg/ml dose.
However, after 24 h, the resistances lowered with such drops in resistance complementing the
observed decreases in cell viability, proliferation, monolayer’s coverage and cell shape.126,127
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Figure 4: Fluorescent images of the cell membrane (red) and nucleus (blue) for (a) control cells
and cells exposed to PLACC900 at (b) 100 µg/ml, (c) 300 µg/ml, and (d) 500 µg/ml after 24 h.

The recovery of cells exposed to PLACC900 was also non-invasively monitored with only
100 and 300 µg/ml doses being used in order to allow for an adequate number of cells to be added
to the electrodes. Overall, the cells ability to recover was dose dependent. Specifically, analysis
showed that after 24 h of exposure to 100 and 300 µg/ml of PLACC900, the cells showed lower
resistance relative to the control (Figure 5b). However, cells exposed to 100 µg/ml PLACC900
had similar resistances to the control within 48 h of recovery, while cells exposed to 300 µg/ml
had similar resistances to the control within 60 h of recovery. After a 48 h exposure to PLACC900,
cells exposed to 100 µg/ml also had slightly lower resistance values relative to the control again
over the first 48 h of recovery, but eventually had the similar resistances to the control cells by 40
h of recovery (Figure 5c). Cells exposed to 300 µg/ml of PLACC900 had slightly lower resistances
relative to the control cells over the full 72 h of recovery. Finally, after 72 h of exposure to the
byproduct, cells exposed to 100 µg/ml had higher resistances relative to the control for the first 40
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h of recovery, while cells exposed to 300 µg/ml had lower resistances relative to the control over
the full 72 h of recovery (Figure 5d). Similarly, AshaRani et al. noted that cells exposed to 400
µg/ml of silver nanoparticles took a month to recover when compared to cells exposed to 100 or
200 µg/ml which were able to recover within 5 or 15 days, respectively.131
The ability of the cells to recover was also confirmed by cell cycle analysis (Figure 5e)
with analysis showing that there were no significant differences in cell cycle phases for G1, G2,
or S after exposure to any of the doses, all relative to the control cells. While previous studies have
shown genotoxic effects of nanoclays, ranging from DNA strand breaks68 to condensed
chromatin132 and micronuclei,133 as well as, changes in gene expression,133 the lack of cell cycle
arrest and normal progression through the cell cycle for cells exposed to PLACC900 hints at DNA
stability134 and lack of DNA damage135 at lower doses.

(a)

(b)
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(c)

(d)

(e)

Figure 5: (a) Representative real-time measurements of normalized resistance for BEAS-2B cells
before and during exposure to PLACC900 from 100-500 µg/ml. Representative real-time
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measurements of normalized resistance for the recovery of BEAS-2B cells over 72 h after exposure
to PLACC900 for (b) 24 h, (c) 48 h, and (d) 72 h. (e) Percentage of cells in the G1, G2, or S phase
of the cell cycle after exposure to 1-100 µg/ml PLACC900 (n=4).

The observed recovery after removal of the exposure could be attributed to a volume-based
dilution of the internalized byproducts and/or lower toxicity that such byproducts have. First,
previous analysis showed that internalized gold nanoparticles were devised between the surviving
cells to lead to a cell recovery profile dependent on the cell growth/division.136 However, in such
studies, the nanoparticles were around 45 and 13 nm.136 For the second, PLACC900 seems to be
following a similar toxicity profile to thermally degraded nanoclays which have previously been
shown to be less toxic relative to their as-received counterparts.40,41 Previous results showed wide
ranges in toxicity of nanoclays with IC50 values as low as around 1 µg/ml39 to more than 1000
µg/ml,137 generally with the organic modifier being the variant.39,68-70 In particular, thermally
degraded byproducts of one pristine and three organically modified nanoclays had higher IC 50s
relative to their as-received counterparts.41 Such lower toxicity was attributed to loss of the organic
modifier, along with changes in morphology, size, and molecular and elemental composition of
the byproduct itself. Additional changes may exist herein most likely due to morphology, size, or
potential entrapment of polymer species within the byproduct. For instance, while some of the
smaller PLACC900 particles may be internalized,138,139 larger particles could disrupt the
membrane and potentially cause damage88 due to their uneven, jagged profile (SEM),87,88 however
with such damage to be recovering in a time-dependent manner (real-time analysis). Additionally,
the variability observed in toxic effects may be due to the different surface morphologies and sizes
of the byproducts. Finally, PLACC900 itself may have effects similar to that of crystalline silica,
i.e., inflammation and collagen deposition, since it contains similar CC900 properties previously
shown to produce a low, persistent inflammation profile in mice.52
Our results indicate that while more information is required to determine mechanisms for
nanocomposites degradation and ultimately toxicity of its end of life cycle byproduct, proper
engineering control and protocols for workers in areas of disposal should be implemented to help
lessen deleterious inhalation exposure.
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Supporting Information

Chapter 4: Toxicity Assessment of Byproducts Resulted from Nanoclay Composite
Disposal by Incineration

Material and Methods
Nanocomposite Preparation
Polylactic acid 6752 (PLA) was melt-mixed with Cloisite 30B (CC) loaded at a 5 wt. %,
in a Thermo-Haake internal mixer operating at 200 ºC and 80 rpm for 5 min. Thin films were then
molded at 200 ºC using a compression press to form PLA-CC nanocomposites (PLACC), as well
as PLA films to be used as controls. Cloisite 30B was obtained from Southern Clay Products
(Gonzales, TX) and, per the manufacturer specifications, organically modified via an ion-exchange
reaction with methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium at a concentration of 90
meq/100 g clay.
Thermal Degradation of PLACC and CC
PLACC (1 g per sample) and CC (0.5 g per sample) were thermally degraded using a
TGA701 Thermogravimetric Analyzer (LECO). To determine the moisture content, the samples
were heated in nitrogen at a rate of 6 ºC/min and in a range of temperatures from 25 ºC to 105 ºC.
To determine the volatile content, the samples were heated from 105 ºC to 950 ºC also in nitrogen
and at a rate of 43 ºC/min. Finally, to determine the ash content, the samples were heated from 550
ºC to 900 ºC in oxygen, at a rate of 15 ºC/min.
Material Characterization of PLA, PLACC, and Associated Nanoclays or Byproducts
Molecular composition of CC, thermally degraded CC (CC900), and thermally degraded
PLACC (PLACC900) was determined using Fourier Transform Infrared Spectroscopy (FTIR,
Digilab FTS 7000) equipped with diamond Attenuated Total Reflection (ATR). Scans were
collected in the range of 4000-400 cm-1 at a resolution of 4 cm-1; a total of 100 scans were coadded to form the final spectrum for each of the samples. Elemental composition of PLACC900
and CC900 was investigated using a Hitachi S-4700 Field Emission Scanning Electron Microscope
(SEM, Hitachi High-Technologies Corporation) equipped with energy dispersive X-ray (EDX)
spectroscopy at 20.0 kV.
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The crystallinity of PLA and PLACC and the degree of exfoliation of CC in PLACC was
determined via X-ray diffraction (XRD). The PANalytical X’Pert Pro XRD was used to determine
crystallinity via a Cu-kα1 8047.2 eV source at 45 kV and 40 mA with a 10 sec/step in a 5-80 º 2θ
range. The Bruker D8 Discovery XRD was used to determine the degree of exfoliation; thin films
were mounted on the sample holder and diffraction was obtained in the 2θ range of 1-10 º at an
increment of 0.02 º and scan speed of 10 sec/step via a Cu-kα1 8047.2 eV source at 40 kV and 40
mA. Basal spacing was determined by Bragg’s equation
nλ=2dsinθ,
where n is an integer, λ is the wavelength of the X-ray radiation (0.1546 nm), d is the spacing
between lattice planes, and θ is the measured diffraction angle.
The absorption spectra for PLA and PLACC was determined in the range of 200-800 nm
via the Shimadzu UV-vis spectrophotometer (Shimadzu Scientific Instruments). UV barrier
properties of the film were determined by measuring transmission at 280 nm, and transparency of
the films was determined by measuring transmission at 660 nm, also via the Shimadzu UV-Vis
spectrophotometer.
The tensile strength, Young’s Modulus, and elongation at break for films of PLA and
PLACC were evaluated via the Instron E1000 (Instron Corporation) under a 2 kN load cell and
using the Bluehill 3 software. For this, rectangular films of PLA and PLACC, 5 mm in width x 32
mm in length x 0.3 mm in thickness, were placed in the Instron grips, and the experiments were
performed with a crosshead speed set at 5 mm/min. A specimen gauge length of about 25 mm was
used for each sample upon gripping in the crosshead.
The size distribution of PLACC900 was determined by dynamic light scattering (DLS)
via the Mastersizer 2000 with a Hydro 2000S accessory (Malvern Instruments). For this, solutions
of PLACC900 dispersed and bath sonicated in cell culture media (Dulbecco’s Modified Eagle
Medium: DMEM) containing 5% fetal bovine serum (FBS) or in phosphate buffered saline (PBS),
were dropped into the Hydro 2000S until laser obscuration was within 10-20 %. The size analysis
was performed 3 consecutive times with a stirrer speed of 1750 rpm and under continuous
sonication.
Cell Culture
Immortalized human bronchial epithelial cells (BEAS-2B) were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) containing 5% FBS, 1 % L-glutamine, and 1 % penicillin138

streptomycin (all reagents were purchased from Life Technologies). The cells were passaged
regularly using 0.25 % trypsin (Invitrogen) and incubated at 37 ºC, 5 % CO2, and 80 % relative
humidity. Before each experiment cells were grown to a confluent monolayer.
Live Cell Count
BEAS-2B were seeded in a 12 well plate (Falcon) at a density of 2.0x105 cells/ml. After
24 h, the cells were exposed to PLACC900 at 100 and 300 µg/ml, which were first sonicated for
8-10 min in media via a bath sonicator (Branson). Cells in only media served as controls. Twenty
four, 48, and 72 h post exposure to PLACC900 the cells were trypsinized and stained with 0.4%
trypan blue solution. Subsequently, 10 µl of the sample containing the stained cells was added to
a hemocytometer, and the number of cells in the 4 outer grids were counted through use of the
Leica DM IL optical microscope using a 10X objective.
Reactive Oxygen Species (ROS) Generation of PLACC900
PLACC900 was dispersed in media via a bath sonicator at doses of 100 and 300 µg/ml.
The solutions were then placed in a 12 well plate with media only serving as the control. After 24,
48, and 72 h of incubation at 37 ºC, 5 % CO2, and 80 % relative humidity, 50 µl of the
PLACC900+media from each dose (and media only as control) was transferred to a blackbottomed 96 well plate. Subsequently, 50 µl of PBS and 50 µl of Lumigen ECL Plus (Lumigen,
Inc.) were added to each well, and the samples were incubated for 5 min in the dark. Luminescence
was read at 600 nm via the FLUOstar OPTIMA plate reader.

Scheme S1: Organic modifier of CC; methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium.
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Results

Table S1: The amount of moisture, volatile, and ash present in PLA and PLACC as determined
by TGA. The symbol * indicates a significant difference between PLA and PLACC (n=4).
Moisture

Volatile

Ash

PLA

0.49 +/- 0.18

99.70 +/- 0.27

0 +/- 0

PLACC

0.60 +/- 0.17

95.37 +/- 0.43*

3.92 +/- 0.10*

Table S2: UV dispersion (determined by Transmittance at 280 nm (T280nm)) and Transparency
(determined by Transmittance at 660 nm (T660nm)) of PLA and PLACC. The symbol * indicates a
significant difference between PLA and PLACC (n=5).
T280nm

T660nm

PLA

3.85 +/- 0.12

4.88 +/- 0.08

PLACC

3.35 +/- 0.21*

7.11 +/- 0.20*

Table S3: Mechanical properties of PLA and PLACC as determined via the Instron. The symbol
* indicates a significant difference between PLA and PLACC (n=5).
Tensile Strength (MPa)
81.2 +/- 19.0
PLA
PLACC 66.8 +/- 22.3

Elongation at Break (mm) Young's Modulus (MPa)
0.436 +/- 0.093
9291.3 +/- 850.9
0.270 +/- 0.053*
11055.8 +/- 1517.6*

Table S4: Average particle size distributions (µm) of PLACC900 in cellular media and control
buffer, PBS (n=3).

<10%
<50%
<90%

PBS
3.00 +/- 0.01
4.57 +/- 0.01
12.67 +/- 0.03

Media
3.12 +/- 0.08
4.84 +/- 0.29
12.14 +/- 1.14
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(a)

(b)

Figure S1: (a) FTIR spectra for CC, CC900, and PLACC900 (n=2). (b) Elemental composition of
PLACC900 and CC900 as determined by EDX (n=5).
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(a)

(b)

Figure S2: Physical characteristics analysis. (a) Crystallinity of PLA and PLACC as determined
via XRD. (b) Exfoliation of CC in PLACC as determined via XRD.
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Figure S3: (a) Absorbance spectra for PLA and PLACC from 200-800 nm (n=3). Representative
films of (b) PLA and (c) PLACC.
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Figure S4: Average particle diameter size distribution of PLACC900 in cellular media or control
buffer, PBS (n=3).

Figure S5: Live cell count of BEAS-2B cells exposed to PLACC900 over 72 h (n=6).
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Figure S6: ROS generation of PLACC900 at varying doses in DMEM (n=6). The symbol *
indicates a significant difference between the control and PLACC900.
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CONCLUSIONS
The analysis performed in this thesis showed that nanoclays, throughout their life cycle,
induced toxic responses upon exposure to lung epithelial cell lines, with such analysis hinting at
nanoclay’s potential to induce toxicity when inhaled. The effects were more pronounced on small
airway epithelial cells (SAECs) than on immortalized human bronchial epithelial (BEAS-2B) cells
since the primary cell lines more closely mimic their tissue of origin. Moreover, our analysis
showed that a model nanocomposite formed upon incorporation of the nanoclays into a
biodegradable polymer, polylactic acid, influenced material’s properties throughout its life cycle,
its degradation, and ultimately toxicity. In such studies, general toxicological profiles included
decreases in viability and proliferation of the exposed cells, as well as changes in cellular
morphology, mitochondrial activity, cellular attachment, and membrane integrity. The differences
in toxicity were correlated to the physical and chemical properties of the nanoclays or
nanocomposites and how such changes were influenced by the life cycle. Such differences were
analyzed and validated through both single point as well as real-time assays.
More specifically, our studies were the first to show that thermally degraded nanoclays,
used to mimic the end of life cycle or the disposal stage of nanoclay systems, had different
toxicological profiles relative to their as-received counterparts, used to mimic the manufacturing
stage of the nanoclay systems’ life cycle. Specifically, the thermally degraded nanoclays generally
showed a lower degree of toxicity relative to their as-received counterparts; this was presumably
due to changes in their physical and chemical properties upon degradation.
Moreover, our studies also showed that organically modified nanoclays generally induced
higher degrees of toxicity in lung cells relative to pristine (non-modified) nanoclays. Further, the
degree of toxicity of organically modified nanoclays was dependent not only on the presence of
the organic modifier, but also on the composition of the modifier, with the organic modifier
directly and indirectly contributing to toxicity via its composition. Briefly, organic modifiers with
bio-reactive groups (i.e. hydroxyls and amines) showed a greater degree of toxicity relative to
organic modifiers with long carbon chains. No large differences in toxicity (or chemical properties)
were however displayed by the organically modified nanoclays’ thermally degraded byproducts,
further verifying the large role the organic modifier plays towards contributing to physical and
chemical properties and ultimately toxicity of nanoclays.
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Complementary, the thermally degraded nanoclays showed lower degrees of toxicity due
to the loss of their aluminosilicate lattice and platelet-like morphology. Further, the thermally
degraded nanoclays no longer had silanol groups present presumably leading to lower membrane
disruptions and reactive oxygen species generation when compared with as-received samples.
Based on our results, detection and mitigation strategies should be implemented in
nanoclay/nanocomposite manufacturing and disposal areas to minimize worker inhalation hazards.
Specifically, further investigations into the amount and sizes of particles workers are being
exposed to should be performed and used to help set up proper occupational exposure limits and
protection equipment that allows for the filtering of nanoparticles of certain sizes. Further,
engineering controls such as better ventilation and encasing appropriate release areas of process
equipment used in nanocomposite manufacturing should be implemented. Finally, with such
toxicity information, safe-by-design manufacturing can be implemented. For instance, nanoclays
functionalized with modifiers containing long carbon chains instead of bio-reactive groups can be
used in the manufacturing of nanocomposites to help make safe, yet still effective products. Also,
further investigations into the manufacturing parameters that influence nanoclay exfoliation within
a polymer, such as temperature, processing time, and processing conditions can be performed to
help decrease the toxicity of nanocomposites in addition to building a more effective product.
With a combinatorial approach of lessening nanoclay exposure and designing safer products with
an understanding of both material properties along with toxicity, the effects of these systems
throughout their life cycle can be minimized.
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